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SUMMARY
This thesis addresses the issue of automated evaluation of severity of illness in psychiatric
populations. In particular, given that both physiology and locomotor activity have been
shown to be modified during mental illness, this work analyses the potential for the use
of these measures to assess the discrimination of mental illness using supervised learning
algorithms. In particular it examines the discriminatory power of information in heart rate
time series and locomotor activity in three ways: 1) using multiple time scales (from minutes
to several days), 2) during specific times (as a proxy for context) and 3) using interactions
between locomotor and physiological time series.
This thesis is comprised of four parts: 1) a review of past work, 2) classification of mental
illness using features from quiescent segments of HR, 3) classification of mental illness using
features from both heart rate and locomotor activity time series over varying time scales,
and 4) evaluation of coupling and interactions between heart rate and activity as features
for classifying illness.
In Part 1), the body of work upon which this thesis builds is summarized in a review of
digital sensors for neuropsychiatric illness. First, the two specific mental illnesses of focus are
discussed: schizophrenia and PTSD. Heart rate variability (HRV) and locomotor activity,
as well as relevant metrics and features therein are reviewed. The growing literature on
digital sensors for monitoring neuropsychiatric illnesses is surveyed, with a focus on passive
monitoring and analyses of HR and locomotor activity, feature extraction, and classification
or regression of clinically relevant outcomes. In Part 2), features from heart rate time series
data are used to train a classifier to distinguish post-traumatic stress disorder from controls
subjects. This work explores the hypothesis that data from quiescent (low activity) segments
will be more useful for discrimination than data from other segments during the 24-hour
recording. This is driven by the knowledge that sleep minimizes exogenous sources of HRV,
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such as social routine and physical activity. Dysautonomia detectable via alterations in HRV
measures such as LF and HF power may thus be amplified during these quiescent segments.
Classification is shown to be improved by segmenting the data using low heart rate segments
as a proxy for the most restful period of sleep.
In Part 3), the work explores the hypothesis that information relevant to pathologically
altered physiology and behavior varies with time scale. Features from both heart rate and
locomotor activity data recorded over several days are used to train a classifier to distinguish
subjects with schizophrenia from healthy controls. The time scale (e.g. window length) of
data is varied and found to affect classifier performance, which has a direct relevance to the
practical usage of the classifier.
In Part 4), the work explores the hypothesis that information between signals is altered in
mental illness and relatively less altered in cardiovascular illness, and that this information
is useful in a machine learning approach to discriminate patients from controls. Interac-
tions between heart rate and locomotor activity are evaluated using information theoretical
approaches, and found to contribute significantly to the classification of schizophrenia over
combining univariate approaches, and differently to the classification of mental versus car-
diovascular illness.
In summary, this thesis demonstrates that physiological data and locomotor activity
data, over multiple time scales, independently provide discriminatory power in evaluating
psychiatric conditions. Furthermore, the interaction between the two domains (movement





Neuropsychiatric illness comprises 13-16% of the total global burden of disease measured in
disability life-adjusted years (DALYs) for all ages, which exceeds the burden of cardiovascular
disease or cancer (Vigo et al. 2016). One in four people in the world will be affected by
mental or neurological disorders at some point in their lives, yet only a small fraction of the
450 million people affected will receive treatment due to pervasive underdiagnosis, a lack of
trained healthcare professionals, stigma, and other reasons (Sayers 2001). These illnesses are
more prevalent among older people and will contribute even more to overall global disease
as life expectancy improves. The burden of mental and substance use disorders increased
by 37% between 1990 and 2010, which for most disorders was driven by population growth
and aging (Whiteford et al. 2013). The prevalence of dementia continues to rise, and by
2050 an estimated 13.8 million Americans will have Alzheimer’s disease (AD; see A1 for
definitions of abbreviations and acronyms used in this thesis) or another dementia. In 2016
in the United States, total payments for healthcare, long-term care, and hospice services for
people 65 years or older with dementia were estimated to be $230.1 billion, and caregivers
provided 18.2 billion hours of unpaid assistance (Alzheimer’s Association 2016). The lack of
effective interventions for neuropsychiatric illness is partially due to limited understanding
of underlying mechanisms, but also due to under-distribution of medications and human
resources in low- and middle-income countries, in which disease burden measured in DALYs
is disproportionately high (Collins et al. 2011).
Autonomic nervous system (ANS) dysfunction occurs in neuropsychiatric illness, result-
ing in dysregulated heart rate (HR), heart rate variability (HRV), galvanic skin response,
skin conductance and temperature, and respiratory rate (Draghici et al. 2016; Karemaker
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2017). Due to the prevalence of HR sensors in wearable devices, and a substantial amount
of literature exploring HRV measurements as markers of ANS modulation, we review studies
that utilize HR and HRV measurements. Note HRV is not one metric; rather, it encompasses
several types of metrics such as time domain (Stein et al. 1994; Kleiger et al. 2005; Bauer
et al. 2006b), frequency domain (Akselrod et al. 1981; Montano et al. 2009), and complexity
measures such as entropy (Costa et al. 2002). Changes in these metrics have been reported
in patients with stress (Thayer et al. 2012), major depressive disorder (MDD; Kemp et al.
2010), bipolar disorder (BD; Henry et al. 2010), schizophrenia (Chang et al. 2009), post
traumatic stress disorder (PTSD; Liddell et al. 2016), Alzheimer’s disease (Femminella et al.
2014) and Parkinson’s disease (PD; Maetzler et al. 2013).
Neuropsychiatric illness is also associated with alterations in behavior, especially physical
movements and social routine. Patients with MDD, BD, or schizophrenia can be significantly
more sedentary than age- and gender-matched healthy controls (Vancampfort et al. 2017).
Diminished motor function, the presence of tremor, and coordination issues also occur in
movement disorders such as Parkinson’s disease. On the other hand, locomotor agitation
can be a sign of mania or psychosis which may be part of the presentation of schizophre-
nia or BD. These abnormalities are detectable by smartphones and wearable devices with
accelerometers or global positioning system (GPS) sensors. Modern smartphones and most
wearables marketed to consumers for fitness purposes have accelerometers and have been
explored in literature on sensing for healthcare. Behavior can also be inferred from social
activity data, such as phone calls, text messages, social media use, and web browser history.
Importantly, passive monitoring via digital sensors can yield information about a patient’s
physiology and behavior in the 99% of the time they are not seeing a clinician, during which
their symptoms fluctuate, they take actions, and are influenced by their environment in ways
that profoundly impact their health (see Table A2 for example aberrations in physiology and
behavior associated with illnesses; Asch et al. 2012). By shifting data from once-per-several-
month visits to near real-time high frequency and high definition, improved monitoring tools
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could provide a richer understanding of the day-to-day variability of neuropsychiatric illness,
enable assessment of patient status before (rather than after) symptoms reach a level war-
ranting intervention, and reduce biases and inaccuracy intrinsic in subjective questionnaires
(Karow et al. 2008; Copeland et al. 2017).
Monitoring is just one step in the virtuous cycle by which data is used to improve patient
management by informing interventions and resource allocation, such as home nursing visits,
adjustments of a mood stabilizing medication, or telepsychiatric counseling sessions. In turn,
the effect of these interventions can be measured at a hitherto unprecedented frequency and
fidelity. Advances in sensor technology and informatics approaches that maximize how data is
collected, analyzed, managed, and utilized by clinicians are shaping the future of care delivery
in many fields of medicine. Furthermore, technology may improve the distribution of limited
provider resources, especially in rural and developing parts of the world, and broader cost-
effectiveness of care. Realizing this vision requires addressing many challenges, spanning
technical, cultural, and economic domains. This thesis contributes technical advances to
the efforts of gathering and analyzing HR and activity data via signal processing, machine
learning, and information theoretical techniques.
Digital sensors in smartphones and wearables generate a vast amount of objectively mea-
sured, high-frequency, high-dimensional time series data. These data contain information
about dysregulation of the ANS, social routine, and other biological rhythms (Johnson et
al. 2016). In contrast, the data used in current clinical practice and biomedical research –
which include self-reported symptoms, lab tests, and vital signs – are subjective, infrequently
sampled, and unidimensional. Traditional methods of analysis used for these data include
univariate significance testing, regression models, and simple summary statistics. However,
means or medians of HR or activity may not differ in a patient with neuropsychiatric illness
compared to a healthy control. Collapsing a time series into one statistic results in the loss
of information related to pathophysiology.
To better capture this information, approaches from signal processing, information the-
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ory, and complexity science are needed. More nuanced “features” of HR and activity time
series include power spectral density attributes, wavelet coefficients, entropy (a measure of
regularity or surprise), autocorrelation, or nonstationarity. These features (also called predic-
tors or covariates) can be used to train machine learning algorithms that perform regression,
continuous parameter prediction, and classification of outputs such as disease phenotype or
questionnaire score (Obermeyer et al. 2016).
Machine learning algorithms estimate rules governing associations between input features
and output labels without being explicitly programmed. Compared to traditional statistical
methods, machine learning can utilize a large number of features even relative to the number
of subjects and combine them in a nonlinear, interactive, and hypothesis-free ways. Such
approaches have been applied to several problems with biomedical relevance such as detect-
ing atrial fibrillation via a smartwatch (Tison et al. 2018), identifying diabetic retinopathy
from retinal fundus images (Gulshan et al. 2016), and classifying skin cancer on par with
dermatologists from dermoscopic images (Esteva et al. 2017). Overfitting is a serious lim-
itation that occurs when an algorithm fails to generalize, i.e. can only accurately classify
inputs from data used to train the algorithm, but fails to achieve high performance when
presented with novel input from an external set of data not used for training. Generaliz-
ability is an obvious and crucial consideration addressed in most notable studies of machine
learning applied to biomedicine via the use of cross-validation and testing on a held out set
of independent or prospectively collected data.
Of note, univariate statistical significance does not guarantee predictivity or clinical util-
ity of a biomarker (Lo et al. 2015). Methods focusing on P-values can miss useful “weak
features” – those that do not significantly differ by output class when assessed via univariate
statistical tests, yet can be used as input to train a multivariate machine learning algorithm
that achieves high accuracy.
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1.2 Opportunities to improve data collection
Digital sensors measure observations about physiology and behavior comprised of at least
three components: true signal that reflects a clinically relevant aberration due to illness,
contextual signal that is attributable to factors unrelated to neuropsychiatric illness, e.g.
heart rate and locomotor activity patterns appear abnormal due to a temporary change in
a patient’s work schedule rather than a change in depressive symptoms, and noise or other
technical challenges including insufficient sampling frequency, a lack of standardization and
calibration of sensors, and noise. Maximizing true signal over contextual signal or noise,
whether in the raw data itself or in the metric derived from the data, is important for
improving classification of illness.
Metadata may enable the estimation of confidence in a signal. For example, GPS readings
and integration with social media could capture context that discriminates if a high locomo-
tor activity entropy is due to a subject’s participation in a social gathering, cultural event, or
travel for leisure as opposed to an abnormal deviation from a normal social and commuting
routine. Information is not evenly distributed amongst collected data, and using comple-
mentary data sources can reduce contextual noise. The concept of data fusion and robust
estimation from noisy data sources has been explored in the setting of electrocardiography
(Li et al. 2008; Clifford et al. 2012a). Evaluating ambulatory HR and locomotor activity
time series at specific times selected in a principled fashion could improve the richness of
clinically relevant information encoded in extracted features, and improve the performance
of classification tasks.
Digital sensors allow for measuring physiology at or above the Nyquist rate, which is
twice the maximum component frequency of the function being sampled (Wescott 2010).
This avoids the common issue of aliasing, whereby distortion or artifact occurs when the
signal reconstructed from samples is different from the original continuous signal (Clifford
et al. 2012b). A sampling rate of 3-6 Hz for heart rate and 10 Hz for movement is usually
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sufficient for satisfying the Nyquist criterion (Winter et al. 1972; Clifford 2002). However,
manufacturers of consumer devices may prioritize battery life over sampling frequency, and
the latter attribute may not be reported in product documentation. Whenever possible,
accounting for sampling frequency and other parameters of signal processing can prevent
errors such as aliasing and improve the rigor and correctness of subsequent analysis.
Lack of standardization and calibration hinders comparisons across studies, and more im-
portantly may limit generalizability of approaches to populations that use different technolo-
gies. Hundreds of different smartphones and wearable devices house different combinations
of sensors, CPU, GPU, and operating systems.
Noise in ECG data is due to poor contact between the electrode and the skin, patient
movement, muscle activity, or power line interference (Clifford 2002). Accelerometer record-
ings can be noisy due to thermal energy, mechanical vibrations, and the location and manner
in which the device is worn (Cemer 2011). Estimation of signal quality indices and data fu-
sion approaches can be used to detect poor quality ECG data, and these methods may also
be applicable to other types of digital sensor data (Clifford et al. 2011; Clifford et al. 2012a).
1.3 Capturing information over different time scales
Interactions in a biological systems manifest in different ways over different spatial and
time scales (Ivanov et al. 1999). For example, time series of BP can exhibit oscillations
on the order of seconds (due to the variations in sympathovagal balance), to minutes (as a
consequence of infection, blood loss, or behavioral factors), to hours (circadian rhythms and
social routines) (Mancia 2012; Parati et al. 2015).
Capturing the multiscale nature of these interactions can add additional predictive in-
formation when attempting to classify illness and/or discriminate between healthy and un-
healthy individuals. Costa et al. 2002 analyzed sample entropy (a metric of information
complexity) of HR time series. The entropy curve, or trajectory of entropies plotted against
time scale or number of coarse-grainings performed on the original time series, was found
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to distinguish atrial fibrillation (AFib) from congestive heart failure (CHF) from healthy
controls. Importantly, at a particular time scale the entropy values were similar for patients
with AFib and for healthy controls. Likewise, there existed one time scale at which entropy
was the same for AFib and CHF, and again for CHF and healthy controls.
Prior work by our group has demonstrated the additional predictive utility of analyzing
HR and locomotor activity data over multiple time scales in patients with schizophrenia (Os-
ipov et al. 2015). It is reasonable to hypothesize features of HR and locomotor activity over
multiple time scales has predictive utility in other mental illnesses involving dysautonomnia.
However, no work has explored the concept of multiscale dynamics in a mental health pop-
ulation outside of schizophrenia. Furthermore, previous explorations of multiscale dynamics
in cardiovascular illness have only compared univariate measures using simple tests of sta-
tistical significance, rather than utilizing more sophisticated machine learning to perform
prediction or classification that may be more clinically useful.
1.4 Interaction between time series to assess physiological or behavioral cou-
pling
The use of multiple data streams – also known as “data fusion” – can improve classification,
estimation, or prediction performance by providing a learning algorithm with non-collinear
data that may contain complementary information about the underlying dynamical system,
e.g. deriving many features from solely heart rate data could result in colinear features. One
data stream can also be used to calculate signal quality indices for the other data (Clifford
et al. 2011), and improve the accuracy of estimations of a signal in the presence of noise
and other artifact (Li et al. 2008). Since smartphones and wearables contain multiple types
of sensors, many monitoring approaches for neuropsychiatric illness have utilized feature
extraction from multiple data streams, and data fusion at the level of the classifier. However,
most studies merely present simple features from different signals to a classifier, rather than
use more robust approaches that can improve the utility of information within the data, such
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as signal quality indices or Kalman filters.
Transfer entropy, mutual information, and other measures of coupling assess information
transfer between variables. These measures from the field of information theory have been
derived from noninvasively monitored physiological data streams in efforts to characterize
the dynamics of complex systems such as aging-related changes in contribution of respiration
and blood pressure to entropy of heart rate (Nemati et al. 2013), and the coupling of HR and
respiration in the study of respiratory-related chemosensitivity (Lee et al. 2012). However, no
study to date involving multiple data streams has utilized the transfer of information between
data streams collected by smartphones or wearable devices – such as HR and locomotor
activity – in the context of monitoring neuropsychiatric illness. Such features may provide
further predictive information about the outcome of interest compared to using features
about each variable independently. A principled comparison of predictive performance when
using features from just one signal, versus multiple signals, versus interactions between
various data streams could improve understanding of how neuropsychiatric illness manifests
in physiology and behavior, as well as further efforts to translate research studies of new
technological approaches into clinically relevant advances in patient monitoring. Finally, as
alluded to in the the previous section, measures of interactions between time series over
multiple time scales may reflect different aspects of the perturbed physiological system than
interactions assessed over solely the original time scale, and thus contain additional predictive
information that enables patient classification.
1.5 Approach of thesis
This work addresses some of the problems of data collection and interaction between multiple
data streams. Specifically, this thesis defends the claim that discrimination of mental illness
using supervised learning algorithms is improved by considering information in HR and/or
locomotor activity data during specific times (as a proxy for context), over several time
scales, and between signals.
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This thesis is comprised of four parts: 1) a review of past work, 2) classification of mental
illness using features from quiescent segments of HR, 3) classification of mental illness using
features from both HR and locomotor activity time series over varying time scales, and 4)
evaluation of coupling and interactions between HR and activity as features for classifying
illness.
In Part 1), the body of work upon which this thesis builds is summarized in a review of
digital sensors for neuropsychiatric illness. First, the two specific mental illnesses of focus are
discussed: schizophrenia and PTSD. Heart rate variability (HRV) and locomotor activity,
as well as relevant metrics and features therein are reviewed. The growing literature on
digital sensors for monitoring neuropsychiatric illnesses is surveyed, with a focus on passive
monitoring and analyses of HR and locomotor activity, feature extraction, and classification
or regression of clinically relevant outcomes (Table A4).
In Part 2), features from HR data are used to train a classifier to distinguish PTSD from
control subjects. Classification is improved by isolating data from quiescent segments of HR.
This work explores the hypothesis that data from quiescent segments will be more useful than
data from other segments during the 24-hour recording. Sleep minimizes exogenous sources
of HRV such as social routine and physical activity (Clifford et al. 2004). Dysautonomia
detectable via alterations in HRV measures such as LF and HF power may thus be amplified
during these quiescent segments.
In Part 3), features from both HR and locomotor activity data are used to train a
classifier to distinguish subjects with schizophrenia from healthy controls. The time scale
(e.g. window length) of data is varied and found to affect classifier performance. This work
explores the hypothesis that information relevant to pathologically altered physiology and
behavior varies with time scale.
In Part 4), interactions between HR and locomotor activity are evaluated using infor-
mation theoretical approaches, and found to contribute significantly to the classification of
schizophrenia compared to not using interaction features, and differently to the classification
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of mental versus cardiovascular illness. This work explores the hypothesis that information
between signals is altered in mental illness and relatively less altered in cardiovascular illness,
and that this information is useful in a machine learning approach to discriminate patients
from controls.
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CHAPTER 2
DIGITAL SENSORS FOR NEUROSPSYCHIATRIC ILLNESS
2.1 Overview
This chapter provides an overview of two mental illnesses the work focuses on – schizophrenia
and PTSD. HRV and locomotor activity are discussed. Finally, relevant studies of the
aformentioned illnesses that use digital sensors are reviewed to provide a foundation of




Schizophrenia is a complex and heterogeneous psychiatric disorder characterized by several
criteria, including at least two of the following symptoms for one month or longer: delusions,
hallucinations, disorganized speech, grossly disorganized or catatonic behavior, or negative
symptoms such as diminished emotional expression; furthermore, there must be impairment
in work, interpersonal relations, or self-care, as well as continuous signs of the disorder for at
least 6 months (American Psychiatric Association 2013). The DSM-V criteria are provided
in Table 2.1. The lifetime global prevalence of schizophrenia is about 1%, and numerous risk
factors include complications during fetal life, older paternal age, male gender, being in a
disadvantaged inner city environment, migrant status, cannabis use, and childhood adversity
(Kahn et al. 2015). The mechanisms of pathophysiology are far from fully understood, with
evidence of abnormal neurotransmitter signaling and receptor function, reductions in grey
and white brain matter, and complement-mediated synapse elimination during postnatal
development. Outcomes vary widely, ranging from total recovery to totally debilitating
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illness requiring chronic care. Life expectancy for people with schizophrenia is reduced by 20
years compared to people without the illness. Pharmacological treatments for schizophrenia
can relieve psychotic symptoms but usually fail to meaningfully improve social, cognitive
and professional functioning. Psychosocial interventions can be useful but are resource-
intensive and inconsistently delivered. Finally, schizophrenia tends to be diagnosed years
after symptoms begin. Relatively little work at the intersection of mental health and digital
sensing technology has focused on schizophrenia compared to depression, BD, or dementia.
Table 2.1: DSM-V criteria for schizophrenia†
Criterion Description
Criterion A Two or more of the following symptoms for > 1 month unless treated
successfully include delusions; hallucinations; disorganized speech;
disorganized or catatonic behaviour; and negative symptoms, such
as affective flattening or loss of initiative
Criterion B Level of functioning is significantly decreased in work, personal rela-
tionships and/or personal care
Criterion C Symptoms of the disorder last ≥6 months
Criterion D Exclusion of schizo-affective disorder, unipolar and bipolar affective
disorder
Criterion E Symptoms cannot be attributed to the use of drugs or medication, or
to a somatic disorder
Criterion F In the case of a pre-existing autism spectrum disorder, at least 1
month with prominent hallucinations or delusions
†American Psychiatric Association 2013
2.2.2 Post traumatic stress disorder
PTSD is a psychopathological response that can develop after exposure to traumatic events
such as violence, natural disasters, or combat. It affects multiple systems ranging from brain
chemistry and circuitry to cellular, immune, metabolic, and endocrine function. The DSM-V
diagnostic criteria for PTSD are shown in Table 2.2.
Symptoms can include nightmares of the trauma, hypervigilance, difficulty sleeping, poor
concentration, and avoidance of places, activities, or persons that remind the affected indi-
vidual of the causal incident (Yehuda et al. 2015). PTSD has a lifetime prevalence of about
8% in the US general population (Resnick et al. 1993). The prevalence of PTSD is higher
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Table 2.2: DSM-V criteria for PTSD‡
Criterion Description Specific examples Requirements
Criterion A Exposure to
stressor • Direct exposure
• Witnessing trauma
• Learning of a trauma
• Repeat or extreme indirect exposure to
aversive details
Exposure to trauma can occur either by
direct or indirect confrontation with
extreme trauma
Criterion B Intrusion
symptoms • Recurrent memories
• Traumatic nightmares
• Dissociative reactions (flashbacks)
• Psychological distress at traumatic
reminders
• Marked physiological reactivity to
reminders
At least one of these five examples is
required
Criterion C Persistent
avoidance • Trauma-related thoughts or feelings
• Trauma-related external reminders such
as people, places or activities







• Persistent negative beliefs and
expectations
• Persistent distorted blame of self or
others for causing trauma
• Negative trauma-related emotions: fear,
horror, guilt, shame and anger
• Diminished interest in activities
• Detachment or estrangement from others
• Inability to experience positive emotions
At least two of these seven examples are
required
Criterion E Alterations in
arousal and
reactivity
• Irritable and aggressive behavior





At least two of these six examples are
required
Criterion F Duration Must experience criteria B, C, D and F for
> 1 month
Acute stress disorder is diagnosed for




Impairment in social, occupational or other
domains
Disability in at least one of these domains
is required
Criterion H Exclusion Not attributable to medication, substance
use or other illness
Symptoms must not be secondary to other
causes
‡American Psychiatric Association 2013
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in developing or war-afflicted countries, in which people are exposed to more severe and/or
more numerous traumas (Karam et al. 2014). Lifetime prevalence is thus especially high in
veterans, ranging from 6-30% (Dohrenwend et al. 2006; Kok et al. 2012; Sundin et al. 2014;
Marmar et al. 2015).
2.3 Heart rate variability
Dysfunction of the balance between sympathetic and parasympathetic branches of the ANS
can manifest as differences in HRV – beat-to-beat variation in heart rate. Although not rou-
tinely used for diagnosis or monitoring, HRV is altered in neuropsychiatric illnesses including
depression, anxiety, schizophrenia, and PTSD (McCraty et al. 2001; Agelink et al. 2002; Co-
hen et al. 2000; Beauchaine 2001; Alvares et al. 2016; Draghici et al. 2016). The relationship
between vagal tone and behavioral reactivity, psychological status, or psychiatric disease is
incompletely understood as it changes with age, is confounded by illness such as cardiovascu-
lar disease, and lacks mechanistic explanations of underlying pathophysiology. Complicating
matters, commonly used anti-psychotic medications affect the ANS; subsequent alterations
in HRV may provide a way of measuring adherence to pharmacological therapy (O’Regan
et al. 2015). HRV can be monitored non-invasively using wearable technology such as pho-
toplethysmography on a smart watch, or an electrocardiogram (ECG) on an adhesive patch.
Several categories or types of HRV measures are summarized here and include time domain,
frequency domain, and entropy measures. For a more comprehensive description of HRV
measurements and the literature exploring clinical utility beyond neuropsychiatric illness,
we refer the reader to the excellent review by Kleiger et al. 2005.
2.3.1 Time-domain HRV metrics
In time domain analysis, the intervals between adjacent normal R waves are characterized,
and a variety of descriptive statistics can be computed from the intervals directly, or the
differences between the intervals.
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SDNN is the standard deviation of all normal RR intervals, and the most commonly re-
ported time domain HRV measure. 30–40% of SDNN magnitude is attributable to day:night
difference in NN intervals. The SDNN is sensitive to ectopic beats, artifacts, and missed
beats (Clifford 2006). These events can artificially shorten or elongate RR intervals and thus
affect SDNN. At least 20 hours of ambulatory monitoring recordings may be required to
calculate SDNN (or other time- and frequency domain measures) (Haaksma et al. 1998).
SDANN is the standard deviation of 5-minute average NN intervals, which provides a
smoothed version of SDNN reflecting long-term fluctuations (Bigger et al. 1989). SDANN
is less sensitive to errors caused by individual artifacts than SDNN because “averaging
many NN intervals minimizes the effects of unedited artifacts, missed beats, and ectopic
complexity” (Kleiger et al. 2005).
ASDNN, or SDNN index, is the mean of the standard deviations of all NN intervals for all
5-minute segments in 24 hours. This metric significantly correlates with SDNN and SDANN
because low and high HRV tend to be global phenomena (Kleiger et al. 1992).
rMSSD is the square root of the mean of the squares of successive NN interval differences.
This metric reflects the average change in interval between beats (Pagani et al. 1985).
NN50 is the number of NN intervals differing by > 50 ms from the preceding interval
(Mietus et al. 2002). pNN50 is the percentage of intervals > 50 ms different from the
preceding interval, or NN50 normalized by the total number of RR intervals. In the presence
of normal sinus rhythm and normal AV-nodal function, each of these measures quantifies
parasympathetic modulation of normal RR intervals driven by ventilation.
Phase-rectified signal averaging
The fast Fourier transform assumes that the signal is stationary and continues for infinite
time. However, RR interval time series exhibit non-stationarity, and are finite in length.
If the signal consists of many short patches of periodicities with a particular frequency,
some of the patches will be in phase with the analyzing sinusoid, while most will be out of
16
phase. Patches with phase shifts differing by π will cancel; only the few patches with no
corresponding patch with a phase shift of π will contribute to the Fourier coefficient and
subsequent power spectra.
Phase-rectified signal averaging (PRSA) is a time-domain method developed to compress
a time series signal into a shorter sequence, keeping relevant quasi-periodicities but elim-
inating non-stationarities, artifacts, and noise (Kantelhardt et al. 2007). First, the signal
is re-sampled evenly in time. Next, anchor points, or some of the indices i, are selected
according to an increase, a decrease, or a change in mean in the signal. For each anchor
point, a window ranging from i−L to i+L is defined where L is the distance from the index
to the boundary of the window. Every window in the time series is aligned and averaged
to generate a PRSA transform, or “curve” x̄(k) where k is the offset from the anchor point.
Because anchor points are phase synchronized with the signal, all patches contribute to the
PRSA signal and its power spectra regardless of non-stationarities.
One useful property of the PRSA is that the amplitude of a spectral component at
frequency f is determined by A2ff , whereas the amplitude of the original signal from which
the PRSA is calculated is given by Af (Bauer et al. 2006b). The power spectrum of a signal,
P (f), is proportional to the square of the amplitude. For 1
f
β
noise with a scale coefficient β,
the power spectrum is given by P (f) ∼ A2f ∼ f−β. We derive the expression for the power
spectrum of the PRSA, given by PPRSA(f) ∼ p2f ∼ A4ff 2 ∼ f−2β+2. Thus, transforming a
signal via PRSA and assessing its power spectrum results in a larger scale coefficient that
is easier to detect when searching for deviations from standard scaling behaviour that are
caused by quasi-periodicities.
The PRSA curve is quantified by estimation of central wavelet coefficients x̃w(s, 0) at var-
ious scales s. Examples of continuous common wavelets include derivatives of Gaussians such
as g1(t) = t exp(−t2/2) (first derivative), ‘Mexican hat’ wavelet g2(t) = (t2 − 1) exp(−t2/2)
(second derivative), and the Haar wavelet h(t) = 1 for − 1 ≤ t < 0), + 1 for 0 ≤ t <
1), 0 (else).
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Deceleration capacity (DC) determines the capacity of the central nervous system to
quickly decelerate the rate. This HRV measure uses the Haar wavelet, s = 2, and the anchor
point definition of increasing RR intervals (decreasing heart rate), and is given by x̃h(2, 0).
DC has been shown to be a better predictor of mortality in survivors of myocardial infarc-
tion than left ventricular ejection fraction (LVEF), the current gold standard risk predictor
(Bauer et al. 2006a; Kantelhardt et al. 2007). Additionally, in a study of PRSA metrics eval-
uated in subjects with schiozphrenia, DC has been shown to be reduced in subjects taking
antipsychotic medication (Birkhofer et al. 2013). Acceleration capacity (AC) - similar to DC
except with an anchor point definition of decreasing rather than increasing RR intervals -
and DC may be sensitive markers for autonomic changes associated with aging (Campana
et al. 2010).
2.3.2 Frequency-domain HRV metrics
Power spectral density (PSD) analysis via fast Fourier transformation or autoregression tech-
niques quantifies the frequency components of RR intervals (Task Force of The European
Society of Cardiology and The North American Society of Pacing and Electrophysiology
1996; Clifford 2002). The PSD is partitioned into very low frequency (VLF) <0.04 Hz, low
frequency (LF) 0.04 - 0.15 Hz, and high frequency (HF) >0.15. LF power is modulated
by baroreflexes, sympathetic, and parasympathetic tone (Billman et al. 1990; Furlan et al.
1990; Bloomfield et al. 1997), whereas HF power is modulated by parasympathetic activity
(Katona et al. 1970; Appel et al. 1989; Billman et al. 1990; Thayer et al. 2010). Pagani et al.
1985 proposed that the LF/HF ratio quantifies the relationship between sympathetic and
parasympathetic tone, which assumes a linear interaction between the two branches of the
ANS on HRV. However, the assumptions underlying this simple model coined “sympathova-
gal balance” have been challenged by evidence showing complex nonlinear effects of varying
cardiac sympathetic and parasympathetic nerve activity on LF/HF; some reports suggest
sympathetic activity may modulate HF power, and conversely parasympathetic activity may
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modulate LF power (Billman 2013).
Removing noise and ectopic beats from RR interval data is necessary for the calculation
of HRV measures. The frequency of ectopic beats and artifacts are linearly related to the
error of the PSD estimate (Clifford et al. 2005). Furthermore, because RR intervals are irreg-
ularly spaced in time, resampling and interpolation of data into uniformly spaced intervals is
required to subsequently perform a Fourier transformation. However, resampling can result
in over-estimation of the PSD. The resampling period affects the computational speed and
error of PSD estimation; Singh et al. 2004 proposed a now widely used sampling frequency
of 4 Hz for the study of autonomic regulation, since it enables the computation of spectral
estimates between DC and 1 Hz which represents an adequate range of autonomic nervous
system response. The Lomb-Scargle periodogram is a more appropriate spectral estimation
technique for unevenly sampled time series, as it provides a less noisy estimate of the PSD
compared to other methods such as the Welch periodogram. Clifford et al. has shown it is
superior to other spectral estimation methods for HRV interval data (Clifford et al. 2005).
The segment length of RR recordings is also an important consideration for discrete
Fourier transform analysis and is governed by the compromise between the need for short
data segments to give acceptable variance and stationarity considerations, and the need for
long data length to give acceptable frequency domain resolution and reduced spectral leakage
(Singh et al. 2004). The recording should be at least 10 times the lower frequency bound
of the investigated component, but no longer to reduce the probability of nonstationarity
(Clifford 2002). Commonly reported segment lengths are 5 minutes and 24 hours. A shorter
recording is more feasible from a research logistics standpoint and will capture high frequency
components. However, short recordings are likely to undersample rare events such as atrial
fibrillation, or phenomena that occur over longer time scales such as changes in HRV due to
the circadian rhythm.
In practice, studies use a wide range of resampling rates, window types, overlap between
segments, and RR interval segment lengths (Singh et al. 2004). In an effort to improve
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the standardization, transparency, and reproducibility of HRV analyses, Vest et al. 2017
developed an open-source HRV analysis toolbox in the Matlab language. The toolbox uses
the minimal number of dependencies and the most basic operators to future-proof the code.
2.3.3 Entropy
In information theory, entropy is defined as the expected value of information in a message.
Signals such as a sine wave or white noise contain little information, and accordingly have
low entropy. On the other hand, the human heart beat is richly complex, with dynamics
influenced by multiple physiological control systems acting over multiple time scales, and
has higher entropy. Entropy and other conceptually related measures calculated from RR
interval time series can quantify the regularity or complexity of underlying physiology and
can reflect alterations in ANS function due to neuropsychiatric illness (Osipov et al. 2015).
This and other measures can be useful in distinguishing time series with similar mean µ
and variance σ values as well as similar power spectral densities, albeit differing levels of
complexity (Figure 2.1).
Figure 2.1: Two toy signals (blue in upper left and orange in lower left) with similar means
µ, variances σ, and power spectra (right upper and right lower subplots). Note the blue




Sample entropy (SampEn) H, first defined by Richman et al. 2000, is a metric of signal com-
plexity derived from the negative logarithm of the conditional probability of the appearance
of longer patterns in a signal, considering the presence of a shorter pattern:




where m is the template length, r is the radius of similarity or distance threshold between
patterns (normalized to be unitless), Am(r) is a probability of matching a template of length
m+ 1, Bm(r) is the probability of matching a template of length m, and N is the number of
elements in the time series (not explicit in the expression, but affects the final value of H).
Two patterns of length m are considered similar if each point of a pattern in one part of the
signal is within distance r from the respective point in the other part of the signal. Because
Am(r) ≤ Bm(r), SampEn is ≥ 0. For a finite N , the theoretical upper bound of SampEn is
≤ ln(N −m). (Richman et al. 2000).
Figure 2.2: Three signals with progressively increasing complexity quantified by SampEn.
The blue signal in the upper left subplot is a sine wave with minimal complexity, indicated
by a SampEn of 0.50. The red signal in the middle left subplot is a sine wave with added
noise and thus additional complexity, indicated by a higher SampEn value around 1.00. The
green signal in the lower left subplot is generated by superimposing Gaussian noise on a sine
wave with the same phase and amplitude as in the previous two plots, and thus has the
highest complexity, indicated by the SampEn value above 2.00.
Lanata et al. 2015 evaluated a small cohort of ten bipolar patients using shirts with em-
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bedded ECG sensors. Subjects were administered questionnaires via a smartphone applica-
tion. Increased SampEn of heart rate time series was associated with clinical improvements
defined by mood transitions from a pathological mood state (featuring depressive and/or
hypomanic symptoms).
Multiscale entropy
To assess complexity at different time scales, the original signal can be coarse-grained to
a lower sampling frequency. Specifically, data points within non-overlapping windows of
increasing length τ are averaged. For the τth time scale, each element of the coarse-grained
time series, y
(τ)









where τ represents the scale factor and 1 ≤ j ≤ N/τ . The length of each coarse-grained
time series is N/τ . The first time scale corresponds to the original time series, the second
time scale corresponds to one coarse-graining, etc. Another method of coarse-graining is to
sample every ith data point, but by ignoring all other data points results in more loss of
information compared to the first method. Entropy or other complexity metrics can then
be calculated using y
(τ)
j . MSE of actigraphy time series data was a predictive feature that
discriminated patients with schizophrenia from controls (Osipov et al. 2015).
Fuzzy entropy
Although SampEn differs by illness status, it is sensitive to small changes in parameter values
and thus exhibits poor statistical stability. Additionally, SampEn only accounts for similar
patterns with similar amplitudes, not similar patterns with different amplitudes. These
shortcomings are addressed by the recently proposed fuzzy entropy Hfuzzy (Liu et al. 2013).
To calculate Hfuzzy, the binary Heaviside classifier in SampEn is replaced with a contin-
uous membership degree between 0 and 1, based on Zadeh’s concepts of fuzzy set theory.
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Hfuzzy is more robust to noise than SampEn and is calculated in a similar manner as MSE.
The k’th MFE value is given by Hfuzzy(y(k)) where y(k) is the original time series x after k
coarse-graining steps.
Fuzzy entropy also normalizes the amplitude of signals by subtracting the local or global
mean or maxima, which enables comparison of signals by trend rather than amplitude alone.
Previous entropy measures would fail to consider two sequences as a match if they differed in
amplitude by more than r even if the trend was identical. For example, consider sequences






(ai − bi)2 = 1 (2.3)
whereas d(a, c) ≈ 6.93 and d(b, c) ≈ 8.25. Although vectors a and b are closer together
in Euclidean space compared to vectors a and c, vectors a and c have a similar trend of
a one-unit increase followed by a one-unit decrease. Depending on the selected radius of
similarity r, previous entropy measures would consider only vectors a and b as matches,
whereas Hfuzzy might also consider vectors a and c as matches. Thus, Hfuzzy could better
detect temporal trends in a signal compared to the amplitude-dependent SampEn. Liu et al.
2013 demonstrated fuzzy entropy of RR interval time series better separated heart failure
patients from healthy controls via a univariate significance test compared to other entropy
measures.
2.3.4 Effects of medications on HRV
Antipsychotic medications exert antagonistic and agonistic activity on muscarinic and α-
adrenergic receptors, and also alter ANS function. This complicates assessment of ANS
dysfunction in patients with mental illness who are taking these medications. Hattori et al.
2017 investigated how four atypical antipsychotic drugs – risperidone, olanzapine, aripipra-
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zole, and quetiapine – affect ANS activity as assessed via spectral analysis of HRV. 241
patients with schizophrenia received an atypical antipsychotic as monotherapy; 90 subjects
received risperidone, 68 olanzapine, 52 aripiprazole, and 31 quetiapine. The quetiapine group
showed significantly diminished sympathetic and parasympathetic activity compared with
the risperidone and aripiprazole groups, with lower LF and HF power. Furthermore, mul-
tiple regression analysis showed that the type of antipsychotic drug significantly influenced
ANS activity.
Van Zyl et al. reviewed the literature on how antidepressant medications affect HRV
(Zyl et al. 2008). Tricyclic antidepressants (TCAs) were associated with declines in most
measures of HRV and significant increases in HR in studies with short recordings (2-10
minutes). Interestingly, no significant changes were found for longer recordings (24 hours).
Treatment effects with selective serotonin reuptake inhibitors (SSRIs) were more variable.
Short recording studies revealed a significant decrease in HR and an increase in one HRV
measure. In two 24-hour recording studies no significant changes were observed.
To account for the affects of pharmacological agents on HRV in patients with mental
illness, studies should maintain subjects on the same medication regimen, and avoid starting
or discontinuing a new therapy. No study has explored if noninvasive measurements of HRV,
locomotor activity, or other continuously monitored data are useful in the evaluation of
medication adherence status of a patient. This application is challenged by the variability of
ANS response to different medications, the myriad of medications taken by HRV patients,
co-existing cardiovascular conditions, as well as numerous confounding factors that affect
sensor readout.
2.4 Locomotor activity and behavior
2.4.1 Rest-activity characteristics
Rest-activity characteristics can quantify variability and amplitude of locomotor activity, and
include mean level during the least active five hours (L5), mean level during the most active
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ten hours (M10), relative amplitude (RA), interday stability (IS) and intraday variability
(IV) (Witting et al. 1990; Van Someren et al. 1999).
L5 and M10 are calculated by sliding a five or ten-hour window through all data, calcu-
lating the mean value of each window, and returning the lowest or highest value respectively.
M10 is activity during the most active period of the day, whereas L5 represents activity
during sleep plus nighttime arousals. RA is a nonparametric and dimensionless measure





The interdaily stability (IS) quantifies the invariability of activity between days. The
IS is equivalent to the 24 hour value from the chi-square periodogram normalized for the
number of data (Sokolove et al. 1978), and is calculated as the ratio between the variance of











where n is the total number of data, p is the number of data per day, x̄h are hourly means,
x̄ is the mean of all data, and xi represents individual data points. IS varies between 0 for
Gaussian noise and 1 for cyclical activity whereby the avareage 24 hour variance around the
mean is equivalent to the overall variance.
The intradaily variability (IV) indicates fragmentation in the daily activity rhythm by
quantifying the “frequency and extent of transitions between rest and activity” (Van Someren













IV varies between 0 for a perfect sine wave to ≈ 2 for Gaussian noise.
Rest-activity characteristics have been found to differ in subjects with neuropsychiatric
illnesses. Subjects with schizophrenia had higher IS and lower IV than the controls, reflecting
a more structured behavioral pattern (Berle et al. 2010). This difference was even more
pronounced in subjects with schizophrenia treated with Clozapine and was not found in
depressed patients. Additionally, IS and IV differed among subjects with schizophrenia,
depression, and controls via ANOVA.
2.5 Monitoring approaches
2.5.1 Smartphones
Smartphones are globally ubiquitous, owned by 72% of Americans and 3B people worldwide,
and are projected to reach a global total of over 5B people by 2030 (Poushter 2016). Im-
portantly, studies in the USA, United Kingdom, Canada, and India have found smartphone
ownership to not be significantly lower among people with serious mental health conditions
compared to the average owner, and ownership by these individuals is projected to increase,
mirroring the trend seen in the general population (Torous et al. 2014; Firth et al. 2016).
Additionally, people tend to keep their phones with them and check them between 46 to
85 times per day (Andrews et al. 2015; Eadicicco 2016). These data thus reflect social and
behavioral manifestations of neuropsychiatric illnesses in the context of daily life rather than
in an artificial clinical setting (Insel 2017). For example, GPS location data measured on
smartphones can be used to estimate behavioral attributes such as percentage of time a
subject spends in certain locations (Figure 2.3). By evaluating the time of day, day of week,
and amount of time spent in each location, the purpose of each location datum can be in-
26
Figure 2.3: Geolocation data measured via smartphone can track time spent at modal loca-
tions. The x- and y-axes are distance from the most commonly visited location. The z-axis is
the percentage of total time spent in a given location, with darker orange encoding a higher
percentage and a lighter yellow encoding a lower percentage. The dark orange peak at the
origin where the individual spends the most time is assumed to be home, and the second-
largest peak (z-axis value) where the individual spends the next most time is assumed to be
work, or vice-versa if the individual spends more time at work than home.
ferred, e.g. work versus home. Additionally, social interactions in the form of calls and text
messages can be monitored and quantified (Figure 2.4). Geolocation, social network activity,
and other attributes reflect behavior and may differ in subjects with neuropsychiatric illness
compared to healthy controls. Several investigators have built smartphone apps for collect-
ing sensor and usage data, including Automated Monitoring of Symptom Severity (AMoSS;
Palmius et al. 2014), Purple Robot (Schueller et al. 2014), and Beiwe (Torous et al. 2016).
A long-term goal for the work described in this thesis is to build a smartphone platform to
enable disease monitoring and classification.
Smartphones can also be used to administer validated questionnaires for evaluating qual-
ity of life and mental well-being (Palmius et al. 20177). Although self-reported questionnaires
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Figure 2.4: Social network activity measured via smartphone can identify mood and illness.
The y-axis encodes unique pairings of sender and recipient IDs. The x-axis encodes time.
The radius of each colored dot is proportional to the number of calls and text messages in
one day. Interactions from a sender-recipient pairing have the same color over time, i.e. all
red dots with the same height on the y-axis represent interactions between the same two
unique individuals. Qualitatively, (a) healthy controls demonstrate more regular amounts
of interaction over time with their social contacts compared to (b) subjects with bipolar
disorder who alternate bouts of high and low levels of interaction.
are prone to recall, social desirability, and confirmation biases, they provide a pragmatic best
estimate of an individual’s mental status and can achieve results comparable to clinician-
administered surveys (Spitzer et al. 1999; Ebner-Priemer et al. 2006; Martel 2008; Solhan
et al. 2009). The inference of mental health questionnaire results from digital sensor data is a
common approach in the literature and could be useful for monitoring the status of subjects
who struggle with adherence or have impaired cognition and executive decision-making ca-
pacity (Table A3; Mohr et al. 2016; Tsanas et al. 2016; Barrett et al. 2017; Aung et al. 2017).
In this section we review recent studies using smartphones to monitor neuropsychiatric ill-
nesses; work that may be related but also involves analysis of heart rate data is reviewed in
later sections.
Monitoring schizophrenia via smartphone
Wang et al. collected passive smartphone sensor data from 21 outpatients diagnosed with
schizophrenia and recently discharged from hospital over a period ranging from 2 - 8.5
months (Wang et al. 2016). Samsung Galaxy S5 phones running the Android operating
system were equipped with the “CrossCheck” app developed in-house that monitors type and
duration of physical activity, sleep duration, number and durations of phone conversations,
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number of SMS, geolocation, phone and app usage, and ambient light and noise. Every three
days, Ecological Momentary Assessment (EMA) questions were administered and sensor data
were aggregated. Generalized estimating equations were used to map associations between
features and EMA responses. Higher scores in attributes related to positive perception of
mental well-being – including calm, hopeful, sleeping well, social, and ability to think clearly
– were associated with waking up earlier, having fewer conversations, fewer phone calls,
and fewer SMS. Higher scores in questions related to negative perception were associated
with staying stationary more in the morning but less in the evening, visiting fewer new
places, having fewer conversations but making more phone calls and SMS, and using the
phone less. Gradient boosted regression trees were used to predict EMA scores from these
features. Models trained on an individual’s data estimated EMA scores for that individual
with a correlation between prediction and outcome of r = 0.77 and p < 0.001. However,
outcomes predicted via leave-one-out cross validation did not correlate with actual outcomes.
A population-wide model may be less useful for individualized predictions given the high
variance of feature phenotypes, compared to models trained on each specific individual’s
past data.
Staples et al. recently reported a three-month observational study of both self-reported
and objective measures of sleep in schizophrenia (Staples et al. 2017). Using the Beiwe app
(available for both iPhones and Android phones), 13 subjects diagnosed with schizophrenia
were given tri-weekly EMAs. Passive data were continuously collected, including accelerom-
etry, GPS, screen use, and anonymized call and SMS activity. Sleep quality was assessed in
a clinical setting using the PSQI, which was compared to both EMAs and sleep estimates
based on passively collected accelerometer data. A cross-validated linear regression model
with mean phone-based EMA scores as the outcome and mean paper-based PSQI scores as
the predictor classified 85% (11/13) of subjects as exhibiting high or low sleep quality. Ac-
celerometry moderately correlated with subject self-assessments of sleep duration (r = 0.69,
95% CI [0.23−0.90]). Active and passive phone data predicted concurrent PSQI scores with
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a mean average error of 0.75, and future PSQI scores with a mean average error of 1.9, with
scores ranging from 0-14.
Among individuals who are diagnosed, hospitalized, and treated for schizophrenia, up to
40% of those who are discharged will relapse within one year. Barnett et al. evaluated a
smartphone platform for monitoring seventeen patients with schizophrenia undergoing active
treatment in order to identify warning signs of relapse, defined as psychiatric hospitalization
or an increase in the level of psychiatric care, such as increase in the frequency of clinic
visits or referral to a partial or outpatient hospital program (Barnett et al. 2018). Patients
were monitored for three months using the Beiwe app, and mobility patterns and social
behavior were gathered and analyzed. Features were extracted from the data, including
daily distance traveled, time spent at home, number of significant locations visited, total
duration of calls, number of missed calls, and number of text messages sent. The app also
administered surveys twice per week to assess anxiety, depression, sleep quality, psychosis,
the warning symptoms scale, and medication adherence. The rate of behavioral anomalies
detected in the 2 weeks prior to relapse was 71% higher than the rate of anomalies during
other time periods. Although anomalies were calculated using each patient’s own data to
account for differences in baseline features, the number of anomalies greatly varied between
subjects. Additionally, many subjects did not relapse, as the cohort enrolled only seventeen
patients and for only three months. The features captured in patients that did relapse may
not have reflected the “potential trajectories and mechanisms that can lead to relapse”. The
anomaly detection approach demonstrated in this paper could be useful for measuring other
outcomes that were not reported but could be clinically useful, such as changes in positive
or negative symptoms of schizophrenia.
Monitoring PTSD via smartphone
Smartphone apps for PTSD have focused on education about the disorder, delivery of cogni-
tive behavioral therapy, self-assessment of symptoms via questionnaires, and access to crisis
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support and other relevant resources (Kuhn et al. 2014). Few papers describe the use of dig-
ital sensors to passively monitor clinical symptoms of PTSD. However, many smartphone-
and wearables-based sensing approaches have focused on anxiety and depression which are
common co-morbidities.
Place et al. conducted a 12-week trial with 73 patients who reported at least one symp-
tom of PTSD or depression (Place et al. 2017). Clinical symptoms were assessed by licensed
social workers who administered the depression and PTSD modules of the Structured Clinical
Interview for Mental Disorders (SCID). An Android app was developed to gather accelerom-
etry, SMS and call, location, device use, and audio data. Extracted features included sum
of outgoing calls, count of unique numbers texted, absolute distance traveled, dynamic vari-
ation of the voice, speaking rate, and voice quality. Feature reduction was performed to
reduce over-fitting and interfeature correlation, and a logistic regression was trained using
10-fold cross validation. Fatigue was not accurately predicted, with an AUC of only 0.56.
Predictions of interest in activities, social connectedness, and depressed mood featured much
better AUCs of 0.75, 0.83, and 0.74 respectively, which is closer to the discrimination perfor-
mance of currently used psychiatric tools and other clinical assays. Finally, subjects reported
comfort with sharing personal data with clinicians and medical researchers. However, it was
unclear if the predictive model outperformed sample-and-hold estimations of mood from the
previous week. This can be viewed using a Bayesian framework, in which the mood state
from the previous week informs the prior, and data from the smartphone app is used to up-
date the model and estimate the posterior. Evaluating subjects at several time points affords
an opportunity to quantify the additional contribution of passive sensor data to predictive
models that use questionnaires or surveys as ground truth.
University of North Carolina, Harvard University, and Verily Life Sciences LLC (South
San Francisco, CA) are leading the AURORA study, a 19-institution five-year effort to per-
form the most comprehensive observational study of mental disorders that occur in the wake
of trauma to date (National Institute of Mental Health 2016). Investigators will screen 5,000
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people arriving in emergency rooms after trauma. After an initial evaluation and a baseline
collection of biological data from blood samples, subjects will be monitored for the next sev-
eral months through the use of mobile technology, such as wrist wearables and smart phones,
to track factors like activity, sleep, and mood. Other assessments will include additional
blood samples, functional brain imaging, and psychological tests. Participant involvement
will continue over a year, generating a wide variety of detailed information on, for example,
health history (including that of earlier trauma), genetics, stress responses (physical and
psychological), behavior, and cognition. This collaboration presents a unique opportunity to
learn more about the factors that mediate the development of mental illness after trauma,
and potentially contribute to new diagnostic and therapeutic approaches. The Aurora study
represents a new trend in public-private partnerships, involving multiple research institutions
and and technology companies such as Verily and Mindstrong Health (Palo Alto, CA).
2.5.2 Wearable accelerometers
Locomotor activity is altered in neuropsychiatric illnesses, due to impaired motor func-
tion, weakness, volitional and behavioral changes, or abnormal sleep patterns and circadian
rhythms (Teicher 1995). Non-invasive body-worn accelerometers can measure these changes,
and were first explored for assessing circadian rhythms (Witting et al. 1990; Sadeh et al.
2002). However, continual monitoring of locomotor activity was not feasible until recently
due to poor battery life, the inability to wirelessly transmit data, and low patient adherence
with research-grade instrumentation. Only recently have these technological constraints been
overcome. Today, personal activity monitoring devices such as fitness bracelets or patches –
also known as “wearables” – are affordable and widely available to public consumers. This is
partly due to the global saturation of the smartphone market, which consequently reduced
the cost of manufacturing and distributing similar component parts. Today, wearables house
sensors that detect heart rate, activity, ambient light, and sleep. These devices have been
used in the studies revealing disturbances in 24-hour routine and circadian rhythm associ-
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Figure 2.5: A “double-plot” of wearable accelerometry or actigraphy data demonstrates
night-to-night patterns. The x-axis is the date, and the y-axis is time of day. Each day is
repeated adjacent to and below the previous day. This aligns the nights of data and can be
particularly useful in depicting circadian rhythm sleep disorders. (a) Actigraphy levels in a
healthy control. (b) Actigraphy levels in a patient with borderline personality disorder.
ated with neuropsychiatric illnesses such as BD and schizophrenia (Figure 2.5). While only
2-4% of individuals in the United States have a wearable device, the market is estimated
to increase to 115 million units in 2018 and generate $50B of revenue (Gandhi et al. 2014;
Statista 2017). Here we review recent studies using wearable accelerometers to monitor
neuropsychiatric illnesses.
Monitoring schizophrenia via wearable accelerometers
Martin et al. found older schizophrenia patients have more disrupted sleep and circadian
rhythms (Martin et al. 2005). 28 older schizophrenia patients (mean age=58.3 years) and
28 age- and gender-matched controls were monitored for three days using Actillume wrist
actigraphs (Ambulatory Monitoring, Inc., Ardsley, New York). Minute-by-minute activity
and light exposure were recorded. Patients spent longer in bed, had more disrupted nighttime
sleep, slept more during the day, and had less robust circadian rhythms of activity and light
exposure compared to controls.
Apiquian et al. evaluated rest-activity characteristics in 20 unmedicated and non-hospitalized
schizophrenia patients and 20 controls for five days using a wrist-worn actigraph (Actiwatch-
16) (Apiquian et al. 2017). Compared to controls, untreated patients showed significantly
lower levels of motor activity and more sleep time.
Walther et al. investigated the relationship between objective measures of motor activity
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and PANSS scores (Walther et al. 2009b). 55 schizophrenia patients were monitored for 24
hours via wrist actigraphy. Low activity levels were correlated with high PANSS negative
syndrome subscale scores. Interestingly, actigraphic parameters did not correlate with motor-
specific questions of the PANSS, challenging the validity of the questionnaire.
This same research group subsequently used 24-hour actigraphy to differentiate schizophre-
nia subtypes in a cohort of 60 hospitalized patients (35 paranoid, 12 catatonic, 13 disorga-
nized) (Walther et al. 2009a). Activity level and movement index (proportion of 2-second
periods with nonzero activity) were highest in paranoid schizophrenics, whereas the mean
duration of uninterrupted mobility was highest in catatonic schizophrenics.
Berle et al. used actigraphy to evaluate patterns of motor activity in 23 schizophre-
nia patients, 23 depressed patients, and 32 control subjects who did not have a history of
mood or psychotic systems (Berle et al. 2010). Total motor activity was lower in patients
diagnosed with schizophrenia or depression than in controls. However, IS was 18% higher
in schizophrenia patients compared to controls, whereas IS did not differ between depressed
patients and controls. IV was 18% lower in schizophrenia patients and 8% lower in depressed
patients compared to controls.
Hauge et al. revisited this same cohort of patients, but analyzed activity data using
Fourier analysis and entropy measurements (Hauge et al. 2011). For each patient, these
features were derived from the first 300-minute segment of activity data that contained ≤
4 consecutive minutes of zero activity. RMSSD/SD was significantly lower in schizophrenia
patients compared to either depressed patients or controls. Sample entropy of activity was
significantly lower in depressed patents compared to either schizophrenia patients or controls.
Finally, the ratio between variance of HF power and variance of LF power was significantly
higher in depressed patients compared to controls.
Wichniak et al. recorded seven days of actigraphy using Actiwatch AW4 devices (Cam-
bridge Neurotechnology Inc., UK) in 73 patients with schizophrenia and 36 age- and sex-
matched controls (Wichniak et al. 2011). Mental status was measured via the PANSS and
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CDSS questionnaires. Schizophrenia patients had lower mean 24-hour activity and mean
10-hour daytime activity levels, and spent more time in bed. Lower activity was associated
with higher PANSS and CDSS scores.
Sano et al. recorded seven days of actigraphy (Actigraph Mini-Motionlogger; Ambula-
tory Monitors Inc., Ardsley, NY, USA) in 19 schizophrenia patients and 11 controls (Sano
et al. 2012). Resting periods obeyed a power-law cumulative distribution whereas active pe-
riods obeyed a stretched exponential distribution. Distribution parameters differed among
schizophrenia patients and controls. For resting periods, the average scaling exponent val-
ues (mean ± standard deviation) were γ̄ = 0.86 ± 0.03 for schizophrenia patients and
γ̄ = 0.99 ± 0.03 for controls. For active periods, the average stretching parameters were
β̄ = 0.57± 0.02 for schizophrenia patients and β̄ = 0.64± 0.02 for controls.
Evaluating the distribution of rest-activity periods was also previously described by Naka-
mura et al. 2007 and Sano et al. 2012. Fasmer et al. 2015 used this approach in a cohort of
24 patients with schizophrenia, 23 with depression, and 29 controls. 12 days of actigraphy
data were recorded per patient using Actiwatches (Cambridge Neurotechnology Ltd., Eng-
land, UK). For active periods, average scaling exponent values (mean ± standard deviation)
were γ̄ = 0.77± 0.13 for schizophrenia patients, γ̄ = 0.88± 0.13 for depressed patients, and
γ̄ = 0.82 ± 0.01 for controls. For inactive periods, average scaling exponent values (mean
± standard deviation) were γ̄ = 0.81 ± 0.17 for schizophrenia patients, γ̄ = 0.93 ± 0.18 for
depressed patients, and γ̄ = 0.71 ± 0.11 for controls. Length of active and inactive peri-
ods and scaling exponents for both active and inactive periods correlated with IS, whereas
only length of active periods and scaling exponents for inactive periods correlated with IV.
The authors concluded the distribution of active and inactive periods differed in depressed
compared to schizophrenic patients.
Shin et al. assessed correlations between locomotor activity and symptom severity of 61
subjects with schizophrenia (Shin et al. 2016). Subjects wore a Fitbit Flex device for a week
to assess their activity, and completed the PANSS questionnaire to assess schizophrenia
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symptoms. Subjects with a high total PANSS score or high positive subscale scores had
significantly lower levels of physical activity than the other groups.
2.5.3 Holter monitoring
Much literature has established a bidirectional relationship between changes in HRV and
neuropsychiatric illness. People with severe mental illness have worse cardiovascular out-
comes than healthy controls, and people with serious cardiovascular illness are more likely
to develop certain neuropsychiatric illnesses (Newcomer et al. 2007; Sowden et al. 2009).
The interplay between mental and cardiovascular health is believed to be mediated by al-
terations in the ANS, endocrine effectors such as cortisol and catecholamines, activation of
pro-inflammatory cytokines, and lifestyle and environmental exposures such as diet, exercise,
and social support (Grippo et al. 2009). In particular, HR and HRV measures can be mea-
sured noninvasively, and reflect the state of the ANS. Alterations in HR and HRV may thus
provide an objective and passively measurable marker of clinical status in neuropsychiatric
illnesses ranging from MDD to BD to schizophrenia (Henry et al. 2010; Cohen et al. 2000).
Cardiac monitoring from body-worn instrumentation is known as Holter monitoring and
was originally performed via large stationary ECG devices. Recently, body-worn patches
adhering to the skin have been developed to measure HR via ECG, actigraphy, and even
metabolites in sweat (Rodgers et al. 2015). Adhesive patches have the potential to improve
adherence with study protocols and device use because they are unobtrusive and always at-
tached to the patient. Most studies using physiological patches have focused on heart disease,
although a few groups have used this technology to evaluate patients with depression, stress,
and schizophrenia. Photoplethysmography (PPG) is another approach for assessing HR via
optical measurements of changes in blood volume, and has become a popular sensing tech-
nique in wearable devices such as fitness bracelets (Allen 2017). Here we summarize several
studies that exclusively focus on the analysis of heart rate data, measured via both tradi-
tional ECG as well as patch-based sensing modalities. Devices utilizing PPG are reported
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in the next section on multi-modal sensing.
Monitoring schizophrenia via Holter monitor
Cardiovascular mortality risk is elevated in patients with schizophrenia, which may be due
to increased prevalence of obesity, smoking, and diabetes, adverse pro-arrhythmic effects
of antipsychotic medication, and altered autonomic function. Bär et al. 2017 calculated
complexity measures of HRV using short-term ECG recordings from 20 unmedicated subjects
with schizophrenia and 20 age- and gender-matched healthy controls. Features included joint
symbolic dynamics, compression entropy, fractal dimension and approximate entropy. For
analysis of symbolic dynamics, every beat duration was compared to the preceding beat.
Whenever the beat durations differed by ≤ 10 milliseconds, the pattern was encoded as ‘0’. If
the beat durations differed by > 10 milliseconds, the pattern was encoded as ‘1‘. A sequence
of six consecutive ‘0‘s or ‘1‘s denoted sequences with low or high variability, respectively.
The frequency of low or high variability sequences was used as a feature. Complexity of HR
time series was significantly reduced in acute schizophrenia. However, when using HR as a
covariate, only fractal dimension remained significantly altered.
d. Overall, the length of two consecutive beats is compared, and a differentiation is being
made whether these differ by more or less than the given time limit.
Monitoring PTSD via Holter monitor
Cohen et al. evaluated frequency-domain HRV measures via power spectral density analysis
using ECG recordings from 14 subjects with post traumatic stress disorder (PTSD), 11 sub-
jects with panic disorder, and 25 matched controls (Cohen et al. 2000). ECG recordings were
made while subjects were resting while recalling the trauma implicated in the development
of their PTSD, or the circumstances of a severe panic attack, as appropriate, and again while
resting. Controls were asked to recall a stressful life event during recall. Both PTSD and
panic disorder groups had elevated HR and low frequency LF power at baseline, suggesting
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increased sympathetic activity. However, PTSD patients did not respond to recall stress
with increases in HR and LF.
Reinertsen et al. used a machine learning approach to dichotomize subjects with PTSD
from healthy controls using features such as LF power, statistical moments, and acceleration
and deceleration capacity (Reinertsen et al. 2017a). 24-hour single-channel ECG recordings
were obtained from 23 subjects with current PTSD, and 25 control subjects with no history
of PTSD. RR intervals derived from these data were cleaned and used to calculate HR and
HRV features – including statistical moments, power spectral density components, entropy,
and acceleration and deceleration capacity – which were used to train a logistic regression
classifier. Performance was assessed via repeated random sub-sampling validation. To reduce
noise and activity-related effects, features were calculated from five non-overlapping ten-
minute quiescent segments of RR intervals defined by lowest HR, as well as random ten-
minute segments as a control method. Feature selection was performed and a median AUC
of 0.86 was achieved out-of-sample test set data. This was significantly higher than the AUC
using 24 h of data (0.72) or random segments (0.67), demonstrating the utility of a novel HR
segmentation approach for improving the classification of PTSD from HR and HRV measures.
Further work should prospectively evaluate if classifier output changes significantly with
worsening symptomatology or effective treatment of PTSD.
2.5.4 Multimodal sensing
Here we review studies that utilize heart rate in addition to other sensor types, including
accelerometry, ambient light, and GPS. A patient with milder severity of an illness such as
schizophrenia may not demonstrate significant alterations in accelerometry or heart rate-
derived features in a univariate sense, but multiple weak features can be aggregated together
to train a classifier that accurately infers symptomatology or clinical status. However, com-
mercially available devices with physiologically and behaviorally relevant sensing technolo-
gies of high accuracy have only recently reached the market. Furthermore, awareness of the
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utility of conglomerating several weaker signals is more prevalent amongst machine learn-
ing practitioners than statisticians and clinical investigators. Relatively few studies employ
multi-sensor fusion approaches, and even fewer focus on neuropsychiatric illness.
Kamdar et al. explored the prediction of emotional state from accelerometry, ambient
light, and heart rate data measured via Samsung Gear S smartwatches (Kamdar et al. 2016).
Data was collected from 13 healthy subjects in a pilot test. A web app was also developed
for users to self-report moods via a Likert scale rating of happiness, energy, and relaxation.
The app also captured user keystrokes and mouse patterns. Each subject wore the Gear S
watch for at least 6 hours and entered at least three self-reported moods over a single day.
Several machine learning algorithms were trained using these features: random forest, gradi-
ent boosted regressor trees, regularized logistic regression, SVM, and k nearest neighbors. A
random forest model explained 51% of the variance of emotional state from device-captured
data. However, top features were derived primarily from user interactions rather than pas-
sively monitored physiology. Furthermore, no classifier accuracy metrics – such as AUC of
classification of mood status – were reported, and the authors also reported high levels of
variance in HR measured with the watch compared to a direct pulse measurement, although
the latter method was not specified.
AlHanai et al. used a combination of auditory, text, and physiological signals to predict
the mood (happy or sad) of 31 narrations from ten subjects as they told either happy or
sad stories (AlHanai et al. 2017). Subjects wore wrist-mounted Samsung Simband devices
which recorded PPG, ECG, accelerometry, skin impedance, galvanic skin response, and skin
temperature. Audio was recorded using Apple iPhones. 386 audio and 222 physiological
features were calculated from the data. A subset of 4 audio, 1 text, and 5 physiologic features
were identified using sequential forward feature selection: subject movement, cardiovascular
activity, energy in speech, probability of voicing, and linguistic sentiment (i.e. negative or
positive). A deep neural network was trained using these features to classify if the story was
happy or sad. To ensure the real-time utility of the model, classification was performed over 5
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second intervals. Model performance was assessed via leave-one-subject-out cross-validation,
and the classifier achieved a mean AUC of 0.92.
Osipov et al. measured HR and accelerometry in 16 subjects with schizophrenia and 19
controls using an adhesive monitoring patch (Protues Digital Health, Redwood City, CA)
(Osipov et al. 2015). Features calculated on both types of data included basic summary
statistics – mean, median, mode, and variance – as well rest-activity characteristics (Van
Someren et al. 1999), multiscale sample entropy (Costa et al. 2002), and multiscale trans-
fer entropy (Schreiber 2000). An SVM learned to dichotomize subjects as either having a
diagnosis of schizophrenia or being a control. Two-fold cross-validation with repeated ran-
dom sub-sampling was performed 1000 times. Using HR features resulted in an AUC of
0.85, whereas using activity features resulted in AUC of 0.90. Using both HR and activity
features resulted in an AUC of 0.99.
Reinertsen et al. measured HR and locomotor activity in 12 medicated subjects with
schizophrenia and 12 healthy controls, and classified contiguous days of data as belonging
to a schizophrenia patient or a healthy control (Reinertsen et al. 2017b). Subjects were
monitored for 3–4 weeks using a disposable adhesive patch sensor worn on the chest and
manufactured by Proteus Biomedical (Redwood City, CA). Features derived from time series
data included classical statistical characteristics, rest-activity metrics, transfer entropy, and
multiscale Hfuzzy. The analysis window length, or number of days of data considered per
record, was varied from two to eight days. An SVM was trained with these features to classify
records as belonging to either a schizophrenia or control subject. Model performance was
assessed via subject-wise leave-one-out-crossfold-validation. An analysis window length of
eight days resulted in a high AUC of 0.96. Reducing the analysis window length to two days
only lowered the AUC to 0.91. The type of most predictive features varied with analysis
window length. Classifier output may have represented illness severity or level of ANS
dysfunction, although verifying this in future work will require gathering information about
symptoms on a daily basis.
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Cella et al. monitored 30 subjects with schizophrenia and 25 controls using wrist-worn
Empatica E4 devices which measured skin conductance, PPG (from which RR intervals
were derived), and accelerometry (Cella et al. 2017). Symptom severity in subjects with
schizophrenia was assessed via the PANSS questionnaire. Subjects were monitored for six
days, and recordings < 60 minutes were excluded. At least two 8-hour recordings were
obtained for each subject, with an average of 3-4 8-hour recordings obtained per subject.
Skin conductance did not vary by patient group, but subjects with schizophrenia had sig-
nificantly lower SDNN and RMSSD values, as well as lower locomotor activity and fewer
hours of structured activity, compared to controls. Chlorpromazine levels were not found to
significantly affect any physiological measures.
2.6 Conclusion
In closing, many studies have explored the use of smartphones, wearable accelerometers,
Holter devices, and multimodal sensors for monitoring of patient physiology, psychology,
and behavior. These technologies continue to decrease in cost and permeate other facets
of daily life. However, several technical challenges remain that if addressed could improve
the accuracy, interpretability, and potential usability of passive monitoring for research and
patient care. Most analyses are performed on all available data in an effort to maximize the
amount of information that may contain clinically relevant insights, despite the presence of
noise and endogenous behavioral or physiological signals unrelated to illness throughout a
recording. The relationship between classifier accuracy and quality of EKG data has been
evaluated, but the influence of data quantity, time of recording, and other contextual infor-
mation on the performance of a machine learning algorithm must still be studied to better
inform monitoring approaches. Finally, univariate measures of signal regularity or complex-
ity over multiple time scales have been found to correlate with illness, but the dynamics
of how different physiological and behavioral signals interact in an information-theoretical
sense, and the association of these dynamics with disease, remains unexplored.
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CHAPTER 3
CLASSIFICATION OF PTSD FROM HEART RATE DATA
3.1 Overview
Objective. HRV characterizes changes in autonomic nervous system function and has been
shown to vary with post traumatic stress disorder (PTSD). However, HR data has noise
and artifactsdue to intrinsic issues with measurement as well as volitional movement and
behavior.
Approach. We proposed to improve the signal-to-noise ratio of HR data via a HR-based
window segmentation approach whereby five 10-minute segments with the lowest median HR
are isolated. These segments may represent quiescent periods, or times when the subject was
least likely to be engaged in volitional motor activity and/or most likely to be sleeping or
resting. To validate the approach, single-channel ECG data were collected from 23 subjects
with current PTSD, and 25 control subjects with no history of PTSD over 24 hours. RR
intervals were derived from these data, cleaned, and used to calculate HR and HRV metrics.
Features were derived from 1) RR data from these segments, 2) RR data from five randomly
selected 10-minute control segments, or 3) all 24 hours of RR data. Classifier performance
was assessed via repeated random sub-sampling validation, and area under the receiver
operating characteristic curve (AUC) was calculated.
Main results. A combination of the four most predictive features derived from quiescent
segments resulted in a median area under the receiver operating curve (AUC) of 0.86 on
out-of-sample test set data. This was significantly higher than the AUC using 24 hours of
data (0.72) or random segments (0.67).
Significance. These results demonstrate our segmentation approach improves the classi-
fication of PTSD from HR and HRV measures, and suggest the potential for tracking PTSD
illness severity via objective physiological monitoring (Reinertsen et al. 2017a). Future stud-
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ies should prospectively evaluate if classifier output changes significantly with worsening or
effective treatment of PTSD. Determining if this approach is useful for clinical decision sup-
port will require a larger randomized controlled trial with monitoring connected to specific
outcomes.
3.2 Motivation and study organization
Patients with PTSD have significantly different measures of heart rate variability (HRV)
compared to healthy controls (Liddell et al. 2016; Minassian et al. 2014). HRV – changes
in beat-to-beat heart rate – can be used to assess changes in the autonomic nervous system
(Clifford 2002; Pan et al. 2016). Recently, twins with PTSD were reported to have 49% lower
low frequency (LF) HRV compared to their brothers without PTSD (Shah et al. 2013). When
attempting to identify differences in autonomic function as measured by HRV, it is important
to control for other factors such as stress, affect, physical activity, and cardiovascular or
neurological disease other than PTSD.
Evaluating HRV during sleep can account for confounding from stress, affect, and phys-
ical activity (Germain et al. 2005). Furthermore, some reports show HRV reductions due to
PTSD are greatest during the night (Woodward et al. 2009; Kobayashi et al. 2014), suggest-
ing that analyzing data only during nocturnal sleep could improve classifier performance.
However, HRV metrics vary by sleep stage due to changes in vagal and sympathetic activity
during REM, light and deep sleep (Vanoli et al. 1995; Viola et al. 2002). Segmentation by
sleep stage may thus improve the signal to noise ratio. For example, in earlier work using this
novel methodology, we showed that comparing HRV metrics in REM sleep, and separately in
deep sleep, better separated sleep apneic patients from healthy controls (Clifford et al. 2004).
This approach may also apply to other illnesses associated with changes in HRV measures,
such as PTSD. However, accurately measuring sleep status or estimating sleep stage from
other data such as HR is difficult.
PTSD has been classified using self-reported data and demographics (Kessler et al. 2014;
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Karstoft et al. 2015; Galatzer-Levy et al. 2014). However, a multivariate classifier separating
PTSD patients and controls using HRV measures or other objective physiological data has
not yet been developed. Additionally, the utility of thresholding on individual HRV measures
to identify PTSD has yet to be evaluated.
Here we propose a novel method of controlling for activity by only evaluating quiescent
segments of RR intervals, with quiescence determined by lowest median HR for each subject.
This segmentation approach may reduce random error from mental and physical activity,
highlight involvement of the autonomic nervous system, and approximate restfulness in the
absence of validated sleep stage data.
The objectives of this work are to: 1) calculate features from HR and HRV measures
indicative of PTSD in male veterans using 24-hour Holter ECG recordings, 2) use these
features to train a multivariate classifier whose output – a probability of membership in
either the PTSD or control group – could potentially be used as a proxy for illness severity
in a patient already diagnosed with PTSD, and 3) improve classifier performance using a
novel segmentation method on RR intervals to reduce noise and potential confounders.
All data processing, feature extraction, and classifier training was performed using Matlab
R2016b (Mathworks, Natick, MA).
3.3 Methods
3.3.1 Subject enrollment
ECG recordings were obtained from 24 male subjects with current PTSD (symptoms within
the past 30 days) and 26 healthy control subjects in a dataset derived from the Emory
Twins Studies first reported by Shah et al. 2013. This smaller cohort was selected to balance
classes, i.e. a similar number of subjects with PTSD as controls. Participants were subjects
with clinical diagnoses of PTSD, and healthy control subjects examined at the same time
at the Emory University General Clinical Research Center. Individuals lacking sufficient
ECG data were excluded (see exclusion criteria in later sub-section). All participants wore
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an ambulatory ECG (Holter) monitor (GE Marquette SEER digital system; GE Medical
Systems, Waukesha, WI) for 24 hours. Participants had matched recording times and sched-
ules. Activity was restricted to non-strenuous walking around the university campus and
medical center, and participants were told to refrain from smoking or drinking alcohol or
coffee. This study was approved by the Emory Institutional Review Board (81004), and all
subjects signed an informed consent.
3.3.2 Data recording
The ECG signal was sampled at 125 Hz. Data were downloaded to a local HIPAA-compliant
data repository using a MARS SEER Light digital recorder. QRS complexes were detected
and annotated in the ECG automatically using the GE MARS software. RR intervals were
calculated from the time difference between adjacent annotated beats.
3.3.3 Data pre-processing and exclusion criteria
RR intervals obtained later than 24 hours after the start of recording were discarded. Ectopic
beats and artifacts were removed via established methods (Task Force of The European So-
ciety of Cardiology and The North American Society of Pacing and Electrophysiology 1996);
non-physiological RR intervals with values >1.5 seconds or <0.33 seconds were discarded,
and RR intervals 20% shorter or longer than the previous RR interval, or 20% shorter or
longer than the overall mean RR interval were discarded. Gaps in the time series were in-
terpolated via linear spline. RR intervals were re-sampled at 3.413 Hz (1024 samples per
five minute segment) to create a uniformly spaced time series for spectral HRV measures.
One subject with PTSD and one subject without PTSD had fewer than 22 hours of ECG
recordings; both were excluded from further analysis. Cleaned RR intervals were obtained
from 23 subjects with PTSD and 25 control subjects (48 total). To demonstrate the utility
of data pre-processing, uncleaned RR intervals were also evaluated as a comparison.
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3.3.4 Identification of quiescent segments
To reduce confounding effects of mental and physical activity, five non-overlapping ten-
minute periods with the lowest median HR – hereafter referred to as “quiescent segments” –
were identified from cleaned RR data for each subject. Figure 3.1illustrates a representative
24-hour RR tachogram from a study subject, with quiescent segments indicated by shaded
regions. Healthy humans cycle through each of the five defined sleep stages with a period
of approximately 100 minutes, and each sleep stage lasts up to 20 minutes; this informed
our selection of segment length (Clifford et al. 2004). For each subject, each feature was
calculated for each of five quiescent segments, resulting in 5×m total features per subject.
For each feature, the median feature value from the five segments was calculated, resulting in
m features per subject to be used for training a logistic regression model. Feature extraction
was also performed on ten-minute segments chosen at random, excluding quiescent segments
of lowest HR, to serve as a control and to investigate if segment length was a confounder.
Figure 3.1: Representative time series of RR interval data from a single subject. Shaded
red areas are ten-minute quiescent segments. Horizontal axis is time of day in hours; 13
corresponds to 1 PM, 1 corresponds to 1 AM, etc. ECG recording started at the origin of
the x-axis (approximately 1 PM).
3.3.5 Feature extraction and Heart Rate Variability measures
Cleaned RR intervals from either a) all 24 hours of ECG recordings, b) random control
segments, or c) quiescent segments were used to calculate features. These features included
the median quiescent window time converted to radians, basic RR interval statistics (mean,
46
median, mode, standard deviation (σrr), interquartile range (IQRrr), skewness, and kurtosis),
AC, DC, power spectral measures (VLF, LF, HF, total power), and other measures of the
distribution of RR intervals (NNN, MNN, PNN, PNN50, RMSSD, and SDNN) (Task Force
of The European Society of Cardiology and The North American Society of Pacing and
Electrophysiology 1996).
3.3.6 Power spectral measures of HRV
HRV power spectral measures were computed from cleaned RR interval time series with a
fast Fourier transform (FFT) and a Parzen window, following our previous methodology
(Shah et al. 2013). The FFT and spectra were corrected for window attenuation and boxcar
sampling. The power spectrum was integrated over four discrete frequency bands: ultra-low
frequency (ULF) <0.0033 Hz; very low frequency (VLF) 0.0033 – 0.04 Hz; low frequency
(LF) 0.04 – 0.15 Hz; and high frequency (HF) 0.15 – 0.40 Hz (Bigger et al. 1992). These
frequency bands measure the renin-angiotensin, sympathetic, and parasympathetic cardio-
vascular control systems (Akselrod et al. 1981). Total power, incorporating the full spectrum
from 0 – 0.40 Hz was also estimated.
3.3.7 Phase-rectified signal averaging
Phase-rectified signal averaging (PRSA) was performed on cleaned RR intervals to quantify
acceleration and deceleration capacity of HR. This method can be used to detect quasi-
periodic oscillations and to separate processes occurring during increasing and decreasing
parts of the signal (Bauer et al. 2006b). Furthermore, PRSA is robust to noise and non-
stationarity. Heartbeat interval shortenings are used as anchors for acceleration-related
PRSA signals, whereas heartbeat interval lengthenings are used as anchors for deceleration-
related PRSA signals. Sampling frequency was set to 512 Hz, and the window length around
anchors was set to 30 elements.
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3.3.8 Assessment of PTSD
The Structured Clinical Interview for Psychiatry Disorders was administered to classify
subjects into two classes: 1) current PTSD with symptoms within the past 30 days, or 2)
no history of PTSD (control subjects).
3.3.9 Feature selection and classification
All twenty features, as well one feature at a time, were used to train a logistic regression. The
output of this binary classifier was the probability of membership in the PTSD class. L1L2
(elastic net) regularization was performed to reduce coefficient values for collinear or non-
predictive features and create a sparser and more generalizable model. Unconstrained dif-
ferentiable multivariate optimization was performed using minFunc. Specifically, maximum
likelihood estimation was performed via quasi-Newton limited-memory Broyden-Fletcher-
Goldfarb-Shanno updating (Bishop 1995). Distributions of features from PTSD and control
subjects were visualized and compared via two-sided Kolmogorov-Smirnov tests. Addition-
ally, given the relatively low number of features, a grid search was performed to assess
combinations of features.
To assess classifier performance on out-of-sample data, we performed bagging with re-
placement, an ensemble method to reduce variance and avoid overfitting (Breiman 1996;
Arlot et al. 2010). Data were randomly split into training and test data at a 70:30 ratio,
with the class balance in training and test sets maintained to reflect the class balance in the
entire data set. By random sampling with replacement, some data may be used more than
once between models, or not be used at all. Features in the training set were transformed to
have Gaussian distributions using either the identity, square root, or logarithmic transforma-
tions. The transformation which provided the lowest k-statistic using the Lilliefors test was
used on both training and test sets. Data were then z-scored to by subtracting the training
mean and dividing by the training standard deviation on both the training and test sets. A
grid search was performed to select the value of λ ranging from 0.001 – 5.0 that maximized
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the test set AUC within the model. The classifier thus learned solely from training data,
and was evaluated solely on test data. Sampling, feature transformation, learning, and clas-
sifier evaluation was repeated nine more times for a total of ten models. AUC, accuracy,
sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV)
were calculated for training and test sets within each model.
3.4 Results
3.4.1 Temporal distribution of quiescent segments
The temporal distribution of quiescent segments does not differ by PTSD status (P = 0.23
via two-sided Kolmogorov-Smirnov test; Figure 3.2). Box plots are not associated with the
y-axis; + indicates the mean, the middle line indicates the median, the box denotes the
interquartile range (IQR) flanked by the 25th and 75th percentiles, the vertical lines outside
of the box indicate the 9th and 91st percentiles, and circles indicate outliers.













PTSD (N = 23)
Ctrl (N = 25)
Figure 3.2: Temporal distribution of quiescent segments does not differ by PTSD status
(P = 0.23). The x-axis denotes hour of the day (i.e. hours past midnight), ranging from 0
to 24; 12 corresponds to noon. Red indicates quiescent segments from subjects with PTSD
(23 subjects); blue indicates quiescent segments for healthy controls (25 subjects).
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3.4.2 Classifier trained on all features
All twenty features were used to train an L1L2 regularized logistic regression. Classifier
performance was assessed for three different segmentation approaches, and using either un-
cleaned or cleaned RR intervals. Using quiescent segments of cleaned RR intervals results
in greater predictivity compared to other segmentation approaches, with a training AUC of
0.87 and a test AUC of 0.70 (Table 3.1).
Table 3.1: AUCs of L1L2 regularized logistic regression models using all HR and HRV
features extracted from RR intervals. Values shown are medians and IQR bounds in brackets.
Train AUC Test AUC
No RR cleaning RR cleaning No RR cleaning RR cleaning
24 hours 0.77 [0.75 0.82] 0.75 [0.70 0.78] 0.54 [0.46 0.64] 0.58 [0.46 0.64]
Random segments 0.76 [0.73 0.80] 0.78 [0.77 0.80] 0.50 [0.45 0.57] 0.56 [0.50 0.71]
Quiescent segments 0.89 [0.87 0.91] 0.87 [0.83 0.89] 0.73 [0.70 0.80] 0.75 [0.71 0.82]
3.4.3 Classifier trained on individual features and combinations of features
To improve classifier performance, individual features and combinations of features were used
to train a regularized logistic regression. Testing many combinations of features is computa-
tionally inefficient, but was feasible here given the small number of features and fast speed
of training a logistic regression model. Classifier performance was assessed for three differ-
ent segmentation approaches, using uncleaned or cleaned RR intervals. A classifier trained
on the most predictive combination of four features derived from quiescent segments of RR
intervals achieves greater predictivity (training AUC = 0.85, test AUC = 0.84) compared to
when using features derived from random segments or 24 hours of RR intervals (Table 3.2).
The most predictive combination of four features derived from 24 hours of RR intervals
is σrr, IQRrr, LF power, and SDNN (Table 3.3). The most predictive combination of four
features derived from quiescent segments of RR intervals were AC, DC, LF power, and SDNN
(Table 3.4). The β coefficients of these most predictive models are shown in Table 3.5, and
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other classifier performance metrics are shown in Table 3.6.
Table 3.2: AUCs of L1L2 regularized logistic regression models using the top four features
extracted from RR intervals. Values shown are medians across sub-samples and IQR bounds
in brackets.
Train AUC Test AUC
No RR cleaning RR cleaning No RR cleaning RR cleaning
24 hours 0.74 [0.73 0.78] 0.73 [0.69 0.74] 0.66 [0.45 0.66] 0.67 [0.62 0.71]
Random segments 0.70 [0.66 0.76] 0.76 [0.72 0.77] 0.61 [0.50 0.64] 0.72 [0.62 0.77]
Quiescent segments 0.85 [0.84 0.88] 0.85 [0.83 0.88] 0.81 [0.70 0.84] 0.86 [0.75 0.88]
Table 3.3: Features extracted from 24 hours of of RR intervals, shown as medians and IQR
bounds in brackets. CTRL refers to the control group. Test AUC reports performance of
univariate classifier trained solely on one feature.
PTSD status
Feature PTSD CTRL Test AUC
AC (sec) −8.28 [−1.27e1 −6.31] −1.04e1 [−1.33e1 −8.18] 0.54 [0.52 0.68]
DC (sec) 8.19 [6.55 1.23e1] 1.05e1 [8.89 1.38e1] 0.58 [0.54 0.73]
LF power (sec2)†, ? 3.51e2 [1.37e2 4.91e2] 5.86e2 [3.76e2 8.76e2] 0.71 [0.64 0.80]
σrr (sec)
? 1.15e−1 [9.15e−2 1.34e−1] 1.29e−1 [1.14e−1 1.51e−1] 0.65 [0.59 0.73]
IQRrr (sec)
? 1.76e−1 [1.26e−1 2.11e−1] 2.08e−1 [1.52e−1 2.34e−1] 0.63 [0.59 0.67]
SDNN (sec)? 3.89e1 [2.97e1 5.42e1] 5.07e1 [4.09e1 6.32e1] 0.61 [0.55 0.75]
†: P < 0.05 comparing feature values from PTSD vs. control subjects via two-sided Kolmogorov—Smirnov test.
?: Feature among combination that maximizes training set AUC.
3.4.4 Distributions of predictive features
Distributions of predictive features were visualized (Figure 3.3 – Figure 3.5). Box plots are
not associated with the y-axis; + indicates the mean, the middle line indicates the median,
the box denotes the IQR flanked by the 25th and 75th percentiles, the vertical lines outside
of the box indicate the 9th and 91st percentiles, and circles indicate outliers.
Segmentation improves separability of some features as determined by two-sided Kolmogorov-
Smirnov tests. AC does not significantly differ by PTSD status when evaluating 24 hours
of data (P = 0.24), but is significantly higher in subjects with PTSD versus controls when
analyzing quiescent segments (P = 0.04; Figure 3.3). Similarly, DC does not significantly
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Table 3.4: Features extracted from quiescent segments of of RR intervals, shown as medi-
ans and IQR bounds in brackets. CTRL refers to the control group. Test AUC reports
performance of univariate classifier trained solely on one feature.
PTSD status
Feature PTSD CTRL Test AUC
AC (sec)†, ? −9.62 [−1.26e1 −6.22] −1.28e1 [−1.91e1 −9.72] 0.77 [0.73 0.82]
DC (sec)†, ? 9.43 [6.64 1.22e1] 1.40e1 [1.11e1 2.06e1] 0.82 [0.73 0.84]
LF power (sec2)†, ? 3.31e2 [1.52e2 5.78e2] 8.71e2 [4.44e2 1.47e3] 0.81 [0.75 0.88]
σrr (sec)
† 4.14e−2 [3.44e−2 5.34e−2] 7.12e−2 [4.9e−2 8.06e−2] 0.82 [0.73 0.84]
IQRrr (sec)
† 5.40e−2 [3.55e−2 5.60e−2] 7.20e−2 [5.50e−2 9.38e−2] 0.78 [0.71 0.81]
SDNN (sec)†, ? 4.68e1 [3.16e1 5.97e1] 6.47e1 [4.32e1 7.70e1] 0.75 [0.57 0.86]
†: P < 0.05 comparing feature values from PTSD vs. control subjects via two-sided Kolmogorov—Smirnov test.
?: Feature among combination that maximizes training set AUC.
Table 3.5: β coefficients of L1L2 regularized logistic regression models trained on four most
predictive features from either 24 hours or quiescent segments of RR intervals. Values shown
are medians across sub-samples and IQR bounds in brackets.
24 hours Quiescent segments
Feature Coefficient value Feature Coefficient
β1 Intercept 0.06 [0.05 0.06] Intercept 0.08 [0.08 0.11]
β2 σrr 0.46 [0.35 0.51] AC 1.12 [1.03 1.60]
β3 IQRrr 0.29 [0.22 0.54] DC 0.80 [0.61 1.06]
β4 LF power 0.00 [-0.03 0.07] LF power 0.32 [0.00 0.67]
β5 SDNN -0.04 [-0.31 -0.00] SDNN 0.30 [0.01 0.39]
differ by PTSD status when evaluating 24 hours of data (P = 0.13), but is significantly
lower in subjects with PTSD versus controls when analyzing quiescent segments (P = 0.01;
Figure 3.4). LF power is lower in PTSD for both 24-hour data (P = 0.01) and quiescent
segments of data (P = 0.01; Figure 3.5). SDNN does not differ by PTSD status for 24 hours
of data (P = 0.06), but is significantly lower in PTSD when analyzing quiescent segments
(P = 0.04; Figure 3.8).
3.5 Discussion
In this study on 23 subjects with current PTSD and 25 controls, HR and HRV features were
calculated and used to train an L1L2 regularized logistic regression to classify PTSD status.
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Table 3.6: Classifier performance on test set data using most predictive logistic regression
models trained on features extracted from RR intervals after using three different segmenta-
tion approaches. Values shown are medians across sub-samples and IQR bounds in brackets.
PPV is positive predictive value and NPV is negative predictive value.
Segmentation approach
Metric 24 hours Random segments Quiescent segments
AUC 0.67 [0.62 0.71] 0.70 [0.62 0.79] 0.86 [0.75 0.88]
Accuracy 0.73 [0.67 0.73] 0.73 [0.67 0.80] 0.80 [0.73 0.80]
Sensitivity 0.57 [0.43 0.71] 0.43 [0.43 0.57] 0.71 [0.57 1.00]
Specificity 0.94 [0.75 1.00] 1.00 [0.88 1.00] 0.94 [0.88 1.00]
PPV 0.92 [0.71 1.00] 1.00 [0.78 1.00] 0.94 [0.83 1.00]
NPV 0.69 [0.67 0.75] 0.67 [0.64 0.73] 0.79 [0.73 0.88]
(a) 24 hours of data (b) Quiescent segments
Figure 3.3: Acceleration capacity (AC) does not differ by PTSD status for 24 hours of RR
intervals (a; P = 0.18) but is higher in subjects with PTSD for quiescent segments (b;
P < 0.05).
A classifier trained on a combination of the four most predictive features – LF power, σrr,
IQRrr, and SDNN for 24 hours of RR intervals, and AC, DC, LF power, and SDNN for
quiescent segments – achieved out-of-sample test AUCs of 0.67 using 24 hours of RR interval
data, 0.72 using random segments, and 0.86 using quiescent segments. The simple HR-based
window segmentation approach isolated data with the highest signal-to-noise by definition,
since data with “signal” was implicitly defined as that with information that maximally
improved predictivity of the classifier.
Sleep disordered breathing and sleep disruption are both associated with PTSD, so prox-
ies of sleep are expected to differ by PTSD status (Yesavage et al. 2014; Germain 2013).
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(a) 24 hours of data (b) Quiescent segments
Figure 3.4: Deceleration capacity (DC) does not differ by PTSD status for 24 hours of
RR intervals (a; P = 0.09) but is lower in subjects with PTSD for quiescent segments (b;
P < 0.05).
(a) 24 hours of data (b) Quiescent segments
Figure 3.5: Low frequency (LF) power differs by PTSD status for both 24 hours of RR
intervals (a; P < 0.05) and quiescent segments (b; P < 0.05).
However, the time of median quiescent segments did not significantly differ with PTSD sta-
tus (P = 0.23; Figure 3.2), indicating these factors were not significant in this cohort. Most
quiescent segments occurred from midnight to early morning in control subjects. A larger
portion of segments were distributed closer to noon in subjects with PTSD. Periods of low
HR – a measure of restfulness, not sleep stage – can occur at any time and may reflect differ-
ences in sleep patterns, differences in activity, or both. Quiescent segments may contain less
noise and movement artifact, as well as reflect lower levels of mental and physical activity,
and thus improve the performance of a classifier trained on features from those segments.
Next, all HR and HRV measures were used as features for a logistic regression classifier.
L1L2 regularization was performed to reduce coefficient values associated with collinear or
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(a) 24 hours of data (b) Quiescent segments
Figure 3.6: σrr (standard deviation of RR intervals) does not differ by PTSD status for
24 hours of RR intervals (a; P = 0.25) but but is higher in control subjects for quiescent
segments (b; P < 0.05).
(a) 24 hours of data (b) Quiescent segments
Figure 3.7: IQRrr (interquartile range of RR intervals) does not differ by PTSD status for 24
hours of RR intervals (a; P = 0.47) but is higher in control subjects for quiescent segments
(b; P < 0.05).
redundant features, and to isolate predictive features. A classifier trained on all 20 features
from 24 hours of RR intervals achieved a low test AUC of 0.58 (Table 3.1). Using features
extracted from quiescent segments improved the test AUC to 0.75, whereas the use of ran-
domly selected control segments resulted in a low test AUC of 0.56. Compared to these low
test AUCs, training AUCs were 0.75, 0.78, and 0.87 for 24 hours, random segments, and qui-
escent segments of RR intervals respectively. These results show a model using all features
over-fits training data and would not generalize to out-of-sample data despite regularization.
Classifier performance was similar when using uncleaned RR interval data.
Regularization attempts to reduce co-linearity by effectively placing a prior on model
coefficients, forcing sparsity with small weights. However, the posterior – formed by updating
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(a) 24 hours of data (b) Quiescent segments
Figure 3.8: Standard deviation of normal-to-normal RR intervals (SDNN) does not differ by
PTSD status for 24 hours of RR intervals (a; P = 0.06) but is higher in control subjects for
quiescent segments (b; P < 0.05).
Table 3.7: Standard logistic regression on all subjects (N=48) using predictive features
extracted from 24 hours of cleaned RR intervals (RRi). OR is odds ratio, and CI is confidence
interval.
Feature β coefficient P-value OR [95% CI]
σrr 0.08 0.90 1.1 [3.1e-01 3.8]
IQRrr 0.10 0.84 1.1 [4.3e-01 2.9]
LF -0.36 0.44 7.0e-01 [2.8e-01 1.7]
SDNN -0.01 0.99 9.9e-01 [3.3e-01 2.9]
the prior with evidence – determines the final form of a model. Thus, with small data sets,
even regularized models trained with many features may not work well compared to the use
of a hard prior via manual feature selection. Therefore, individual features and combinations
of features were used to train lower-dimensional models.
Given m = 20 total features and a subset of k = 1, 2, . . . ,m features, the number of





. To ensure feasible computation time and a parsimonious and interpretable model, the
maximum number of features used in a combination was limited to four, i.e. k = 1, 2, . . . , 4.
Furthermore, using more than four features led to the selection of colinear features and
overfitting on the training data (results not shown).
Values of some individually predictive features, and test set AUC and accuracy for clas-
sifiers trained these features, are shown in Table 3.3. Distributions of some features were
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Table 3.8: AUCs of L1L2 regularized logistic regression models using the top four features
extracted from cleaned RR intervals, for either all subjects (N=48) or just paired twins
(N=38). Values shown are medians across sub-samples and IQR bounds in brackets.
All subjects Paired twins
Train AUC Test AUC Train AUC Test AUC
24 hours 0.73 [0.69 0.74] 0.67 [0.62 0.71] 0.70 [0.66 0.72] 0.64 [0.56 0.75]
Random segments 0.74 [0.73 0.80] 0.74 [0.57 0.77] 0.79 [0.75 0.83] 0.76 [0.58 0.78]
Quiescent segments 0.85 [0.83 0.88] 0.86 [0.75 0.88] 0.86 [0.82 0.88] 0.81 [0.69 0.86]
compared via a two-sided Kolmogorov-Smirnov test, but selected the most predictive comn-
bination features on the basis of maximizing training AUC. For classification, features should
be chosen on the basis of predictability rather than significance, because significance alone
does not guarantee predictability (Lo et al. 2015). For 24 hours of RR intervals, LF power
significantly differed by PTSD status and was one of the four most predictive combination
of features (Table 3.3). The other most predictive features were σrr, IQRrr, and SDNN,
but these did not significantly differ by PTSD status. For quiescent segments, the median
value of the four most predictive combination of features – AC, DC, LF power, and SDNN
– significantly differed by PTSD status (Table 3.4).
AC did not differ by PTSD status for 24 hours of RR intervals, but was higher in subjects
with PTSD for quiescent segments (Figure 3.3). Similarly, DC did not differ by PTSD status
for 24 hours of RR intervals, but was lower in subjects with PTSD for quiescent segments
(Figure 3.4). AC may reflect physiologic performance when parasympathetic withdrawal
occurs, whereas DC measures general parasympathetic augmentation (Bauer et al. 2006b;
Pan et al. 2016). Although some literature suggests that AC also measures sympathetic
activation, this is unlikely because sympathetic modulations occur at 0.1 Hz, which may be
four times faster than the modulation frequency of AC, depending on the underlying heart
rate (Julien 2006).
LF power differed by PTSD status for both 24 hours and quiescent segments of RR in-
tervals (Figure 3.5). Differences in these measures by PTSD status may be exacerbated in
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quiescent segments. In PTSD, vagal augmentation is expected during slow wave sleep, which
may be altered by increased insomnia or sleep-disordered breathing. Other physiologic path-
ways may also be affected during abnormal sleep episodes; low LF may reflect baroreceptor
insensitivity (Khoury et al. 2012). These findings underscore physiologic changes that occur
with PTSD.
When shifting from 24 hours to quiescent segments, σrr and IQRrr became less predic-
tive, whereas AC and DC became more predictive. In quiescent segments, σrr in controls
was greater than σrr in subjects with PTSD (Figure 3.6). σrr, IQRrr, and SDNN measure
variability of RR intervals, and were all significantly lower in quiescent segments from sub-
jects with PTSD. This finding is consistent with previous reports of lower variability of HR
being associated with PTSD (Tan et al. 2009; Tan et al. 2011). Additionally, the lack of
significance or predictivity of these features (aside from SDNN, which was a predictive fea-
ture) from 24 hours of RR intervals is unsurprising because quiescent segments were selected
on the basis of low resting HR values, which excludes periods with higher variability. Con-
cerning AC and DC, quiescent segments approximate restfulness rather than sleep state, but
may also correspond to slow-wave sleep, during which vagal activity may be augmented and
the predictivity of PRSA measures increased.
We calculated β coefficients of L1L2 regularized logistic regressions trained on four most
predictive combination of features from 24 hours or quiescent segments of RR intervals
(Table 3.5). Although LF power and SDNN were among the most predictive features when
using either 24 hours or quiescent segments of RR intervals, the β coefficients of these
features significantly differed depending on the segmentation approach. For example, the
median β coefficient for LF power computed from 24 hours of RR intervals was close to
zero, but for quiescent segments, the median β coefficient was 0.32. This difference suggests
interactions between features that reflect the complexity of the underlying physiology, and/or
a dependence on time scale.
A regularized classifier trained on the most predictive combination of four features from
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a) quiescent segments outperformed classifiers using b) all 24 hours of RR intervals, or c)
on random control segments, with test AUCs of a) 0.86, b) 0.67, and c) 0.70 respectively
(Table 3.6). Using quiescent segments instead of 24 hours of RR intervals improved every
performance metric except specificity, which did not change. Using quiescent segments
instead of random segments improved every performance metric except specificity and PPV,
which decreased. This suggests classifier performance depends on the information within
segments rather than the quantity of data.
We also compared the distribution of classifier output using a Wilcoxon signed rank test
to account for the paired nature of these data, and found a statistically significant differ-
ence between Pestimated(PTSD | features from subjects with PTSD) and Pestimated(PTSD |
features from control subjects) (P<0.001). This suggests the classifier accurately discrimi-
nated PTSD status.
Here the AUC can be interpreted as the ability of a model to classify PTSD status using
disease-associated physiological changes. Although learning was done with data from healthy
controls, this approach would be suited for monitoring patients with established PTSD. It
would not be a screening test for the general population. Future studies could assess how
treatments affect physiology, and classify or even predict post-intervention recovery.
We note several limitations of our study. First, our cohort consisted only of 23 subjects
with PTSD and 25 controls. This small sample size may not have been adequately powered
to detect smaller effect sizes. Our study design would be more elegant with discordant
pairs only; however, this would eliminate ten unpaired twins and could reduce statistical
power. To evaluate this we compared classifier performance using all subjects (N=48) versus
using only paired twins (N=38) (Table 3.8). No statistically significant differences were
found using a two-sided Wilcoxon rank-sum test between all subjects and only paired twins
cohorts in training or test AUCs for any segmentation approach. This may be due to two
competing effects. Reducing sample size could diminish the ability of the classifier to learn
predictive features, and decrease out-of-sample test set performance by learning features
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not representative of the population distribution. Furthermore, HRV may be about 50%
heritable (Su et al. 2010). If HRV and PTSD share an underlying genetic and physiological
cause, and our approach evaluates features related to this mechanism, adding paired twins
could confound the study, enrich both positive and negative classes with similar physiology-
based features, and reduce classifier performance. However, focusing on twins could reduce
the random error caused by differences in cardiovascular or autonomic physiology between
subjects. Our results suggest the inclusion of non-twins does not reduce the impact of our
findings, since we aimed to developed a system for monitoring physiology of subjects with
PTSD rather than for screening a correlated population.
A second limitation of our work was only recording 24 hours of ECG data per subject.
Our approach could potentially enable home-based continuous physiologic monitoring of
the efficacy of a PTSD intervention. However, doing so would require longer monitoring
than 24 hours and additional validation studies. Additionally, longitudinal monitoring could
necessitate a specific, rather than sensitive assay, to prevent alarm fatigue driven by false
positives. Prospective studies with larger sample sizes and a testable intervention will need
to be performed in order to determine clinical utility.
A third limitation is our lack of locomotor activity data, which if present may have
enhanced the accuracy of our classifier. Previously we have shown the addition of locomotor
activity to HRV metrics improves accuracy of classification of schizophrenia (Osipov et al.
2015). This could also be the case for PTSD; locomotor activity may improve signal quality
assessment or directly indicate disturbed sleep, sedentary behavior, or avoidance of traumatic
stimuli.
A fourth limitation is model output being probability of a PTSD diagnosis, which is a
coarse proxy for illness severity. Our method would estimate a low probability of illness for
a subject who is diagnosed with PTSD yet has atypically low levels of ANS dysfunction.
Other aspects of PTSD symptomatology described in the DSM-V – such as negative alter-
ations in mood or problems concentrating – have yet to be evaluated in the context of HRV
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measures. Estimating particular manifestations of PTSD severity may be more clinically
useful than estimating PTSD status. However, doing so would require larger studies with
multimodal data including high-resolution ECG recordings, locomotor activity, and clinical
questionnaires.
Despite several limitations, this approach of classifying mental illness from physiological
data has applications beyond PTSD. Changes in ANS function and psychological stress occur
in other psychiatric illnesses such as bipolar disorder and depression, and are detectable
using noninvasive physiological sensors (Burns et al. 2011; Sano et al. 2013; Tsanas et al.
2016; Palmius et al. 20177). Previously we used HRV measures and locomotor activity to
accurately separate subjects with schizophrenia from healthy controls (Osipov et al. 2015).
Our novel approach of extracting features from quiescent segments of RR intervals could also
be applied to locomotor activity, which correlates with illness status and HR. Techniques
that improve the signal-to-noise ratio and enable fusing of complementary data sources could
aid the classification of other mental illnesses. Other possible applications of this approach
are to monitor adherence to medication, or to assess efficacy of an intervention. Interpreting
model output as illness severity rather than a probability of class membership could alert a
caregiver of deterioration or a sustained problem in a patient.
The utility of computational approaches to interpret multiple statistical and dynamic
features of physiological signals has become increasingly apparent in all fields of biomedicine.
Complex, information-rich settings such as critical care or sleep medicine are especially fertile
sources of data with which to build tools and address clinical questions (Monasterio et al.
2012; Behar et al. 2013).
3.6 Conclusion
We classified PTSD in 48 male veterans using L1L2 regularized logistic regression trained
on HR and HRV features. Classifiers trained on the most predictive four features from 24
hours or random ten-minute control segments of RR intervals achieved test AUCs of 0.67
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and 0.70, respectively. Test AUC was increased to 0.86 by segmenting RR intervals into
quiescent ten-minute segments to filter out activity- or noise-related effects. This approach
demonstrates the feasibility of a simple HR-based windowing approach for identifying seg-
ments of data with information correlating to the output classes predicted by the model.
To our knowledge this is the first report of classification of PTSD status using non-invasive
physiological features. This approach may provide a long-term ambulatory index of PTSD
severity, have applications in the study and management of other mental illnesses, and be
useful for other clinical disciplines where cardiovascular disease and stress are significant
factors. We emphasize a passive monitoring approach would not be used for diagnosing
patients in lieu of a trained clinician, and would rather be used to assess patient status in
near real-time. Large randomized controlled trials comparing passive monitoring of PTSD
to standard of care are required to determine the viability of this approach for clinical deci-




COMBINING HEART RATE AND LOCOMOTOR ACTIVITY DATA TO
CLASSIFY SCHIZOPHRENIA
4.1 Overview
Objective. Schizophrenia has been associated with changes in HR, HRV, and locomotor ac-
tivity. A previous study used HRV and locomotor activity features to accurately dichotomize
patients from controls, and achieved nearly perfect classification with an AUC of 0.99 when
using the ten days of data with the least missing data among all days of data (Osipov et
al. 2015). However, the window length – number of contiguous days of time series data
from which features are derived – dictates the time scale over which relevant phenomena are
represented, and remains an under-explored topic in the field of passive sensing for health
monitoring. A scale of hours to days contains information about circadian rhythms and
sleep, a scale of days to weeks contains information about social drivers of behavior (i.e.
cadence of the work week), and a scale of months may be necessary to measure physiology
or behavior mediated by hormonal cycles or seasons. The selection of window length of data
thus may be an important consideration for continuous patient monitoring.
Approach. In an effort to simulate real-time monitoring of patients diagnosed with
schizophrenia, we used objective HR and activity data to classify contiguous days of data as
belonging to a patient or a healthy control. HR and physical activity recordings were made
on 12 medicated subjects with schizophrenia and 12 healthy controls. Features derived from
these data included classical statistical characteristics, rest-activity metrics, transfer entropy,
and multiscale fuzzy entropy. We varied the analysis window length from two to eight days,
and selected features via minimal-redundancy-maximal-relevance. A support vector ma-
chine was trained to classify schizophrenia from control windows on a daily basis. Model
performance was assessed via subject-wise leave-one-out-crossfold-validation.
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Main results.An analysis window length of eight days resulted in an area under a receiver
operating characteristic curve (AUC) of 0.96. Reducing the analysis window length to two
days only lowered the AUC to 0.91. The type of most predictive features varied with analysis
window length.
Significance. Our results suggest continuous tracking of subjects over short time may
differentiate patients with schizophrenia from healthy controls (Reinertsen et al. 2017b).
Further research is needed to determine whether this approach can accurately detect varia-
tions in symptom severity in short periods of time.
4.2 Motivation and study organization
Schizophrenia is a chronic psychiatric disease and global health problem with a lifetime
prevalence of 4.0/1,000 (Saha et al. 2005). It is among the most disabling and economically
catastrophic disorders; the overall cost of schizophrenia to the U.S. in 2002 was estimated
at $62.7B due to clinical care, medication, and unemployment (Wu et al. 2005). Onset usu-
ally occurs in early adult years. Schizophrenia is characterized by delusions, hallucinations,
disorganization of speech and behavior, and a higher rate of co-occurring psychiatric disor-
ders. Depression prevalence is 25%, which is higher than the rate in the general population
(Buckley et al. 2009), and lifetime risk of suicide is 5% (Hor et al. 2010; Kahn et al. 2015).
Schizophrenia is diagnosed via clinical interview, in which the psychiatrist asks the pa-
tient and family members about characteristic symptoms and assesses if social and/or occu-
pational dysfunction has occurred for at least six months. However, schizophrenia impairs
insight which can hinder the accuracy of self-reporting, challenging both initial diagnosis
as well as subsequent monitoring of clinical status. Although treatment with medications
can relieve psychotic symptoms, adherence to therapy is poor and patients generally do
not achieve substantial improvements in social, cognitive and occupational functioning (By-
erly et al. 2007). Cognitive-behavioral therapy, cognitive remediation, and educational and
employment support are helpful but resource-intensive, as well as reliant on patient voli-
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tion and/or social support systems. Given the burden of advanced illness on the patient,
family members, and society, and the tendency for psychotic relapse and/or exacerbation,
objective measures of clinical status could have tremendous benefit in the management of
schizophrenia. Currently, psychiatric care in the United States is not delivered via a tele-
health mechanism, and follow-up of clinically stable patients with schizophrenia occurs in
an ambulatory outpatient setting every several weeks to months depending on severity. An
accurate, passive, and objective measure of clinical status and/or severity could enable ear-
lier identification of relapse, more rapid adjustment of medication dose to compensate for
fluctuating symptoms, and identification of more detailed phenotypes of illness.
Differences in power spectral and/or entropy measures of both activity and heart rate
(HR) have been reported in schizophrenia patients versus healthy controls (Bär et al. 2008;
Wulff et al. 2012; Hauge et al. 2011). These sophisticated measures include frequency compo-
nents and information theory complexity, contain more information than classical statistical
characteristics such as the mean of a signal, and reflect changes in the ANS.
Previously we reported differences in ANS function, sleep patterns, and locomotor activity
in subjects with schizophrenia versus healthy controls. We accurately distinguished patients
already diagnosed with schizophrenia from healthy controls by training a machine learning
algorithm with features derived from HR and locomotor activity selected from the highest-
quality ten days of data recorded from a body worn patch (Osipov et al. 2015). Using both
HR and activity features improved classification accuracy compared to using features from
just one data type. However, the amount of data used was selected on the basis of maximizing
classifier performance rather than practical study design considerations. Furthermore, time
scales of relevant physiology and behavior differ. A feature calculated from a few days
of data may contain information about systems mediated by circadian rhythms and sleep.
Alternatively, a feature calculated from a week or more of data may contain information
about social activity, behavior, and lower-frequency physiological dynamics. Assessing if
feature selection and classifier performance varies with different lengths of data could improve
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our understanding of how features relevant to mental illness depend on time scale. Such
work could contribute to passive, objective, and near real-time monitoring of schizophrenia
patients to detect early signs of illness relapse, medication adherence, or treatment efficacy.
Here we vary the analysis window length of recorded HR and locomotor activity data, extract
features from these data, train a support vector machine (SVM) to differentiate patients with
schizophrenia from healthy controls, and evaluate classifier performance for differing analysis
window lengths.
4.3 Methods
4.3.1 Participants and data collection
16 clinically stable outpatient subjects diagnosed with schizophrenia, and 19 healthy control
volunteers without a history of mental disorders were recruited for the study. All subjects
were unemployed. Although the prevalence of schizophrenia is only 4/1000 in the general
population, this balanced cohort was appropriate for our study aim: to develop a method
for estimating illness severity in subjects with an established diagnosis of schizophrenia. Age
and gender did not significantly differ among the two groups, as assessed via a two-sided
Student’s t-test and Fisher’s exact test, respectively. Subjects diagnosed with schizophre-
nia were taking anti-psychotic medications including Olanzapine, Risperidone, Aripiprazole,
Perphenazine, Fluphenazine, Ziprasidone, Haloperidol, and Quetiapine.
HR and locomotor activity were monitored for 3-4 weeks using a disposable adhesive
patch sensor worn on the chest and manufactured by Proteus Biomedical (Redwood City,
CA). Electrocardiogram (ECG)-derived HR data were collected every 10 min by calculating
mean HR over 15-sec intervals. Accelerometry-derived locomotor activity data were collected
every 5 min by calculating mean acceleration over 15-sec intervals. Data were transmitted
to a mobile phone via Bluetooth and further uploaded to a central server for processing.
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4.3.2 Data pre-processing
Matlab R2016a (Mathworks, Natick, MA) was used to analyze HR (beats per minute, or
BPM) and locomotor activity (normalized units ∈ [0, 1]) time series data, which were col-
lected with variable recording rates and lengths. Data collected at an insufficient sampling
rate – after an interval exceeding 1.5× the sampling period, which equals 15 min for HR
and 7.5 min for activity – were discarded. Additionally, HR values lower than 20 BPM or
higher than 160 BPM were labeled as low-quality and removed. A day was considered to
have sufficient data if it contained both a) at least 50 HR data points and b) at least 50
locomotor activity data points. Subjects with fewer than 10 days of sufficient data were
removed.
Four subjects with schizophrenia lacked sufficient amounts of data, and 12 subjects with
schizophrenia possessed sufficient amounts of data. Prior to analysis, excess control subjects
were removed at random to ensure both groups had 12 patients (24 subjects total). HR data
were re-sampled to 10-min intervals, and activity data were re-sampled to 5-min intervals,
both via linear interpolation.
Data pre-processing, feature extraction, classifier training, and model evaluation were
performed for sliding contiguous windows of length of w days where w ∈ [2, 4, 6, 8]. Days
with at least 50 HR and at least 50 activity data were considered viable. Days with fewer
data were skipped. The ith analysis window started at day di and ended at day di + w − 1
where di is the i
th day of data. i started at 1 and incremented to the last day of viable data
for a subject. If a day was not viable, i.e. lacked sufficient data, no features were extracted,
schizophrenia status was not estimated, and the algorithm incremented to the next day.
4.3.3 Statistical characteristics
HR and locomotor activity are affected in schizophrenia so we calculated classical statistical
characteristics of HR and activity, including mean, median, mode, standard deviation (σ)
and interquartile range (IQR) (Bär et al. 2008; Hauge et al. 2011; Rachow et al. 2011).
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4.3.4 Rest-activity characteristics
Circadian rhythm disruption has been shown to play a significant role in schizophrenia (Wulff
et al. 2012). We calculated rest–activity characteristics of HR and activity, including mean
level during the least active five hours (L5), mean level during the most active 10 hours
(M10), relative amplitude (RA, equation 1), interday stability (IS, Equation 2) and intraday
variability (IV, Equation 3) (Witting et al. 1990; Van Someren et al. 1999).
4.3.5 Behavioral features
The same features were extracted as described in our previous work, including basic sta-
tistical characteristics, rest-activity characteristics, and multiscale transfer entropy (MTE)
between HR and activity data. 36 total features were calculated, which are described in
Osipov et al. 2015. However, instead of multiscale entropy (MSE) we calculated multiscale
fuzzy entropy, a novel metric of sequence complexity described earlier in this thesis.
4.3.6 Multiscale fuzzy entropy
Lower time scales of MSE provide the best features for training a classifier to distinguish
schizophrenic from healthy subjects (Osipov et al. 2015). Therefore we evaluated MFE of
HR and activity data for the first four time scales (in the coarse-graining sense, not window
length). Furthermore, a classifier trained on MFE of HR data from patients with heart
failure outperformed a classifier trained on MSE of the same data (Liu et al. 2013). Thus,
we calculated MFE of HR and activity data for the first four time scales, using parameter
values mHR = 3, mact = 2, rHR = 0.1, and ract = 0.15.
4.3.7 Transfer entropy
Transfer entropy given by TX→Y is a measure of directional coupling between two concur-
rently sampled time series X = {x1, x2, ..., xN} and Y = {y1, y2, ..., yN}. Formally, TX→Y is
a reduction in uncertainty, given by the conditional entropy of yi given its past values minus
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where i indicates a given point in time, t and w are the time lags in X and Y respectively,
and k and l are the block lengths of past values in X and Y respectively. k and l were both
set to 1 to improve computational speed (Lee et al. 2012).
Multiscale transfer entropy (MTE) was calculated by coarse-graining HR and activity
time series τ times, estimating joint probability distribution functions via D-V partitioning,
and calculating THR→act(τ) and Tact→HR(τ) for τ = 1, 2, ..., τmax time scales.
4.3.8 Feature selection
In order to reduce the number of features used and minimize overfitting, a feature selec-
tion approach was necessary. Features were z-scored, discretized, and ranked via minimum
Redundancy Maximum Relevance (mRMR) criteria (Peng et al. 2005). This approach si-
multaneously minimizes mutual information between individual features x in a feature set
S:






and maximizes mutual information between features x and classes (sometimes referred
to as labels or targets) c:
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where I(x; y) is the mutual information between variables x and y, and p(x), p(y), and







These two constraints for D and R are combined into one expression φ(D,R) which is
optimized as follows:
max φ(D,R) = D −R (4.5)
The mRMR algorithm ordered features by values of φ from highest to lowest. Hereafter,
“most predictive” refers to the subset of features with the highest values of φ.
Statistical characteristics, rest-activity characteristics, MTE, and MFE were calculated
and 36 features total were ranked via mRMR. The most predictive i features (where i ∈
1, 2, ...,m) were used to train a machine learning algorithm.
4.3.9 Classification of schizophrenia status among subjects
Subjects were classified as either having a diagnosis of schizophrenia or being healthy, using
libsvm, an open-source SVM library (Chang et al. 2011). The two–dimensional matrix of
features consisted of W windows by m features, and the one-dimensional array of labels
consisted of W binary labels. Each analysis window was labeled as 1 if belonging to a
schizophrenia patient, or 0 if belonging to a healthy control. A Gaussian radial basis function
kernel with γ = 0.0312 was selected based on previous work (Osipov et al. 2015).
The most predictive features identified via mRMR were used to train the SVM, which
output probability estimates of a subject being labeled as schizophrenic, P (SZ), rather
than healthy. Classifier performance was assessed via subject-wise leave-one-out crossfold
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validation (LOOCV; given N patients, N −1 patients are used to train the classifier and the
remaining patient is used as the test set), and various attributes of classifier performance were
calculated, including area under the receiver operating characteristic curve (AUC), accuracy,
sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV).
The number of most predictive features (number of features maximizing the AUC) was also
determined.
Pre-processing, feature extraction, and classifier assessment were performed for analysis
window lengths of two, four, six, and eight days. The SVM was trained using windows, not
on individual days or subjects.
4.4 Results
The number of features resulting in the maximum AUC, and the maximum AUC value itself,
both differed with analysis window length (Figure 4.1). With a analysis window length of
two days, the model achieved a maximum AUC of 0.91 using three most predictive features.
With an analysis window length of eight days, the model achieved a maximum AUC of 0.96
using 11 most predictive features. Table 4.1 lists other classifier performance metrics for
varying window lengths.
Box plots of the most predictive features (i.e. the combination of features which maxi-
mized the training AUC) for two-day and eight-day analysis windows are shown in Figure 4.2
and Figure 4.3 respectively. For two-day analysis windows, the three most predictive fea-
tures in order of more to less predictive are 1) the standard deviation of activity (σact), 2)
the multiscale fuzzy entropy of heart rate at the first time scale (MFEHR,1), and 3) the mode
of activity (Moact).
For eight-day analysis windows the 11 most predictive features in order of more to less
predictive are 1) MFEHR,1, 2) IQRact, 3) Moact, 4) the multiscale transfer entropy from
activity to HR at the first time scale (coarse-graining) (MTEact→HR,1), 5) σact, 6) MFEact,4,
7) MFEHR,4, 8) the intraday variability of activity (IVact), 9) MTEact→HR,2, 10) MFEact,2,
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Figure 4.1: AUC versus number of most predictive features, selected out of 36 total features
via mRMR, used to train the SVM. The blue line represents two-day analysis windows
and the red line represents eight-day analysis windows. The maximum AUC for two-day
analysis windows is 0.91 using the three most predictive features, and the maximum AUC
for eight-day analysis windows is 0.96 using the 11 most predictive features.
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Figure 4.2: Box plots of most predictive features selected via mRMR using two-day analysis
windows. The SZ label on the x-axis indicates features from schizophrenia patients. These
three features in combination maximized the training AUC. The red + indicates the mean,
the middle horizontal red line indicates the median, the blue box denotes the interquartile
range (IQR) flanked by the 25th and 75th percentiles, and the vertical lines outside of the
box indicate the 9th and 91st percentiles. The median value of every feature significantly
differed by schizophrenia status, with P < 0.05 calculated via two-sided Wilcoxon rank-sum
test.
Probability density estimates of classifier output (estimated probability of a window of
data belonging to a subject with schizophrenia) for schizophrenia patients distinctly differed
from those of control subjects. This difference was large for both two-day (Figure 4.4a) and
eight-day analysis windows (Figure 4.4b).
ROC curves showed a positive correlation between analysis window length and AUC
(Figure 4.5). AUC values ranged from 0.91 for two-day analysis windows to 0.96 for eight-
day windows. Increasing window length increased most metrics of classifier performance
(Table 4.1) with only a few exceptions. Increasing window length from two to four days
reduced sensitivity from 0.89 to 0.85 and NPV from 0.79 to 0.76. Increasing analysis window
length from four to six days reduced specificity from 0.98 to 0.94, and PPV from 0.98 to
0.97. Increasing window length from six to eight days reduced NPV from 0.77 to 0.76.
To assess the relative contribution of each type of feature (i.e. heart rate, locomotor
activity, or both combined) we compared classifier AUC versus feature type for analysis
window lengths of two or eight days. With an analysis window length of two days, features
from HR resulted in a classifier AUC of 0.80, features from locomotor activity resulted in























































Figure 4.3: Box plots of most predictive features selected via mRMR using eight-day analysis
windows. The SZ label on the x-axis indicates features from schizophrenia patients. These
11 features in combination maximized the training AUC. The red + indicates the mean,
the middle horizontal red line indicates the median, the blue box denotes the interquartile
range (IQR) flanked by the 25th and 75th percentiles, and the vertical lines outside of the
box indicate the 9th and 91st percentiles. The median value of every feature significantly
differed by schizophrenia status, with P < 0.05 calculated via two-sided Wilcoxon rank-sum
test.
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(a) Two-day analysis windows
















(b) Eight-day analysis windows
Figure 4.4: Probability density estimates of classifier output – estimated probability of a
window of data belonging to a subject with schizophrenia – using (a) two-day and (b) eight-
day analysis windows. Leave-one-out cross-validation was performed. Classifier output is on
the x-axis, and proportion is on the y-axis; all y-values for a class sum to unity.

















2-day window: AUC = 0.91
4-day window: AUC = 0.94
6-day window: AUC = 0.95
8-day window: AUC = 0.96
Figure 4.5: Receiver operating characteristic (ROC) curves vary with analysis window length.
Leave-one-out cross-validation was performed. Blue, red, yellow and purple denote two, four,
six, and eight-day windows respectively. The y-axis is the true positive rate, or sensitivity.
The x-axis is the false positive rate, or 1− specificity.
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a classifier AUC of 0.91 (Table 4.2). These results demonstrate an improvement classifier
performance when using features from both HR and locomotor activity data, compared to
using features from either category alone.
HR and activity data, estimated P (SZ), optimal classifier thresholds, and data quantity
were visualized against 24-hour intervals into the study for a representative subject with
schizophrenia (Figure 4.6a) and a representative healthy control subject (Figure 4.6b).
Table 4.1: Classifier performance metrics versus window length, using both HR and activity
features. Leave-one-out cross-validation was performed. Reported metric is for held-out test
set data. PPV indicates Positive Predictive Value and NPV indicates Negative Predictive
Value.
Window length (days)
Metric 2 4 6 8
AUC 0.91 0.94 0.95 0.96
Accuracy 0.85 0.89 0.89 0.91
Sensitivity 0.89 0.85 0.87 0.87
Specificity 0.76 0.98 0.94 0.99
PPV 0.87 0.98 0.97 0.99
NPV 0.79 0.76 0.77 0.76
Table 4.2: Area under the ROC curve (AUC) vs. window length and feature type used to
train support vector machine. Leave-one-out cross-validation was performed. AUCs reported
for held-out test set data, calculated via leave-one-out-cross-validation.
Window length (days)
Feature type(s) 2 8
Heart rate (HR) 0.84 0.90
Activity 0.86 0.89
HR and activity 0.91 0.96
4.5 Discussion
We built on previous work using features derived from HR and activity to classify medicated
schizophrenia patients from healthy controls. Here we evaluated the relationship between
analysis window length and classifier accuracy.
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(a) Subject with schizophrenia
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(b) Healthy control subject
Figure 4.6: HR data (top row), activity data (second row), classifier output (probability of
schizophrenia, or P (SZ); third row), and data quantity versus time (bottom row) for a (a)
schizophrenia patient and a (b) healthy control subject. Heart rate is in beats per minute
(BPM), activity is in normalized units (N.U.), P (SZ) is a probability, and data quantity is
in raw counts. P (SZ) for a window length of two days is shown by the red +’s. The classifier
threshold for a two-day window is P (SZ) = 0.45, is shown by the red solid line. P (SZ) for
a window length of eight days is shown by the blue circles. The classifier threshold for a
window length of eight days, P (SZ) = 0.73, is shown by the blue dashed line. On the data
quantity plot, the minimum data quantity (at least 50 HR and at least 50 activity data)
required to make a estimate of P (SZ) on a given day is shown by the black dotted line.
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(a) HR data from all subjects

















(b) Activity data from all subjects
Figure 4.7: Distribution of raw a) HR data and b) activity from all subjects, separated by
schizophrenia status. Distributions of HR data were significantly different (P¡0.001; two-
sample Kolmogorov-Smirnov test), but medians were not significantly different (P=1.00;
two-sided Wilcoxon rank sum test). Results were identical when these tests were performed
on activity data.
Using two-day analysis windows, a maximum AUC of 0.91 was achieved using the three
most predictive features. Using eight-day analysis windows, a maximum AUC of 0.96 was
achieved using the 11 most predictive features (Figure 4.1). Both AUCs sharply increased as
initial features were added. For the two-day model, adding more than three features steadily
lowered the AUC, aside from a slight rise in classifier performance when moving from 16 to
17 features. On the other hand, for 4-, 6-, and 8-day models the AUC stayed close to 0.90
for a wide range of 10 to 25 features. This may be due to the fact that, for the two-day
model, the number of data points is low enough that higher-dimensional models begin to fit
more noise.
The ranking of features via mRMR criteria depended on analysis window length (4.2,
4.3). The most predictive feature from two-day analysis windows was σact with a median
± IQR of 0.08 ± 0.05 units for the schizophrenic group compared to 0.13 ± 0.04 units for
the control group. This difference was statistically significant (P < 0.05, Wilcoxon rank-
sum test), contrasting with results from Hauge et al. 2011, which also reported significantly
lower levels of mean activity in schizophrenic patients. Our algorithm did not identify mean
activity as a predictive feature. However, that work reported the evaluation of long-term
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patients from an open ward, whereas our study evaluated outpatients in relative symptomatic
remission. Illness severity and behavioral markers may have differed.
The 2nd most predictive feature for two-day analysis windows was MFEHR,1, with a
median ± IQR of 0.95 ± 0.50 in schizophrenic patients and 1.30 ± 0.40 in controls. The
3rd most predictive feature for two-day analysis windows was Moact, with a median ±
IQR of 0.013± 0.002 in schizophrenic patients and 0.012± 0.001 in controls. All three most
predictive features for two-day analysis windows differed significantly by schizophrenia status
(P < 0.05, Wilcoxon rank-sum test).
The most predictive feature for eight-day windows was MFEHR,1, with a median ± IQR
of 0.89 ± 0.46 for schizophrenic patients and 1.24 ± 0.19 for controls (4.3). This difference
was consistent and statistically significant for both two- and eight-day analysis windows
(P < 0.05, Wilcoxon rank-sum test). Other predictive features for eight-day analysis win-
dows represent the spread of the distribution of activity, such as IQRact and σact. We note
skewness, kurtosis, mean, or median of activity were not predictive features. Furthermore,
aside from MFEHR,1 and MFEHR,4, no other HR statistics were predictive.
MTEact→HR,i denotes the transfer entropy, or amount of uncertainty reduced in future
values of HR by knowing the past values of activity given past values of HR, at a time
scale i. For two-day analysis windows, MTEact→HR,i was not a predictive feature for any
time scale. However, when using eight-day analysis windows, MTEact→HR,i was a predictive
feature for i = 1 and i = 2. When using two-day analysis windows, MTEact→HR,i was still
predictive; however, it was not as predictive as the most predictive three features described
above. These results suggest activity-driven changes in HR become more predictive at longer
time scales.
We used the mRMR framework to select features on the basis of maximizing predictivity
(relevance), and minimizing collinearity (redundancy) (Peng et al. 2005). Although our
most-predictive features were all separable in a univariate sense, features should be selected
by predictivity rather than significance for classification tasks (Lo et al. 2015). Features
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may be inseparable in a univariate sense but strongly separable in higher dimensions. On
the other hand, a feature may significantly differ between classes in a univariate or even
multivariate sense, but may still not contribute predictive accuracy to a model.
With two-day analysis windows, the SVM classifier produced grossly distinct distributions
of output for schizophrenia patients versus healthy controls, demonstrating excellent classifier
performance (Figure 4.4a). However, a few analysis windows were mislabeled. Using eight-
day analysis windows resulted in similar excellent classifier performance evidenced by large
separability of classifier output between windows of data from schizophrenia patients and
healthy controls (Figure 4.4b).
AUC increased with analysis window length, from 0.91 for two days, up to 0.96 for eight
days (Figure 4.5). In our previous work, an SVM was trained using the 10 days missing the
least data from each subject, and achieved an AUC of 0.99 (Osipov et al. 2015). In this
work, classifier performance was slightly lower because we did not pick “best” days among
several weeks of data. Rather, we slid an analysis window through all days from all patients
and trained a classifier on individual windows. This approach better represents a realistic
scenario in which only a few days of patient data are obtained.
We also assessed how analysis window length affects the sensitivity, specificity, positive
predictive value, negative predict value, and accuracy of the classifier for different window
lengths (Table 4.1). Specificity exceeded 0.90 for four-, six-, and eight-day windows. The
AUC uniformly increased with window length. Compared to two-day windows, four-day
windows resulted in a higher AUC, accuracy, and specificity, but sensitivity dropped from
0.89 to 0.85. A decrease in sensitivity is undesirable when the cost of missing a true positive
is high (e.g. suicide). A monitoring system to track illness severity of patients already
diagnosed with schizophrenia might thus prioritize sensitivity, although doing so increases
false positives.
Analysis window length determined which features are most predictive, mediates classifier
performance, perhaps due to differing time scale of relevant physiology and behavior. Prior
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work on the association between schizophrenia and disturbances in the ANS as measured
by heart rate variability metrics has shown a similar dependence on physiologically and
behaviorally relevant time scales (Bär et al. 2008; Rachow et al. 2011). A feature calculated
from two days of data may contain information about systems mediated by circadian rhythms
and sleep. Alternatively, a feature calculated from eight days of data may contain information
about social activity, behavior, and lower-frequency physiological dynamics. On the scale of
days to weeks, social drivers of behavior (i.e. cadence of the work week) that are not present
on the scale of hours may become more apparent in these data. Schizophrenia patients
typically have disrupted social routines (Kahn et al. 2015). Recordings on the order of
months may be necessary to measure physiology or behavior mediated by hormonal cycles
or seasons. The selection of analysis window length thus may be an important consideration
in the design of studies for monitoring patients with mental illness.
We assessed the relative contribution of HR and locomotor activity features to classifier
accuracy. Previously we have shown a combination of HR and activity features outperforms
either HR or activity features alone (Osipov et al. 2015). Here we show the same trend
for both two- and eight-day analysis windows (Table 4.2). For two-day analysis windows,
using activity features (AUC of 0.86) resulted in better classifier performance than HR
features (AUC of 0.84). For eight-day analysis windows, using HR features (AUC of 0.90)
resulted in slightly better classifier performance than activity features (AUC of 0.89). Using
both HR and activity features together improved the AUC, for both two- and eight-day
analysis windows. Locomotor activity and HR are correlated – the former introduces artifact
and random error to HR, and HR tends to rise during locomotor activity – yet contribute
complementary and non-redundant information about subject behavior that improves the
predictive accuracy of a classifier.
Individual data for patients, estimated probabilities of schizophrenia P (SZ), and data
quantity for each 24-hr interval were visualized for a representative schizophrenia patient
(4.6a) and healthy control subject (4.6b). Time series data were re-sampled during signal
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processing, so overall data quantity per 24-hr interval was almost equal between schizophrenia
and control subjects. Upon visual inspection, HR appears more periodic for the schizophrenia
patient compared to the control. This observation is consistent with MFEHR,1 being signif-
icantly lower in schizophrenia patients than in controls for both two- (4.2) and eight-day
analysis windows (4.3), and with previous reports of lower HR complexity in these patients
(Rachow et al. 2011).
For some schizophrenia patients, estimated P (SZ) occasionally fell below the classifica-
tion threshold (Figure 4.6a). Likewise, for some control subjects, estimated P (SZ) rose above
the threshold (Figure 4.6b). Due to the lack of more richly labeled data, it is unclear if this
misclassification indicates control subjects have schizophrenic-like days and schizophrenia
patients have normal-like days. Regardless, averaging strategies could theoretically reduce
false positives. The optimal trade-off between sensitivity or specificity is determined by the
use case and cost of false positives or false negatives; here we simply maximized the AUC.
We note several limitations of our study. Our sample size was relatively small and limited
to patients from one geographic region and institution. Also, several factors such as mental
and behavioral state, social status, and medication usage affect HR and activity.
Although we controlled for employment status as a proxy for social routine – which relates
to activity and restfulness to some extent – we did not explore other potential confounders
that could affect HRV or locomotor activity. Literature suggests potential confounders such
as weight, BMI, diet, smoking status, renal function, etc. have a moderate effect on HRV.
However, the dominant factor by an order of magnitude is the mental response (Bernardi et
al. 2000). The second-largest dominant factor is physical movement (Knoepfli-Lenzin et al.
2010). In this work we also analyzed locomotor activity, which we have previously shown
contains predictive information for classifying subjects by schizophrenia status (Osipov et al.
2015).
Stress relates to mental state with physiological and behavioral manifestations, and could
thus influence our features. Skin conductance, a biomarker for stress mediated by the sym-
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pathetic nervous system, has been shown to differ in schizophrenia patients (Bär et al. 2008).
Additionally, cortisol secretion and stress sensitivity may be associated with schizophrenia,
or subsequent development of schizophrenia following the prodromal phase of the illness
(Walker et al. 2013; Holtzman et al. 2013). Stress affects activity as well as other aspects of
mobile device usage; Sano et al. 2013 reported using using screen on, mobility, call or activity
level information to distinguish stressed from non-stressed individuals with an accuracy of
75%.
Aside from matching employment status, we did not directly control for stress in our
study. Doing so with conscious patients is challenging especially in an ambulatory set-
ting. Additionally, stress invariably accompanies social risk factors such as physical abuse,
sexual abuse, maltreatment and bullying, which are associated with increased risk of later
schizophrenia (Stilo et al. 2010).
Evaluating data solely from periods of lower activity or stress based on physiology could
reduce confounding from these random variables. Recently we attempted to reduce noise in
data and improved classifier performance by selecting quiescent periods of data with lowest
median HR, which is a proxy criterion for restfulness (Reinertsen et al. 2017a). More sophis-
ticated change point detection approaches could potentially sort data into parametrically
similar segment, and even further increase the signal-to-noise ratio of features derived from
data within each segment (Adams et al. 2007).
Antipsychotic medications have been reported to exacerbate ANS dysfunction in schizophre-
nia patients, potentially putting patients at greater risk of cardiac mortality (Rechlin et al.
1994; Birkhofer et al. 2013; Huang et al. 2013). On the other hand, Mondelli et al. demon-
strated that antipsychotic medication can reduce cortisol secretion and normalize HPA-axis
hyperactivity in patients suffering from psychosis (Mondelli et al. 2010). Bär et al. 2008
did not find significant changes in ANS function after antipsychotics were administered to
patients, while Henry et al. 2010 et al. found that risperidone, valproate, or mood stabilizers
did not significantly affect HRV in bipolar or schizophrenia patients. We lacked more de-
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tailed information about the type, dose, or adherence of antipsychotic medications taken by
patients in our study. We thus cannot claim our results generalize to non-medicated subjects
with schizophrenia. However, a classifier affected by a patient’s medication could potentially
be used to monitor adherence and treatment efficacy.
Illness severity in schizophrenia fluctuates from day to day (Kahn et al. 2015) and strongly
correlates with measures of ANS dysfunction such as HR variability (Henry et al. 2010;
Montaquila et al. 2015; Bär et al. 2005; Bär et al. 2008). Our classifier output varied from
day to day (Figure 4.4a), was based on measures of ANS dysfunction and behavior, and may
have reflected fluctuations in illness severity. However, we lacked detailed information about
daily changes in symptoms, e.g. Brief Psychiatric Rating Scale survey data, which would be
necessary for training a classifier to estimate illness severity accurately.
Lastly, some hyper-parameters of our model, such as entropy template length and mini-
mum amount of data per day, were selected from prior work instead of optimized. Classifier
performance could likely be improved using techniques such as Bayesian optimization (Ghas-
semi et al. 2014; Shahriari et al. 2016).
4.6 Conclusion
We evaluated the relationship between analysis window length of data recordings and clas-
sifier accuracy in a small cohort of schizophrenia patients and healthy controls. A support
vector machine was trained on HR and locomotor activity data obtained via body-worn
patches and windowed over varying lengths ranging from two to eight days. A novel metric
– multiscale fuzzy entropy – contributed to the predictive accuracy of our model. Our ap-
proach accurately classified schizophrenia status in a small cohort of subjects with an AUC
of 0.91 for an analysis window length as short as two days, and an AUC of 0.96 for an
analysis window length of eight days. Features selected as most predictive also varied with
analysis window length. This work serves as technical proof of feasibility of using HR and
activity features to differentiate patients with schizophrenia from healthy controls. Further
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research is needed to determine whether this approach can accurately detect variations in
symptom severity in short periods of time.
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CHAPTER 5
INTERACTIONS BETWEEN HEART RATE AND LOCOMOTOR
ACTIVITY
5.1 Overview
Objective. Changes in heart rate (HR) and locomotor activity reflect changes in autonomic
physiology, behavior, and mood. These systems may involve interrelated neural circuits that
are altered in psychiatric illness, yet their interactions are poorly understood. We hypothe-
sized interactions between HR and locomotor activity could be used to discriminate patients
with schizophrenia from controls, and would be less able to discriminate non-psychiatric
patients from controls.
Approach. At least ten days of contiguous HR and locomotor activity were recorded
via wearable patches in 16 patients with schizophrenia and 19 healthy controls. Measures
of signal complexity and interactions were calculated over multiple time scales, including
sample entropy, mutual information, and transfer entropy. A support vector machine was
trained on these features to discriminate patients from controls. Additionally, time series
were converted into a network with nodes comprised of HR and locomotor activity states,
and edges representing state transitions. Graph properties were used as features. Leave-one-
out cross validation was performed. To compare against non-psychiatric illness, the same
approach was repeated in 41 patients with atrial fibrillation (AFib) and 53 controls.
Main results. Network features enabled perfect discrimination of schizophrenia patients
from controls with an areas under the receiver operating characteristic curve (AUC) of 1.00
for training and test data. Other bivariate measures of interaction achieved lower AUCs
(train 0.98, test 0.96), and univariate measures of complexity achieved the lowest perfor-
mance. Conversely, interaction features did not improve discrimination of AFib patients
from controls beyond univariate approaches.
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Significance. Multiscale network dynamics quantified interactions between HR and loco-
motor activity. These features enabled perfect discrimination of subjects with schizophrenia
from controls, but were less performant in a non-psychiatric illness. This is the first quantita-
tive evaluation of interactions between physiology and behavior in patients with psychiatric
illness.
5.2 Motivation and study organization
Schizophrenia is a severely disabling and chronic mental illness which affects over 21 million
people worldwide (Saha et al. 2005). Currently schizophrenia is diagnosed and managed by
mental health professionals, whose availability is often scarce, particularly in low- and middle-
income countries (Saxena et al. 2007). Additionally, in the context of stable schizophrenia
treated in the outpatient setting, months to years can pass between clinical visits despite
changes in patient status over shorter time scales (NICE guideline (CG178) 2014).
To assess clinical status more frequently and without direct observation, noninvasive
technologies such as smartphones and wearable devices that measure locomotor activity via
accelerometry, heart rate (HR), and other signals have been investigated. High resolution
accelerometry has also been used to measure changes in social routine and circadian rhythms
in mental illnesses such as depression, bipolar disorder, and schizophrenia (Van Someren et
al. 1999; Reinertsen et al. 2017b; Millar et al. 2004; Berle et al. 2010). Pulse sensors and
electrocardiography (ECG) are used to assess HR and heart rate variability (HRV) measures,
which indicate dysfunction in the autonomic nervous system (ANS). These tools could alert
providers to a change in a patient’s condition, monitor the effectiveness of interventions, and
identify mediators of illness severity (Steinhubl et al. 2015).
While HR and locomotor activity have been assessed in a univariate sense, measures
of interaction between these signals have not yet been explored, and may incrementally
improve disease classification. In theory, information is transferred between cardiovascular
physiology and behavior over several time scales. In normal individuals, circadian rhythms
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mediate the increase in blood pressure and heart rate during the early morning prior to
an increase in consciousness, which in turn leads to waking and locomotor activity in the
morning. Conversely, the rising of an individual from a chair leads to a rise in blood pressure,
heart rate, and sympathetic tone. These responses, interactions, and transitions between
physiological and behavioral states vary over time scale, and are partially mediated by the
baroreflex and central command, a feed-forward neural mechanism that contributes to motor
and cardiovascular function during arousal and exercise (Hall 2010). Since patients with
schizophrenia have ANS dysfunction, their physiological and physical responses to changes
in HR and locomotor activity may be abnormal (Chang et al. 2009; Montaquila et al. 2015;
Alvares et al. 2016).
Interactions between time series can be quantified via mutual information and transfer
entropy. However, such measures are often calculated using an entire time series and fail to
capture transitions between physiological and behavioral states that could provide clinically
useful information. To better assess these dynamics, a time series can be evaluated over
multiple time scales, and can also be represented as a network. Attributes of this network
may provide a more nuanced measure of system complexity. Previously, networks have been
constructed using beat-to-beat intervals from ECGs (known as RR intervals) of patients
with congestive heart failure, and visually contrasted with networks from healthy controls
(Campanharo et al. 2011). Recently we demonstrated the utility of network representations
for the early prediction of sepsis, indicating an association between systemic inflammation
and a loss of information flow between HR and blood pressure (Shashikumar et al. 2017a).
To our knowledge, interactions between different signals such as HR and locomotor activity
have never been quantified in patients with mental illness. Measures of these interactions
could have clinical utility if found to correlate with disease status or symptom severity.
We hypothesized that measures of interactions between HR and locomotor activity over
multiple time scales can be used to distinguish patients with schizophrenia from healthy
controls. We also evaluated the additional predictive power of interaction measures for dif-
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ferentiating between patients with schizophrenia and controls. To better understand the
generalizability and limitations of this approach, we also tested if such interactions could
differentiate atrial fibrillation (AFib) from sinus rhythm when applied to 10-minute wrist-
band pulse and locomotor activity recordings from quietly seated subjects. This contrasted
from the schizophrenia analysis because AFib is cardiac-specific, and the recordings occurred
in a highly controlled setting, which limits the ability to assess behavior. We thus hypoth-
esized that measures of interaction between HR and locomotor activity are less useful in
discriminating disease status in AFib than in schizophrenia.
5.3 Methods
The overall approach is illustrated in Figure 5.1. The data and preprocessing are described
in the following four subsections, followed by the extracted features in the subsequent seven
subsections, and finally the classifier in the last subsection.
5.3.1 Schizophrenia study: participants and data collection
16 clinically stable and medicated outpatient subjects diagnosed with schizophrenia, and 19
healthy control volunteers without a history of mental illness were recruited for the study
(previously described by Osipov et al. (Osipov et al. 2015). Subjects were unemployed.
Age and gender did not significantly differ among the two groups, as assessed via a two-
sided Student’s t-test and Fisher’s exact test, respectively. HR and locomotor activity were
monitored for 3-4 weeks using a disposable adhesive patch sensor worn on the chest and
manufactured by Proteus Biomedical (Redwood City, CA). ECG-derived HR data were
collected every 10 min by calculating mean HR over 15 sec intervals. Locomotor activity
data were collected every 5 min by calculating mean acceleration over 15 sec intervals. Data
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Table 1: Characteristics of schizophrenia patients. Values shown are medians and
IQR bounds in brackets.
Patient Control P-value
N 16 19 -
Heart rate (BPM) 81.2 [70.2 92.3] 74.5 [64.7 85.2] < 0.01


























where n is the total number of data, p is the number of data per day, xh are hourly means, x is 
the mean of all data, and xi represents individual data points.
2.5. Behavioral features
The same features were extracted as described in our previous work, including basic statistical 
characteristics, rest-activity characteristics, and multiscale transfer entropy (MTE) between 
HR and activity data. 36 total features were calculated, which are described in Osipov et al 
(2015). However, we calculated multiscale fuzzy entropy, a novel metric of sequence com-
plexity, instead of multiscale entropy (MSE).
2.5.1. Multiscale fuzzy entropy. Activity disorganization is one of the diagnostic criteria for 
schizophrenia (Kahn et al 2015). Hauge et al (2011) indicated that entropy can be used to esti-
mate such disorganization. Moreover, our group has demonstrated that MSE applied to actig-
raphy provided information on disorganization in schizophrenic patients (Osipov et al 2015). 
MSE is the calculation of sample entropy (SampEn) H for a range of time scales of original 
signal (Richman and Moorman 2000, Costa et al 2002). This metric of signal complexity is 
derived from the negative logarithm of the conditional probability of the appearance of longer 
patterns in a signal, considering the presence of a shorter pattern:
H (m, r, N) = − ln A
m(r)
Bm(r) (4)
where m is the template length, r is the radius of similarity or distance threshold between pat-
terns, Am(r) is a probability of matching a template of length m  +  1, Bm(r) is the probability 
of matching a template of length m, and N is the number of elements in the time series. Two 
patterns of length m are considered similar if each point of a pattern in one part of the signal is 
within a normalized distance r from the respective point in the other part of the signal.
To vary time scales of data used to calculate entropy, the original signal was coarse-grained 
to a lower temporal sampling frequency (i.e. by half for each coarse-graining). Coarse-grained 
time series were constructed by averaging the data points within non-overlapping windows 
of increasing length τ. For the τth time scale, each element of the coarse-grained time series, 
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co tributions of each group of features by training machine learning algorithms to
classify schizophrenia patients from controls. Finally, we repeat this approach for a
cohort of patients with atrial fibrillation and discuss how ...
2. Result
2.1. Multiscale mutual information
I(HR; act)
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Figure 1: Multiscale mutual information. A) For schizophrenia patients, the ratio of
mutual information between HR and activity (I(HR; activity)) to the 95th percentile
of I calculated by shu✏ing the original time series 100 times is greater than unity for
all time scales ⌧ . B) For controls in the schizophrenia cohort, the same ratio in A) is
greater than unity for all time scales ⌧ . C) I(HR; activity) of schizophrenia patients
(sz) is significantly higher than in controls (ctrl) for the first three time scales.
Asterisks indicates P<0.05 via Wilcoxon rank-sum test. D) For atrial fibrillation
(AFib) patients, the same ratio in A) is less than unity for all time scales ⌧ . E) For
controls in the AFib cohort, the same ratio in A) is close to unity for all time scales ⌧ .
F) I(HR; activity) in AFib patients is significantly lower than in controls (ctrl) for all
four time scales. Asterisks indicates P<0.05 via Wilcoxon rank-sum test.
2.2. Multiscale transfer entropy
THR!act and Tact!HR were calculated for patients and controls in both the schizophrenia
(Figure 2) and atrial fibrillation cohort (Figure 3).
Figure 5.1: Schematic of data processing and classification alg rithm. DV partitions are
computed from time-lagged and coarse-grained HR and locomotor activity, which are trans-
formed to a network representation. Topological attributes of the networks are used as input
features to a machine learning classifier. DV partitions are also used to compute transfer
entropy for between HR and locomotor activity (and vice-versa) for varying lags and time
scales. Finally, mutual information and sample entropy are calculated for varying time scales.
These features are used to train a classifier to estimate the probability of a subject belonging
to the unhealthy class, P (sz).
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5.3.2 Schizophrenia study: data pre-processing
Data points in the time series of HR (measured in beats per minute, or BPM) and locomotor
activity (measured in normalized units ∈ [0, 1]) with an interval exceeding 1.5× the average
sampling period, which equaled 15 min for HR and 7.5 min for activity data – were discarded.
Additionally, HR values lower than 20 BPM or higher than 160 BPM were labeled as low-
quality and removed. HR and activity data were re-sampled to 5 min intervals via linear
interpolation. The root mean square (RMS) energy of acceleration for the ith interval was
calculated (equation 5.1).
Matlab R2017a (Mathworks, Natick, MA) was used for data pre-processing, feature ex-
traction, machine learning classification, and data visualization.
5.3.3 AFib study: participants and data collection
97 subjects recruited for the study were adult patients (18-89 years old) who were hospital-
ized and undergoing telemetry monitoring at Emory University Hospital, Emory University
Hospital Midtown, and Grady Memorial Hospital (previously described by Shashikumar et
al. 2017 (Shashikumar et al. 2017b). The study was approved by the institutional review
board of each hospital. Patients were recruited at random with an over-sampling of patients
with AFib; rhythms were reviewed by an ECG technician, physician study coordinator, and
cardiologist. 44 subjects had AFib and 53 had other rhythms. Three subjects with AFib
had insufficient data to generate subsequent features and were excluded from analysis. Eight
channel multi-wavelength photoplethysmography (PPG) and tri-axial accelerometry (x, y, z)
were recorded simultaneously at a sampling frequency fs of 125 Hz for 5 min using a research
version of the wrist-worn Simband device (Samsung, Seoul, South Korea).
5.3.4 AFib study: data pre-processing
PPG data from a green light wavelength (520-535 nm) were selected because the commer-
cially available version of the Simband contains green light sensors. Data were de-trended,
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outliers greater than the 95th or less than the 5th percentile were removed, and a 41st order
bandpass filter was used with passband 0.0008 - 0.04 Hz. RR intervals were estimated from
minima of peaks in the cleaned PPG data, non-physiological RR intervals greater than 2
sec or less than 0.375 sec were removed, and RR intervals occurring less than the sampling
period (1/fs sec) after the prior data point were removed.
5.3.5 RMS energy of acceleration
The RMS energy of acceleration during the ith segment of RR intervals is given by
RMS energy =
√
~x2 + ~y2 + ~z2
N
(5.1)
where ~x, ~y, and ~z are x, y, and z-axis accelerometry values in the ith segment, and N is
the number of accelerometry data within this segment.
5.3.6 Statistical moments
The mean, median, mode, variance, skewness, and kurtosis of HR and activity were calcu-
lated for both schizophrenia and AFib groups.
5.3.7 Varying time scales via coarse-graining
Interactions between physiological systems manifest on multiple time scales, and these in-
teractions may differ in healthy versus unhealthy individuals (Ivanov et al. 1999). To assess
measures of complexity and interaction over multiple time scales, coarse-grained time series
were constructed by averaging the data points within non-overlapping windows of increasing
length. The number of time scales τ corresponds to the number of coarse-grainings per-
formed. For the τ th time scale, each element of the coarse-grained time series, y
(τ)











where τ represents the scale factor and 1 ≤ j ≤ N/τ . The first time scale corresponds
to the original time series, the second time scale corresponds to one coarse-graining, etc.
5.3.8 Sample entropy
Sample entropy H is a metric of signal complexity described in 2.1. Here we calculated
MSE Hτ where τ indicates the number of coarse-grainings performed. Optimal parameter
values m, r, and the number of coarse-grainings τmax were selected via Bayesian optimization
(Ghassemi et al. 2014; Shahriari et al. 2016). The same parameter values were used for
calculating sample entropy for both HR and activity, i.e. mHR = mact, and rHR = ract.
5.3.9 Mutual information
The mutual information of two discrete random variables X and Y , given by I(X;Y ),
measures how much knowing one of the two variables reduces uncertainty about the other.
Mutual information was calculated over multiple time scales, e.g. multiscale mutual infor-
mation (MMI). Significant instances of mutual information were determined by Monte Carlo
surrogates, i.e., data randomly shuffled in time. For each subject and time scale, mutual
information were computed for 100 surrogates. Transfer entropy from the original source
time series was deemed to be statistically significant if it was greater than the 95th percentile








where p(x, y) is the joint probability function of X and Y , and p(x) and p(y) are the
marginal probability density functions of X and Y respectively.
For example, if X and Y are independent, then knowing X does not give any information
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about Y and vice versa, so their mutual information is zero.
5.3.10 Darbellay-Vajda (D-V) adaptive partitioning
The computation of transfer entropy and the transformation of time series into a network
representation requires estimating joint probability density functions (PDFs). PDFs were
estimated via the D-V adaptive partitioning algorithm, in which two time series X and Y are
substituted with their ranks ranging from 1 (smallest value) to N (largest value) in sorted X
and Y , in a manner similar to some non-parametric statistical tests. The transformed time
series of X and Y are U = {u1, u2, ..., uN} and V = {v1, v2, ..., vN}. The two-dimensional
space defined by ui−t and vi−w is then recursively partitioned into squares of varying sizes.
Initially the space is divided into four equal quadrants where boundaries are at the mid-
points. The null hypothesis that data points are evenly distributed across the four quadrants




(Mi − µ2M) (5.4)
where Mi is the number of data points in the i
th square and µM is the mean number
of data points per square. If sχ2 is greater than the critical chi-square statistic value for
p = 0.05, χ295%, with n
2 − 1 degrees of freedom where n is the number of dimensions or
time series being partitioned, the null hypothesis is rejected, the distribution of the data is
not uniform, and the partitioning continues such that the quadrant is split into four sub-
quadrants. The partitioning process continues recursively until all partitions satisfy the
χ2 test for containing equal proportions of data. If sχ2 ≤ χ295%, the null hypothesis is not
rejected, the partitions in the current iteration are discarded, and the current four quadrants
are considered to be one partition. Squares that do not contain data do not contribute to
the estimation of transfer entropy or network representations of time series.
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5.3.11 Transfer entropy
Transfer entropy given by TX→Y is a measure of directional coupling between two concur-
rently sampled time series X = {x1, x2, ..., xN} and Y = {y1, y2, ..., yN}, and is defined in
more detail by Equation (4.1). Optimal parameter values of t (time lag in X), w (time lag in
Y ), and τmax were selected via Bayesian optimization (Ghassemi et al. 2014; Shahriari et al.
2016).
Significant information flows were determined by Monte Carlo surrogates, i.e., temporally
shuffled time series were created and evaluated for larger values of TX→Y than the original.
For each subject, time scale, and parameter value, transfer entropies were computed for 100
surrogates generated by randomizing the order of HR and activity time series. Transfer
entropy from the original source time series was considered statistically significant if it was
greater than the 95th percentile of the surrogate results.
5.3.12 Multiscale network representations of time series
Lagged time series over several time scales were converted into multidimensional networks
following the methods described by Shashikumar et al. (Shashikumar et al. 2017a). A map
M from the time series X ∈ T to a network g ∈ G can be given by M : T ⇒ G, where
X = {X1, X2, ..., Xk}, k is the total number of time series being considered, and Xi ∈ RL,
with L being the length of the time series, and g = {S,A} consisting of a set of nodes S
and adjacency matrix A. The total number of nodes N correspond to the total number of
partitions obtained from the D-V partitioning algorithm. Each partition pi (i = 1, ...N) is
assigned to a node ni ∈ N in the graph g. Every data point in X is assigned to one of the
partitions. The adjacency matrix A is a NxN matrix where aij corresponds to the transition
from node ni to node nj. Transitions from node ni and nj are represented by the weight aij.
Attributes of this graph, i.e. multiscale network representation (MSNR) features, were used
to classify illness. This process was repeated for time series after several coarse-grainings, to
construct networks over multiple time scales.
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Network attributes were computed using the Matlab Tools for Network Analysis open
source toolbox from the Strategic Engineering Research Group (Massachusetts Institute of
Technology 2011):
• Number of nodes are the total number of nodes in the network.
• Number of edges are the total number of edges in the network.
• Link density is the total number of edges divided by the maximum possible edges in
the network.
• Average degree is the average value of the degree of all nodes in the network, where
the degree of a node is defined as the total number of its neighboring edges.
• Number of loops are the total number of independent loops in the network, also
know as the “cyclomatic number” or the number of edges that need to be removed so
that the network cannot have cycles.
• Loop3 are the total number of loops of size 3 in the network.
• Loop4 are the total number of loops of size 4 in the network.
• Average clustering coefficient c(u) for node u is defined as the ratio of the number
of edges between the neighbors of u to the number of possible edges between them;
the average clustering coefficient C(G) of a network is the average of c(u) over all the
nodes in the network.
• Assortativity coefficient is the Pearson correlation coefficient r of degree between
pairs of linked nodes. Positive values of r indicate a correlation between nodes of
similar degree, while negative values indicate relationships between nodes of different
degree. In general, r lies between −1 and 1. When r = 1, the network is said to have
perfect assortative mixing patterns, when r = 0 the network is non-assortative, while
at r = −1 the network is completely disassortative.
• Algebraic connectivity is the second smallest Eigenvalue of the Laplacian matrix of
a network, where the Laplacian matrix is the difference between the sum of degrees of
the diagonal elements in adjacency matrix and the adjacency matrix.
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• Closeness centrality cc(u) for node u is the inverse of sum of distance from node u to
all other nodes in the network, where the closeness centrality of a graph is the average
mean of the above is the average of cc(u) taken over all the nodes in the network.
• Average eccentricity is determined by first computing the eccentricity of a node or
vertex u, defined as e(u) = max{d(u, v) : v ∈ V }, where the distance d(u, v) is the
length of the shortest path from u to v, and V is the set of all nodes. The average
effective eccentricity is the average of effective eccentricities over all nodes or vertices
in the network.
• Maximum effective eccentricity is also known as the effective diameter, and is
defined as the maximum value of effective eccentricity over all nodes in the graph.
• Trace is the sum of the eigenvalues of the adjacency matrix, ∑λ.





5.3.13 Binary classification of illness status
Features were used to train a support vector machine (SVM) algorithm with a linear kernel
to classify subjects into the schizophrenia or healthy control class, i.e. to perform a binary
discrimination task. Classifier performance was assessed via subject-wise leave-one-out cross-
fold validation (LOOCV). Given N patients, N−1 patients are used to train the classifier and
the remaining patient is used as the test set. Features in the training set were transformed
to have Gaussian distributions using either the identity, square root, or logarithmic transfor-
mations. The transformation resulting in the most normal data, e.g. the lowest k-statistic
using the Lilliefors test, was determined from the training set and then applied to the test
set to prevent leakage of information. Data in both training and test sets were normalized by
subtracting the training mean and dividing by the training standard deviation. Predictions
for each subject – defined as the probability of having a diagnosis of schizophrenia – were
pooled across crossfolds to report a single pooled area under the receiver operating curve
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(AUC; Airola et al. 2009). AUCs were calculated and reported for both training and test
sets, and different models (i.e. the set of features used to train the SVM) were compared by
calculating the integrated discrimination improvement (IDI; Pencina et al. 2008), given by:
IDI = (Snew − Sold)− (Pnew − Pold) (5.5)
where S is the integral of sensitivity over all possible cut-off values over (0, 1) interval, P
is the integral of 1−specificity, and “new” and “old” refer to the two models being compared
(Pencina et al. 2008).






where ŝevents and ŝnonevents are the standard error of paired differences of new and old
model-based predicted probabilities across all event and non-event subjects respectively.
5.4 Results
5.4.1 Mutual information
Mutual information between HR and activity (I(HR; act)) was calculated over four time
scales τ1−4. I(HR; act) for patients with schizophrenia and controls and compared via
the two-sided Wilcoxon rank-sum test. I(HR; act) significantly different for the first three
timescales (P < 0.05), whereas the difference in medians was not significant for τ = 4
(Figure 5.2A). The opposite trend was observed in the AFib group; for all time scales, pa-
tients exhibited significantly lower values of I(HR; act) compared to controls (P < 0.05;
Figure 5.2B).
Significance of mutual information between HR and activity was estimated using surro-
gates whereby each time series was shuffled 100 times and Isurrogate was calculated for each
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Figure 5.2: MMI between HR and activity for A) patients with schizophrenia and controls,
and B) AFib patients and controls. Data is shown via notched box plots; the horizontal red
line denotes the median, the notches denote 95th percent confidence intervals of the median,
borders of the blue box denote the 25th and 75th percentiles, and the lower and upper
whiskers denote the minimum and maximum values, respectively. The y-axis is mutual
information in bits, and the x-axis denotes different time scales and sick versus healthy
subjects. Asterisks indicates P<0.05 via the Wilcoxon rank-sum test.
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instance. A mutual information ratio was calculated. The numerator was the 95th percentile
of Isurrogate and the denominator was I of the original data. For all time scales, this ratio was
significantly less than the red dashed line of unity for patients with schizophrenia and con-
trols, demonstrating significant mutual information between HR and activity (supplemental
Figure A1). In contrast, patients with AFib displayed mutual information ratio metrics near
or greater than unity, suggesting the observed values of I could have been due to random
chance. However, for control subjects the mutual information ratio was close to or slightly
below unity for all time scales except τ = 4, for which the ratio was slightly above unity.
5.4.2 Transfer entropy
MTE from HR to activity (THR→act) and from activity to HR (Tact→HR) were calculated for
patients and controls in both the schizophrenia and AFib groups. In the schizophrenia group,
THR→act was higher in patients than in controls for the first three time scales (τ = 1, 2, 3),
but did not differ for τ = 4 (Figure 5.3A). Similarly, Tact→HR was higher in patients than in
controls but for all time scales (Figure 5.3B). In the AFib group, both THR→act and Tact→HR
were lower in patients with AFib than in controls for all time scales (Figure 5.3C & D).
Following a similar approach as described earlier, a transfer entropy ratio was calculated,
with the numerator being 95th percentile of THR→act, surrogates, and the denominator being
THR→act of the original data (supplemental Figure A2). Patients with schizophrenia had ratios
significantly less than unity, suggesting statistically significant values of THR→act. In contrast,
both AFib patients and controls had ratios close to or above 1, suggesting observed non-
significant flow of information from HR to activity in that cohort. The flow of information
from activity to HR, Tact→HR, was assessed the same way, and found to be significant for
both patients and controls in both the schizophrenia and AFib cohorts.
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Figure 5.3: MTE from A) HR to activity (TEHR→act) for patients with schizophrenia and
controls, B) activity to HR (TEact→HR) for patients with schizophrenia and controls, C) A)
HR to activity (TEHR→act) for AFib patients and controls, and D) activity to HR (TEact→HR)
for AFib patients and controls. Data is shown via notched box plots; the horizontal red line
denotes the median, the notches denote 95th percent confidence intervals of the median,
borders of the blue box denote the 25th and 75th percentiles, and the lower and upper
whiskers denote the minimum and maximum values, respectively. The y-axis is transfer
entropy in bits, and the x-axis denotes different time scales and sick versus healthy subjects.
Asterisks indicates P<0.05 via the Wilcoxon rank-sum test.
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5.4.3 Network representations of time series
MSNR were constructed from HR and locomotor activity time series data. For the schizophre-
nia group, three time scales were optimal (Figure 5.4A), whereas for the AFib group, the
first time scale was optimal (Figure 5.4B). Gross differences in network structure, measured
by complexity, node count and edge count, varied both by patient type and time scales.
5.4.4 Classifier performance
Nine feature groups were used to train a support vector machine: 1) statistical moments,
2) MSE, 3) MMI, 4) MTE, 5) MSNR, 6) MSE and MTE, 7) MSE and MSNR, 8) MTE
and MSNR, and 9) MTE, MSE, and MSNR. LOOCV was performed to assess classifier
performance. Receiver operating characteristic curves (ROCs) were plotted for schizophrenia
(Figure 5.5A) and AFib cohorts (Figure 5.5B), and areas under the ROCs (AUCs) were
reported for training and test sets (Table 5.1).
In the schizophrenia cohort, MSNR features – alone or in combination with any other
feature – resulted in perfect classifier performance in both training and test data (Table 5.1).
Model performance was compared using the IDI. MTE demonstrated improved performance
versus MMI, and MSNR demonstrated improved performance versus MMI, with P < 0.05
for each (Table 5.2).
In the AFib cohort, MSE resulted in the maximum test AUC. MTE alone outperformed
MSNR for both training and test AUCs, but did not improve classifier performance when
used in combination with MSE. Model performance on test set data was compared using the
IDI. MMI outperformed MSE, and MSNR outperformed MMI (Table 5.2).
5.5 Discussion
We assessed interactions between HR and activity by calculating mutual information, trans-









































































































































































































































































































































Figure 5.4: MSNR of HR and activity data; each colored circle represents a six-dimensional
state defined by a value of HR (e.g. 74 BPM), locomotor activity (e.g. RMS of accelerometry
value of 1.7), two time-lagged values of HR, and two time-lagged values of activity. Thus,
each state represents a temporal trajectory through physiological and behavioral states.
Lines between nodes denote transitions in time from one node to the next. A) Network
representations of data from a single subject with schizophrenia (denoted in red) demonstrate
a higher number of physiological and behavioral states at τ2, and a lower number of states
at τ3, compared to states from a healthy control subject (denoted in blue). τi indicates the
ith time scale. B) Network representations of data from a single subject with AFib (denoted
in red) demonstrate a higher number of physiological and behavioral states and more state
transitions compared to a healthy control subject (denoted in blue). The properties of these
networks were quantified using graph theoretical approaches, and these properties were used
as features to train a support vector machine to classify patients from healthy controls.
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Stat Moments (AUC = 0.80)
MSE (AUC = 0.96)
MMI (AUC = 0.83)
MTE (AUC = 0.94)
MSNR (AUC = 1.00)
MSE + MTE (AUC = 1.00)
MSE + MSNR (AUC = 1.00)
MTE + MSNR (AUC = 1.00)
MTE + MSE + MSNR (AUC = 1.00)





















Stat Moments (AUC = 0.89)
MSE (AUC = 0.93)
MMI (AUC = 0.75)
MTE (AUC = 0.91)
MSNR (AUC = 0.89)
MSE + MTE (AUC = 0.93)
MSE + MSNR (AUC = 0.90)
MTE + MSNR (AUC = 0.89)
MTE + MSE + MSNR (AUC = 0.89)
Figure 5.5: ROC curves of models for classifying patients with A) schizophrenia or B) AFib
from healthy controls using combinations of different features. Features were calculated
from at least ten continous days of HR and locomotor activity. Stat Moments is statistical
moments, MSE is multiscale entropy, MMI is multiscale mutual information, and MSNR is
multiscale network representations. The Y-axis is the true positive rate and the X-axis is
false positive rate.
ing a network from HR and activity time series is a novel approach that utilizes the D-V
partitioning algorithm, which is computationally fast and does not require the specification
of as many hyperparameters as other partitioning methods (Hudson 2006). Measures of
interactions between HR and activity as well as attributes of each signal were calculated and
used to train a machine learning algorithm to classify schizophrenia subjects from controls.
Perfect classification accuracy was achieved in the schizophrenia cohort using MSNR fea-
tures, whereas combined univariate analyses on separate HR and activity resulted in lower
AUCs. On the other hand, network features did not add significant differentiating power to
the classifier when evaluating a non-mental population with AFib. To our knowledge, this
is the first use of interactions between HR and activity to distinguish patients from controls.
Univariate features such as statistical moments and MSE were less predictive compared
to interaction features, yet enabled classification of schizophrenia significantly better than
chance. MSE outperformed statistical moments in both schizophrenia and AFib groups.
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Table 5.1: AUCs indicating classifier performance for nine feature groups, or models. The
model is described in column 1, results from the schizophrenia cohort are reported in columns
2-3, and results from the AFib cohort are reported in columns 4-5.
Schizophrenia Atrial fibrillation
Model Training AUC Test AUC Training AUC Test AUC
Statistical moments 0.98 0.84 0.91 0.89
MSE 0.98 0.95 0.94 0.93
MMI 0.90 0.81 0.81 0.77
MTE 1.00 0.94 0.96 0.91
MSNR 1.00 1.00 0.92 0.90
MSE + MTE 1.00 1.00 0.98 0.92
MSE + MSNR 1.00 1.00 0.96 0.90
MTE + MSNR 1.00 1.00 0.99 0.89
MTE + MSE + MSNR 1.00 1.00 0.99 0.89
Measures of complexity of physiological and behavioral time series may better capture men-
tal illness-associated loss in system autoregulation compared to simpler descriptions of the
distribution of data (Berle et al. 2010; Montaquila et al. 2015). These results are consistent
with our previous work on classifying patients with schizophrenia from healthy controls by
learning univariate features of complexity where the test AUC did not reach 1.00 (Reinertsen
et al. 2017b).
Mutual information I quantifies linear and nonlinear dependence between two variables
(Duncan 1970). If HR contains information about, or vice-versa, I will be > 0. I is likely to
be nonzero in the groups studied here because activity can lead to an increase in HR due to
a rise in peripheral oxygen demand, and increased HR can precede a rise in activity due to a
behavioral response to external cues. We assessed if I across several time scales contributed
to classifier performance. In patients with schizophrenia, MMI resulted in lower classification
performance compared to other types of features, albeit better than random chance, with a
test AUC of 0.83 (Figure 5.2). In patients with AFib, MMI enabled classification of AFib
patients with a test AUC of 0.75.
To assess if mutual information between HR and activity was due to random chance,
we shuffled each time series 100 times, calculated Isurrogate each time, and calculated the
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Table 5.2: Comparison of model performance on test set data via the IDI. A positive IDI
with P < 0.05 indicates the new model achieves a statistically significant improvement in
classification performance versus the old model. Models are listed in column 1, results from
the schizophrenia cohort are reported in columns 2-3, and results from the AFib cohort are
reported in columns 4-5.
Schizophrenia Atrial fibrillation
Models IDI P-value IDI P-value
MSE vs. MMI -0.316 0.073 -0.297 0.005
MMI vs. MTE 0.277 0.047 0.184 0.064
MMI vs. MSNR 0.449 0.009 0.243 0.026
MSE vs. MTE -0.034 0.820 -0.113 0.213
MSE vs. MSNR 0.133 0.317 -0.054 0.452
MTE vs. MSNR 0.172 0.215 0.059 0.560
ratio of I of the original data to the 95th percentile of Isurrogate. This ratio was far less
than unity for both patients and controls in the schizophrenia group, suggesting significance
(supplemental Figure A1). Interestingly, this was not the case for the AFib group; the median
ratio was close to and slightly above unity for patients whereas the median was below or
close to one for controls. These data suggest a modest reduction in coupling between HR and
activity in patients with AFib compared to controls within the same group, but more broadly
demonstrate a difference in mutual information by group that may be due to measurement
method (Proteus patch for schizophrenia subjects versus SimBand smartwatch for AFib
subjects) rather than illness class. SimBand recordings were much shorter at only five
minutes long, so there are far fewer gross movements. Longer recordings to capture broader
time scales may be necessary to reveal interactions between HR and activity. However,
differences between the two groups did not introduce bias, as the classification task was
to dichotomize patients from controls within the same group, rather than to distinguish
schizophrenia, AFib, and healthy controls in a trinary classification task.
Directed information flow between HR and activity may be more predictive than asym-
metric I. Thus we calculated transfer entropy THR→act and Tact→HR. Both THR→act and
Tact→HR were higher in patients with schizophrenia than controls for all time scales (Fig-
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ure 5.3). We also assessed significance of transfer entropy using surrogate shuffling. The
median ratio of the 95th percentile of Tsurrogate to THR→act,original was less than unity for
all time scales and for both patients with schizophrenia and controls, although ratios were
slightly lower in patients with schizophrenia versus controls (supplemental Figure A2). Sim-
ilar to the surrogate analysis of I, this ratio was slightly greater than unity for patients
and controls in the AFib group. In contrast, Tact→HR was equal to or very close to zero for
all subjects in both the schizophrenia and AFib groups, demonstrating significant directed
transfer of information from activity to HR regardless of illness group or control status.
MTE outperformed MMI features for both the schizophrenia and AFib group, suggest-
ing the direction of information transfer between HR and activity can be used to distinguish
mental illness from health, or cardiac illness from health. Increases in activity following an
increase in HR is partially mediated by the ANS, and ANS dysfunction occurs in schizophre-
nia. THR→act and THR→act may be predictive features because of altered coupling between
HR and activity in schizophrenia.
Surprisingly, MMI or MTE features enabled classification of AFib with performance
superior to random chance. The AFib cohort served as a control; patients did not hvae
psychiatric illness, and they were assessed in a seated position in a clinical lab setting that
ostensibly reduces the likelihood of significant HR-activity interactions. However, AFib can
cause symptoms such as palpitations and dyspnea (Lip et al. 2016; in addition, irregular
pulsations conducting through the arm in AFib may result in subtle effects on movement
detectable by a wristband. These factors could have contributed to observed associations
between HR and locomotor activity in patients with AFib, even when they were asked to sit
quietly.
Directed transfer of information between two signals likely occurs at specific regions
in time rather than constantly throughout. The distribution of these regions could be a
more nuanced and predictive feature of illness than global measures of information transfer.
However, such distributions are not captured by mutual information or transfer entropy
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of entire time series. To better assess system dynamics and interactions between signals,
we constructed network representations of HR and activity time series (Shashikumar et al.
2017a). Each node represents a physiological and behavioral state, and was formed from
a partition in a six-dimensional space comprised of lagged forms of HR and activity: 1)
HR(t), 2) HR(t− 1), 3) HR(t− 2), 4) act(t), 5) act(t− 1), and 6) act(t− 2). Our approach
exploits Takens’ theorem, which describes how a dynamical system can be reconstructed
from a sequence of lagged observations, given a sufficient embedding dimension D (Takens
1981). Although the optimal D is unknown, a lagged embedding approach can yield more
information about the properties of a dynamical system compared to analyzing only the
observed time series.
Networks over various time scales from a representative subject with schizophrenia and
AFib are shown in Figure 5.4. Although the number and connectivity of nodes exhibit
variance across subjects within an illness group, networks from patients with schizophrenia
visually differed from networks derived from controls. Because the maximum number of
edges in a directed graph with n nodes is n(n − 1), even slight differences in node count
are amplified in other network properties that correlate with edge count, connectivity, and
complexity. These data suggest a decreased number of physiological states and transitions
in schizophrenia, consistent with previous reports of more structured patterns of cardiac
physiology and behavior compared to healthy controls (Chang et al. 2009; Berle et al. 2010;
Montaquila et al. 2015).
On the other hand, networks from patients with AFib featured similar numbers of nodes
but greater connectivity between nodes compared to controls. Severe AFib is characterized
by an “irregularly irregular” heart rhythm, which presumably results in a larger number of
physiological states compared to a healthy subject. However, the occurrence of AFib may
have been rare in our patient cohort, thus not significantly adding to the number of HR-
activity states. Despite a similar number of nodes, transitions between nodes were sufficiently
altered in AFib to enable discrimination of patients from controls.
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Corroborating the markedly discernible visual differences in networks, MSNR features
enabled the classifier to perfectly discriminate patients with schizophrenia from healthy con-
trols, with train and test AUCs of 1.00 (Table 5.1 and Figure 5.5). However, MSNR features
did not outperform MTE features for AFib patients. These results indicate a difference in
interactions and temporal structure between HR and activity in patients with mental versus
cardiovascular illness.
Finally, a comparison of significant differences in classifier performance via IDI in the
schizophrenia cohort demonstrated statistically significant improvements of MTE versus
MMI, and MSNR versus MMI, with P < 0.05 (Table 5.2). In the AFib cohort, MMI
versus MSE and MSNR versus MMI were significantly different. MSNR outperformed MTE
in the schizophrenia cohort, but MTE outperformed MSNR in the AFib cohort, which may
suggest MTE and MSNR capture different mechanisms of coupling between heart rate and
movement. Additionally, the probability of a statistically significant difference will increase
in a larger cohort, but effect sizes of each type of feature may also differ in mental versus
cardiovascular patients, so these results should not be over-interpreted. Moreover, a lower
P-value does not necessarily correspond to a superior feature or model (Lo et al. 2015).
It should be noted that AUCs from different models can be definitively compared without
significance tests when performing LOOCV – a model achieving an AUC of 1.00 perfectly
classifies all subjects, and this performance is deterministic and repeatable insofar as the
features used to train the model are non-stochastic and do not vary across experiments.
Network representations captured more illness-related information compared to other in-
formation theoretical measures of complexity and interaction. Fasmer et al. evaluated time
series of locomotor activity over 12 days from depressed and schizophrenic patients, mapped
these data to a graph, and evaluated measures of complexity (Fasmer et al. 2018). Depressed
patients were found to be significantly different from both controls and schizophrenic pa-
tients, with evidence of less regularity of the time series. However, the nodes in the graph
were univariate and only comprised of motor activity states, whereas the work here reports
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multivariate states comprised of both HR and activity. Campanharo et al. qualitatively eval-
uated network representations of chaotic Lorenz and Rossler equations, but the relationship
between network attributes and properties seen in physiological data such as noise, auto-
correlation, periodicity, and non-stationarity remain unknown (Campanharo et al. 2011).
Simple dynamical systems can be generated with known and varying levels of these proper-
ties, and attributes of the resulting network representations can be studied. Understanding
this mapping could yield insight about the physiological meaning of altered interactions
between HR and activity time series in illness.
We note several limitations of this study. Each group was small, consisting of 16 patients
with schizophrenia and 19 controls, and 41 AFib patients and 53 controls. We used LOOCV
to estimate generalizability of our classifier, but performance metrics may differ for a new
group. Comprehensive feature selection was not performed; rather, features from one or
several feature groups in combination were compared. Only an SVM classifier was used, but
a different machine learning algorithm could achieve better classification performance.
ANS dysfunction in schizophrenia may be partially mediated by inflammation. The con-
centrations of IL 1-β, IL-6, and transforming growth factor-β have been shown to vary with
clinical status, may predict subsequent relapse, and are known to also affect cardiovascular
function (Kirkpatrick et al. 2013). Inflammation is inversely associated with changes in time-
and frequency-domain HRV measures, even in sub-clinical adult populations without serious
cardiovascular disease (Haensel et al. 2008). Regarding behavior, alterations of locomotor
activity in schizophrenia have been attributed to cognitive dysmetria, or functional discon-
nectivity between neural centers of cognition, motor function, and coordination (Honey et al.
2005). However, most studies of schizophrenia did achieve data collection at a sufficiently
high frequency to discern more nuanced measures such as directed transfer of information.
Further research is needed to elucidate the mechanisms governing interactions between phys-
iology and behavior in schizophrenia and other mental illnesses, and potentially exploit these
mechanisms for clinically useful applications such as relapse prediction or remote monitoring
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of the efficacy of new therapeutics.
5.6 Conclusion
We demonstrated measures of multiscale interactions – mutual information, transfer entropy,
and network properties – between HR and activity enable discrimination of patients with
schizophrenia from controls. We repeated this approach using data from patients with AFib,
and found network and interaction features did not improve prediction over complexity
measures that ignored interactions between HR and activity. To our knowledge this is
the first evaluation of interactions between physiological and behavioral states in a mental






The work presented in this thesis explores opportunities to improve algorithmic discrimina-
tion of patients with mental illness from healthy control subjects using supervised learning
algorithms. Predictive features from HR and/or locomotor activity data were evaluated
during specific times (as a proxy for context), over several time scales, and between signals.
6.1.1 Need
One in four people in the world will be affected by mental or neurological disorders, yet only
a small fraction of them will receive treatment due to pervasive underdiagnosis, a lack of
trained healthcare professionals, stigma, and other reasons (Sayers 2001). Currently, mental
illnesses are diagnosed via clinical interview, in which the psychiatrist asks the patient and
family members about characteristic symptoms and social and/or occupational dysfunction.
However, brain disorders such as schizophrenia can impair insight and hinder the accuracy
of self-reporting, challenging both initial diagnosis. PTSD is often underdiagnosed due to
social stigma or lack of care access. Finally, even after a diagnosis is established, the nature
of mental illness and how psychiatric care is delivered can also result in suboptimal follow-up
and monitoring of clinical status.
A growing understanding of ANS dysfunction in neuropsychiatric illness, advances in
technology, and a clinical need for objective and reproducible metrics has motivated explo-
ration of noninvasive monitoring of HR, locomotor activity, and other measures (Chang et
al. 2009; Liddell et al. 2016; Vancampfort et al. 2017). Importantly, passive monitoring via
digital sensors in smartphones and wearables can yield information about a patient’s physi-
ology and behavior in the 99% of the time they are not seeing a clinician Asch et al. 2012).
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Digital health approaches – whereby physiology and behavior of patients are measured in
near real-time and in their native contexts, features are extracted from these data streams,
and machine learning or other computational approaches infer clinically useful information –
could provide a richer understanding of the day-to-day variability of neuropsychiatric illness,
enable assessment of patient status before (rather than after) symptoms reach a level war-
ranting intervention, and reduce biases and inaccuracy intrinsic in subjective questionnaires
(Karow et al. 2008; Copeland et al. 2017).
Although promising, the field of “digital mental health” faces numerous technical chal-
lenges and areas that remain unexplored. One such topic is the uncertainty of ascribing
meaning to aberrations in a time series that may be instead caused by a non-pathological
mechanism. Metadata can aid discrimination here by adding contextual information. For
example, GPS readings or social media can distinguish elevated entropy of locomotor activity
being due to mental illness, or alternatively due to a subject’s participation in a social gath-
ering, cultural event, or travel for leisure. Data fusion and robust estimation from noisy data
sources has been explored in the setting of electrocardiography for the detection of abnormal
rhythms due to cardiovascular disease (Li et al. 2008; Clifford et al. 2012a), and most studies
using HR and activity discard days with or subjects who lack sufficient data. However, few
digital health studies employ contextual analysis of data, whereby data is emphasized during
periods of presumed high signal-to-noise ratio of an illness-induced feature. In particular,
evaluating HRV measures during times when a subject is likely to be asleep may reduce
motion artifact and increase the ability of a classifier to detect autonomic dysregulation.
A second topic is differing time scales of relevant physiology and behavior differ. For ex-
ample, a feature calculated from ten minutes of HR and activity data contains information
about the ANS or short-term movements. 24-48 hours of data contains information about
systems mediated by circadian rhythms and sleep. A week or more of data contains infor-
mation about social activity, behavior, and lower-frequency physiological dynamics. Few
studies of passive monitoring for mental illness account for varying time scales.
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A third topic is measures of interaction between signals, such as HR and activity. In the-
ory, information is transferred between cardiovascular physiology and behavior over several
time scales. In normal individuals, circadian rhythms mediate the increase in blood pres-
sure and heart rate during the early morning prior to an increase in consciousness, which
in turn leads to waking and locomotor activity in the morning. Conversely, the rising of an
individual from a chair leads to a rise in blood pressure, heart rate, and sympathetic tone.
These responses, interactions, and transitions between physiological and behavioral states
vary over time scale, and are partially mediated by the baroreflex and central command, a
feed-forward neural mechanism that contributes to motor and cardiovascular function during
arousal and exercise (Hall 2010). Since patients with several types of mental illness – such
as schizophrenia or PTSD – have ANS dysfunction, physiological and physical responses to
changes in HR and locomotor activity may be abnormal (Chang et al. 2009; Montaquila
et al. 2015; Alvares et al. 2016).
6.1.2 Overview of contributions
This work demonstrates classification of mental illness using features from HR and accelerom-
eter data is improved by considering information during specific times, over several time
scales, and between signals.
In Chapter 1, an introduction is provided and the problems of data collection, time scales,
and interactions between data streams are described.
In Chapter 2, past work is surveyed. The clinical epidemiology, pathophysiology, treat-
ment, and ANS alterations are described for schizophrenia and PTSD. Time- and frequency-
domain HRV metrics, entropy, and the effects of medication on HRV are reviewed. Rest-
activity characteristics of locomotor activity is described. The growing literature on digital
sensors for monitoring neuropsychiatric illnesses is surveyed in four parts, organized into
smartphones, wearable accelerometers, Holter monitors, and multimodal sensing. The focus
of this chapter is on passive monitoring and analyses of HR and locomotor activity, feature
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extraction, and classification or regression of clinically relevant outcomes (Table A4).
In Chapter 3, the classification of PTSD from HR time series is reported. To improve
the signal-to-noise ratio of HR data, a HR-based window segmentation approach is proposed
whereby five 10-minute segments with the lowest median HR were isolated. This work tested
the hypothesis that these segments represented quiescent periods, or times when the subject
was least likely to be engaged in volitional motor activity and/or most likely to be sleeping or
resting. Single-channel ECG data were collected from 23 subjects with current PTSD, and
25 control subjects with no history of PTSD over 24 hours. RR intervals were derived from
these data, cleaned, and used to calculate HR and HRV metrics. Features were derived from
1) RR data from these segments, 2) RR data from five randomly selected 10-minute control
segments, or 3) all 24 hours of RR data. Classifier performance was assessed via repeated
random sub-sampling validation, and area under the receiver operating characteristic curve
(AUC) was calculated. A combination of the four most predictive features derived from
quiescent segments resulted in a median AUC of 0.86 on out-of-sample test set data. This was
significantly higher than the AUC using 24 hours of data (0.72) or random segments (0.67).
These results demonstrate the segmentation of HR data into quiescent periods improves the
classification of PTSD from HR and HRV measures compared to the use of all collected data
(Reinertsen et al. 2017a).
In Chapter 4, the classification of schizophrenia using varying time scales of HR and
locomotor data is reported. This work tested the hypothesis that classifier performance
and most predictive features varied with time scale. Features from both HR and locomotor
activity data were used to train a classifier to distinguish contiguous days of data as belonging
to a schizophrenia patient or a healthy control. HR and physical activity was recorded from
12 medicated subjects with schizophrenia and 12 healthy controls. Derived features included
statistical moments, rest-activity metrics, transfer entropy, and multiscale fuzzy entropy. The
time scale (e.g. window length) of data was varied from two to eight days, and found to
affect classifier performance. An analysis window length of eight days resulted in a test set
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AUC of 0.96. Reducing the analysis window length to two days only lowered the AUC to
0.91. The type of most predictive features varied with analysis window length. These results
demonstrate that time scale, or total length of recorded data, affects classifier performance
and most predictive features (Reinertsen et al. 2017b).
In Chapter 5, the classification of schizophrenia by evaluating interactions between HR
and locomotor activity is reported. This work tested the hypothesis that information be-
tween HR and locomotor activity is altered in mental illness and relatively less altered in
cardiovascular illness, and that this information is useful in a machine learning approach to
discriminate patients from controls. HR and locomotor activity were recorded via wearable
patches in 16 patients with schizophrenia and 19 healthy controls. Measures of signal com-
plexity and interactions were calculated over multiple time scales, including sample entropy,
mutual information, and transfer entropy. A classifier was trained on these features to dis-
criminate patients from controls. Additionally, time series were converted into a network
with nodes comprised of HR and locomotor activity states, and edges representing state
transitions. Graph properties were used as features. To compare against non-psychiatric
illness, the same approach was repeated in 41 patients with AFib and 53 controls. Network
features enabled perfect discrimination of schizophrenia patients from controls with an AUC
of 1.00 for training and test data. Other bivariate measures of interaction achieved lower
AUCs (train 0.98, test 0.96), and univariate measures of complexity achieved the lowest
performance. Conversely, interaction features did not improve discrimination of AFib pa-
tients from controls beyond univariate approaches. This is the first quantitative evaluation
of interactions between physiology and behavior in patients with psychiatric illness (paper
submitted).
6.2 Limitations
This work faces several limitations. The first limitation is the small sample size in each study.
The PTSD work only involved 23 subjects with PTSD and 25 controls, the schizophrenia
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cohort consisted of 16 patients with schizophrenia and 19 controls, and the AFib cohort
was comprised of 41 patients and 53 controls. These sample sizes may result in models of
insufficient variance; in a univariate sense the statistical power may not be large enough to
detect smaller effect sizes. Since effect size could not be estimated because previous work
this thesis builds upon did not evaluate univariate effects, statistical power could not be
estimated, and the rigorous evaluation of generalizability versus sample size in a supervised
learning framework is well beyond the scope of this work. The notion of adequate sample
size tends to be imprecise, but based on the author’s experiences, researchers in both the
biomedical sciences and machine learning consider sample sizes below one hundred to be
“small”.
A second limitation of some of these studies is ECG recordings that are no greater than 24
hours per subject. A home-based continuous physiologic monitoring system could potentially
evaluate the efficacy of a therapeutic intervention such as medication or cognitive behavioral
therapy. However, doing so would require longer monitoring than 24 hours and additional
validation studies. An interesting and clinically important topic to study would be if 24-hour
measures could predict therapeutic response at far later time points, such as one week or one
month after the intervention. Additional work would need to explore how to reduce false
positives and prevent alarm fatigue in the setting of longitudinal monitoring.
A third limitation of the supervised learning approach used in this work – either a logistic
regression or support vector machine – is model output of probability of belonging to the
ill class, which is merely a coarse proxy for illness severity in the form of ANS dysfunction
or locomotor abnormalities. This method would estimate a low probability of illness for a
subject who is diagnosed with a mental illness yet has atypically low levels of ANS dysfunc-
tion. Other aspects of PTSD or schizophrenia symptomatology described in the DSM-V
have yet to be evaluated in the context of HRV measures. Furthermore, the generic clinical
descriptor of “motor agitation” or “locomotor disturbances” has not been precisely defined
in a quantified manner. Inferring the severity of specific manifestations of mental illness
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severity could be useful, but doing so would require larger studies with multimodal data
including high-resolution ECG recordings, locomotor activity, and clinical questionnaires or
visits to provide labeled data.
A fourth limitation (related to the previous) of concern for studies conducted over several
days is the day-to-day fluctuation of symptom severity in schizophrenia and PTSD (Kahn et
al. 2015). In the schizophrenia study, classifier output varied from day to day (Figure 4.4a),
was based on measures of ANS dysfunction and behavior, and may have reflected fluctuations
in illness severity. However, detailed information about daily changes in symptoms, e.g. Brief
Psychiatric Rating Scale survey data, was unavailable. Such data would be necessary for
training a classifier to estimate illness severity accurately, rather than a general probability
of belonging to the ill class.
A fifth limitation of this work is controlling for employment status as a proxy for social
routine – which relates to activity and restfulness to some extent. However, other potential
confounders that could affect HRV or locomotor activity were not explored. Literature
suggests potential confounders such as weight, BMI, diet, smoking status, renal function, etc.
have a moderate effect on HRV. However, the dominant factors are mental response (Bernardi
et al. 2000) and physical movement (Knoepfli-Lenzin et al. 2010). Stress relates to mental
state with physiological and behavioral manifestations. Skin conductance, a biomarker for
stress mediated by the sympathetic nervous system, has been shown to differ in schizophrenia
patients (Bär et al. 2008). Additionally, cortisol secretion and stress sensitivity may be
associated with schizophrenia, or subsequent development of schizophrenia following the
prodromal phase of the illness (Walker et al. 2013; Holtzman et al. 2013). Stress affects
activity as well as other aspects of mobile device usage; Sano et al. 2013 reported using
using screen on, mobility, call or activity level information to distinguish stressed from non-
stressed individuals with an accuracy of 75%. Aside from matching employment status,
stress was not controlled for in these studies. Doing so with conscious patients is challenging
especially in an ambulatory setting. Additionally, stress invariably accompanies social risk
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factors such as physical abuse, sexual abuse, maltreatment and bullying, which are associated
with increased risk of later schizophrenia (Stilo et al. 2010).
A sixth limitation is how antipsychotic medications affect the illness of interest, thus
modifying HRV measurements, but also may exert a direct effect on the cardiovascular
system and contribute to ANS dysfunction (Rechlin et al. 1994; Birkhofer et al. 2013; Huang
et al. 2013). Mondelli et al. demonstrated that antipsychotic medication can reduce cortisol
secretion and normalize HPA-axis hyperactivity in psychotic patients (Mondelli et al. 2010).
The literature has conflicting reports; Bär et al. 2008 did not find significant changes in ANS
function after antipsychotics were administered to patients, while Henry et al. 2010 et al.
found that risperidone, valproate, or mood stabilizers did not significantly affect HRV in
bipolar or schizophrenia patients. Our database lacked more detailed information about the
type, dose, or adherence of antipsychotic medications taken by patients in the schizophrenia
cohort; results herein may not generalize to a non-medicated patient population. However,
a classifier affected by a patient’s medication could potentially be used to monitor adherence
and treatment efficacy.
A seventh limitation is the selection of hyperparameter (e.g. entropy template length
and minimum amount of data per day) values from prior studies instead of optimized in
a first-principles or data-driven manner. Classifier performance could likely be improved
using techniques such as Bayesian optimization (Ghassemi et al. 2014; Shahriari et al. 2016)
which were employed in the final chapter of work on interactions between HR and locomotor
activity.
An eighth limitation is the use of LOOCV, which has low variance but high bias and
computational cost compared to k -fold cross validation methods with fewer folds. The
limitation here is not necessarily intrinsic to this method; rather, the issue lies in that only
one cross-validation method, and only one (regularized logistic regression or support vector
machine) learning algorithm were used for each experiment. A more robust approach would
involved comparing several well-established learning algorithms including logistic regression,
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support vector machine, random forest, and deep neural networks. Additionally, a larger
sample size and the use of a held-out validation set in addition to training and test sets,
or an entirely independent and newly collected validation cohort of subjects, would improve
the probability that models are capturing a consistent attribute of pathology rather than a
unique aspect of the data, and would generalize to a new population.
6.3 Future work
Passive monitoring of physiology and behavior, feature extraction from time series data,
and machine learning to estimate, classify, or predict outcomes has the potential to shift
today’s model of encounter-driven patient care towards ambulatory monitoring and remote
management. Several technical topics relevant to this thesis are being actively investigated,
including change point detection (CPD), entropy measures, and network dynamics to as-
sess interactions between multivariate data streams. Other areas of future direction and
opportunity for the field of mobile mental health include overcoming limitations of clinical
trials, addressing challenges of low-resource settings, and using monitoring to affect patient
outcomes.
6.3.1 Change point detection
HR and locomotor activity are non-stationarity phenomena – stochastic processes whose
unconditional joint probability distribution changes over time (Manuca et al. 1996). Conse-
quently, parameters such as mean and variance also change. In addition to non-stationarity,
these time series demonstrate long-range correlations, autoregression, and complex interac-
tions with other systems (Ivanov et al. 1999; Hausdorff et al. 1995; Pedro et al. 2001; Xiong
et al. 2017).
Time varying autoregressive and point process based techniques have been developed to
quantify the relationship between multiple variables in non-stationarity physiological time
series and to extract spectral indices of autonomic control (Barbieri et al. 2008; Gederi et
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al. 2014). However, these techniques model each time series individually and it is unclear
they can be used to identify dynamic behaviors that could serve as physiomarkers for illness
classification. Furthermore, they make the assumption that data is non-stationarity, so
segmentation or other methods of removing non-stationarity is required.
One simple approach to reduce nonstationarity and noise from extraneous factors is
to evaluate data solely during periods of low activity. This approach whereby quiescent
periods of data with lowest median HR were analyzed in lieu of the entire time series was
demonstrated to improve classifier performance in a cohort of subjects with PTSD and
healthy controls, suggesting restful periods contain features that are more attributable to
illness class (Reinertsen et al. 2017a). More sophisticated change point detection approaches
could potentially sort data into parametrically similar segments, and even further increase the
signal-to-noise ratio of features derived from data within each segment (Adams et al. 2007).
A popular techniques to artificially remove non-stationarities is ‘detrending’ via removing a
mean, slope, or nonlinear fit in an arbitrary piecewise manner Lan et al. 2010; Wu et al.
2007. However, detrending tends to create large artifacts around changes in stationarity
Raffalovich 1994; Nelson et al. 1981.
Changepoint detection (CPD) – the estimation of points in time where the probability
distribution of a stochastic process changes – can enable the analysis of stationary segments
of data and reveal underlying structure. This results in the division of time series into
segments that meet the criteria for stationarity. Bernaola-Galvàn Pedro et al. 2001 used
time series segmentation and CPD to investigate non-stationarities in human HR time series
and found mean level jumps between HR segments were smaller in heart failure patients
compared to healthy controls. Furthermore, HR interval segments were found to follow a
power law distribution, for both heart failure patients and healthy controls.
A variety of CPD methods exist and have been applied to physiological data such as HR,
yet little work has been done to determine the optimal algorithm for a given dataset based
on its properties or ultimate downstream task (e.g. supervised learning to dichotomize dis-
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ease). Cakmak et al. 2018 demonstrated a principled approach for selecting a CPD algorithm
for a specific task, such as disease classification. Eight key algorithms were compared, and
the performance of each algorithm was evaluated as a function of temporal tolerance, noise,
and abnormal conduction (ectopy) on realistic artificial cardiovascular time series data. Ar-
tificial data was used because ground truth of change points were known and thus CPD
algorithm performance could be assessed, and optimal parameters estimated. On artificial
data, Modified Bayesian Changepoint Detection achieved superior positive predictive value
(PPV) for identification of change points while Recursive Mean Difference Maximization
(RMDM) achieved the highest true positive rate (TPR).
Algorithms were also applied to HR time series data from 22 patients with REM-behavior
disorder (RBD) and 15 healthy controls, using the parameters selected using artificial data.
Features were derived from the detected changepoints to discriminate patients from healthy
controls using a K-Nearest Neighbors approach. Segment lengths – time between estimated
changepoints – were fitted to a Pareto distribution and characterized by scale and shape
parameters. These two parameters were calculated for each subject and used as features.
For classification, a K-Nearest Neighbors (KNN) approach with ten-fold cross validation was
used. To find the optimal number of neighbors and distance metric for KNN, Bayesian op-
timization was performed. The objective function of KNN was defined as the percentage
of neighbors belonging to the same class for each point, and the highest area under the
precision-recall curve was calculated using this metric. KNN was chosen as a simple exam-
ple to illustrate the technique, rather than as an optimal classifier. Performance metrics
calculated were accuracy, AUC, AUCPR, TPR, PPV, and F1 score. For the classification
task, features derived from the RMDM algorithm provided the highest leave one out cross
validated accuracy of 0.89 and true positive rate of 0.87.
Automatically detected changepoints provide useful information about subject’s physi-
ological state which cannot be directly observed. However, the choice of CPD algorithm
depends on the nature of the underlying data and the downstream application, such as a
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classification task. This work is the first meaningful comparison of CPD algorithms, and
a novel utilization of the technique towards a classification task. Future work in CPD in-
volves additional characterization of methods such as robustness in the presence of noise,
utility when combined with features from other data streams, and . CPD applied to HR,
activity, and other physiological time series or even questionnaire scores could add predictive
value to a supervised learning approach in a variety of illnesses, including neuropsychiatric
conditions.
6.3.2 Entropy measures
Entropy is defined as the average amount of information produced by a stochastic source of
data. Complex dynamical systems tend to generate time series with high entropy, whereas
simple functions such as white noise or sine waves produce time series with low entropy. En-
tropy of HR or locomotor activity reflect average complexity of the underlying physiological
system. These measures, especially over multiple time scales, have been shown to corre-
late with and even precede clinical illness such as AFib (Shashikumar et al. 2017b), sepsis
(Shashikumar et al. 2017a), heart failure (Costa et al. 2002; Liu et al. 2013; Zhao et al.
2015), and mental illness such as schizophrenia and PTSD (Osipov et al. 2015; Reinertsen
et al. 2017a).
Sample entropy or “SampEn” (eq 2.1) is perhaps the most popular in the literature.
However, SampEn can change significantly and/or non-monotonically with small changes
in parameter values and thus exhibits poor statistical stability. Additionally, SampEn only
accounts for similar patterns with similar amplitudes, not similar patterns with different
amplitudes. These shortcomings have been addressed by replacing the binary Heaviside
classifier with a continuous membership degree between 0 and 1, based on fuzzy set theory
(Chen et al. 2007), and replacing probability estimation with density estimation for entropy
approximation (Lee et al. 2001; Liu et al. 2013; Li et al. 2013). This novel “fuzzy approxi-
mation of entropy” improves robustness to noise and classifier accuracy when using entropy
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as a feature for machine learning.
Various entropy approaches have been compared for discriminating AF, including fuzzy
entropy, sample entropy, coefficient of sample entropy, and a novel extension of fuzzy entropy
that adjusts for heart rate by subtracting the natural log value of the mean RR interval (Liu
et al. 2018). For classifying AF and non-AF rhythms, fuzzy entropy achieved AUCs of
92.72%, 95.27% and 96.76% for 12-, 30- and 60-beat window lengths respectively. This was
higher than the performance of the other techniques.
Entropy calculations require selecting hyperparameters such as the template length m,
the radius or normalized distance r within which two sequences are considered a match,
and the overall segment length of data to be assessed. Most studies use hyperparameter
values from previous literature, rather than a rigorous approach based on first principles.
For example, Zhao et al. 2015 recommends r = 0.1 times the standard deviation of RR time
series, but this observation is empirical and based on results within a single study.
Optimization methods have been explored for parameter estimation, including grid search,
random search, and Bayesian optimization. This method treats the unknown objective func-
tion as random, and places a prior over it using a Gaussian process (Shahriari et al. 2016).
After gathering the function evaluations, which are treated as data, the prior is updated to
form the posterior distribution over the objective function. The posterior distribution, in
turn, is used to determine what the next query point should be. Bayesian optimization has
been utilized for estimating values of sample entropy (Shashikumar et al. 2017a), transfer
entropy (Reinertsen et al. 2018), and other information theoretical properties of time series
that are used as features for machine learning-based classification of disease.
Areas of future work include other optimization methods such as genetic algorithms.
Computational speed is still a challenge in the assessment of long time series. Physiological
underpinnings of altered complexity are still being explored both in theoretical and experi-
mental work. Lastly, the analysis of local versus global complexity of time series may enable
a dynamic approach whereby the optimal parameters used within a local segment of data
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is determined using prior information rather than using a single set of parameters for the
entire time series. Such an approach would be complemented by change point detection to
select segments, and multiscale analysis to parse complexity over various timescales.
6.3.3 Network dynamics
Network or graph representations of time series may capture different illness-related informa-
tion compared to other information theoretical measures of complexity of the original time
series. Fasmer et al. evaluated time series of locomotor activity over 12 days from depressed
and schizophrenic patients, mapped these data to a graph, and evaluated measures of com-
plexity (Fasmer et al. 2018). Depressed patients were found to be significantly different from
both controls and schizophrenic patients, with evidence of less regularity of the time series.
Campanharo et al. qualitatively evaluated network representations of chaotic Lorenz and
Rossler equations, but the relationship between network attributes and properties seen in
physiological data such as noise, auto-correlation, periodicity, and non-stationarity remain
unknown (Campanharo et al. 2011). To study these properties, simple dynamical systems
can be generated with known and varying levels of these properties and converted into
networks. Understanding this mapping could yield insight about the physiological meaning
of altered interactions between HR and activity time series in illness.
Multivariate graphical representations can also be used to assess interactions between
variables. Prior work on graphical representations of time series have been univariate, com-
prised only of motor activity states, whereas the work in this thesis and by Shashikumar et
al. 2017a explores multivariate states comprised of HR and activity, or HR and BP. Future
work should incorporate even higher dimensionality by including other clinically relevant
time series data. Early exploration of this multivariate approach is occurring in the inten-
sive care unit, where several types of data are monitored in near-real time at a high sampling
frequency. However, network analysis could also be useful in mental health. One example is
using natural language processing on social media or passive audio recording to generate a
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time series of sentiment, and creating multivariate states or nodes of a graph represented by
that sentiment as well as physiological and locomotor activity time series. Finally, data with
different formats could be fused into a classifier separately from a network representation of
time series. For example, results of lab tests such as serum creatinine represent important
clinical information, but are not time series, and could thus be input as features alongside
network properties to a machine learning algorithm.
6.3.4 Overcoming limitations of clinical trials
Strict inclusion and exclusion criteria are employed to test interventions against a clean
background, rather than a real-world scenario in which adherence to the intervention or data
collection protocol can be more challenging. Data are collected from patients using long,
paper-based questionnaires, journals, or web-based surveys. These tools are inconvenient
and time-consuming to patients and do not reflect the context of their daily lives. Only 2%
of the eligible population in the U.S. participate in clinical trials (Woodcock et al. 2017).
Those who do participate attend an average of 11 trial site visits over six months which can
require traveling a significant distance. Finally, conducting trials for patients with serious
neuropsychiatric illness can be especially challenging due to limited ability to adhere to study
protocols.
Mobile and internet-connected technologies can help address some of these issues by en-
abling trials to be carried out at a participant’s home or local physician’s office – a “virtual”
or “remote” trial – rather than at a central trial site (Seyfert-Margolis 2018). Virtual trials
could also increase the rate of enrollment in exploratory or clinical studies (Savage 2015).
For example, over eight months the MyHeart Counts app attracted over 48,000 people who
consented to participate in a study of cardiovascular health; 40,000 people uploaded data
including surveys on diet, well-being, risk perception, work-related and leisure-time physical
activity, sleep, and cardiovascular health (McConnell et al. 2017). During the initial seven-
day monitoring period, participants’ motion was recorded via phone accelerometry. After
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one week, 4,990 people completed a six-minute walk test. Similarly, the mPower app, built
using Apple’s ResearchKit framework in a collaboration with the University of Rochester
and Sage Bionetworks, aims to quantitatively assess symptoms of Parkinson’s disease, and
has been downloaded by 48,000 people with 9,520 subjects consenting to sharing their data
(Bot et al. 2016). Novartis has worked with Science 37, a technology company that devel-
ops decentralized clinical trial technology and design, on virtual trials for cluster headache,
acne and nonalcoholic steatohepatitis (NASH) (Novartis 2018). Recently, these two entities
announced a strategic alliance to initiate up to 10 new decentralized and technology-driven
remote clinical trials over the next three years. In addition to bolstering trial enrollment and
retention, digital sensors could detect more subtle or nuanced effects of an intervention that
could be missed by traditional outcome measures. The quantity and intrinsic speed of data
gathering and processing afforded by sensors and software could also better enable adaptive
trials, whereby investigators use accumulated data and modify or redesign the trial while
the study is still ongoing (Chow 2014).
Digital sensor data is likely to complement rather than replace data obtained in current
research trials such as blood biomarkers and imaging. The Emory Healthy Aging Study
is an example of this multifaceted approach and will be the largest clinical research study
ever conducted in Atlanta, GA (Emory University 2016). The goal is to develop a midlife
biomarker of Alzheimer’s disease, since it is now well established that the disease begins about
two decades prior to the onset of symptoms. Developing new ways to detect the disease in
the asymptomatic phase is key for developing preventative treatments. To accomplish this
goal, the Emory Healthy Aging Study first aims to recruit 100,000 individuals to participate
in an online study to assess risk factors identified via health questionnaires, smartphones,
and wearable devices. The second aim is to deeply phenotype a subpopulation of 3000 of
these subjects every few years to assess risk factors by profiling genetics, cardiovascular
physiology, blood and spinal fluid biomarkers, and brain and retinal imaging. Analyses of
subjects’ profiles, including their amyloid status, will facilitate discovery of new biomarkers
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with diagnostic and prognostic utility.
6.3.5 Addressing needs in low-resource settings
Mobile and wearable technologies have become dramatically cheaper over the past few
decades, and could help address the under-distribution of medications and personnel related
to neuropsychiatric care in low-resource settings (Collins et al. 2011). Young males, ethnic
minorities and people living in socioeconomically disadvantaged areas are more likely to ex-
perience “severe mental disorders including schizophrenia, bipolar disorder, and depression
with psychotic symptoms” (Jongsma et al. 2018). Furthermore, even in a wealthy country
such as the USA, ethnic minorities have significantly less access to care than do European
Americans (Mcguire et al. 2008). Compounding this issue, the poorest countries spend the
lowest percentages of their overall health budgets on mental health, and have less relative
availability of diagnostic encounters and interventions (Saxena et al. 2007). Telepsychiatry
and teleneurology can extend the geographic reach of clinicians in regions with limited health
resources, but this approach is still limited by the supply of trained professionals. To deliver
interventions in a more scalable manner, smartphone and internet-based methods have been
explored, including prerecorded video tutorials, self-help interventions, online communities
or support groups, and guides to help patients navigate their healthcare system (Kazdin et
al. 2013). Digital sensors could complement these approaches by enabling detection of early
signs of illness relapse, medication adherence, or treatment efficacy. Although technology-
based care delivery methods such as telemedicine are becoming increasingly available in
health systems, passive monitoring has yet to become an established component of clini-
cal workflow, especially in resource-poor regions. Many attempts at delivering affordable
healthcare technologies into such environments have not achieved the intended levels of im-
pact due to a focus only on cost or simplicity. Attention to sustainable business practices,
local cultural dynamics, and integration with existing resource and workflow may enable
the potential of these technologies to educate and assist patients and providers; Clifford
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2016 provides a thorough review of these considerations and proposes structural ecosystem
changes to help achieve empowerment.
6.3.6 Using monitoring to affect patient outcomes
Although much work has focused on demonstrating feasibility of passive sensing, the gap
between data capture and meaningful improvements in patient outcomes has yet to be closed
(Patel et al. 2015). A growing body of literature has shown that smartphones not only can
monitor patients but can also send information to patients in a way that affects clinical
outcomes. SMS can increase adherence to antiretroviral therapy and smoking cessation (Free
et al. 2013), and smartphone delivery of cognitive behavioral therapy can reduce anxiety,
depression, stress, and substance use (Ehrenreich et al. 2017). Recently, Freeman et al.
conducted the largest RCT of a psychological intervention for a mental health problem
(Freeman et al. 2017). 3,755 students with insomnia from 26 UK universities were enrolled
in the trial, with 1,891 receiving digital CBT for insomnia (“Sleepio”), and 1,864 receiving
standard practice treatment. Digital CBT was accessible via web browser, and sleep diaries
and relaxation audio was accessible via smartphone. At ten weeks, Sleepio significantly
reduced insomnia, paranoia, and hallucinations compared to the usual practice. However,
no large RCT focused on neuropsychiatric illness has reported a positive impact of passive
monitoring on outcomes. A recent difference-in-differences random effects meta-analysis of
RCTs of remote patient monitoring did not find statistically significant impacts on any of
six outcomes including body mass index, weight, waist circumference, body fat percentage,
systolic blood pressure, and diastolic blood pressure (Noah et al. 2017). Interventions based
on health behavior models and personalized coaching – relevant to neuropsychiatric care –
were most successful.
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6.3.7 Ongoing and future studies of note
Large-scale ongoing and future studies of neuropsychiatric disease are increasing utilizing
smart devices as a complementary or even central method of gathering participant data
(Table A5). Some studies are described briefly here.
Faurholt-Jepsen et al. will assess up to 400 patients with bipolar disorder, randomizing
them to either 1) a smartphone-based monitoring system including a feedback loop between
patients and clinicians, and cognitive behavioral therapy, or 2) standard treatment. The
study will evaluate outcomes such as re-admissions, symptomatic severity, and quality of
life.
Verily, University of North Carolina, and Harvard University are leading the AURORA
study, which is a 19-institution five-year endeavor to perform the most comprehensive ob-
servational study of trauma to date.
Emory University is conducting the Healthy Aging Study on 100,000 participants. The
overarching goal is to develop a midlife biomarker of Alzheimer’s disease, since it is now well
established that the disease begins about 2 decades prior to the onset of clinical symptoms.
The UCLA Depression Grand Challenge Study aims to enroll 100,000 people in a 10-year
study. The aim is to screen for depression, analyze participants’ genetics, measure early
adversity and life stress and assess symptoms.
These and other studies of similar scope are of interest because they seek to 1) gather
data from multiple clinical sites in an effort to demonstrate generalizability of monitoring
approaches, 2) link physiomarkers gathered from smart devices with traditional biomark-
ers from cerebrospinal fluid, blood, genome studies, and imaging, and 3) generate novel
hypotheses about disease mechanism, progression, and possible interventional targets.
6.3.8 Closing remarks
This thesis contributes to the effort of illness classification via features from heart rate
and accelerometer time series data. Classification performance is improved by considering
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information during specific times, over several time scales, and between signals. Passive
sensing is an important but early step in the iterative process by which data is used to improve
patient management, e.g. revise parameters of CBT or other psychotherapy, adjust doses or
selection of pharmacological agents, or modify recommended lifestyle and behavior changes.
In turn, the effect of these interventions can be measured close to real-time. Thus, digital
sensors will likely form an integral component of how healthcare is delivered in many clinical
specialties: a feedback loop starting with data-driven insight about pathophysiology and/or
treatment, that in turn optimizes therapy, and ultimately improves patient outcomes.
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APPENDICES
A.1. Questionnaires, surveys, and scales
The self-reporting of symptoms is an extremely useful gauge of patient progress or acuity.
Although such surveys have been traditionally administered via paper, or more recently
via web pages, it is increasingly common to capture such data through an approach called
Ecological Momentary Assessment (EMA), whereby questions can be delivered to the subject
via smartphone in response to triggers, a certain time, or a pattern of interest in gathered
data. The questions can be repeatedly administered if the user does not answer. While
there is little evidence so far as to the effect this has on such scales, the flexibility this offers
provides a new avenue for research into such systems, whereby timing of the response, and
even corrections during the process could be analyzed to extract further information about
the state of a patient. In this section we review a variety of the most relevant surveys for
neuropsychiatric EMA and provide the evidence base for their traditional use.
The Perceived Stress Scale (PSS) was developed to measure psychological stress, defined
as “the extent to which persons perceive that their life demands exceed their ability to cope”
(Cohen et al. 1983). The PSS predicts both objective biological markers of aging (Espel et al.
2004), cortisol levels (Malarkey et al. 1995), immune markers (Maes et al. 1999), depression
(Carpenter et al. 2004), and increased risk for disease among persons with higher perceived
stress levels.
The Hamilton Rating Scale for Depression (HRSD, HAMD, or HAM-D) is a multiple
item questionnaire used to quantify the results of an interview assessment of symptoms in
an adult patient diagnosed with depression (Hamilton 1960). Severity of depression is as-
sessed by probing mood, feelings of guilt, suicide ideation, insomnia, agitation or retardation,
anxiety, weight loss, and somatic symptoms among 17 to 29 dimensions (depending on ver-
sion; often referred to as the HAMD-17 or HAMD-29 respectively) with a score on a 3 or
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5 point scale. A score of 0-7 is considered to be normal. Scores of 20 or higher indicate
moderate, severe, or very severe depression, and are usually required for entry into a clinical
trial. However, the HRSD has been criticized as a test because it places more emphasis
on insomnia than on suicide ideas and gestures (Bagby et al. 2017). An antidepressant
may show statistical efficacy even when thoughts of suicide increase but sleep is improved.
Alternatively, even if a medication effectively reduces depressive symptoms, if sexual and
gastrointestinal symptoms worsen as a side effect, efficacy can be underestimated. Results of
a large meta-analysis suggest that HRSD achieves good overall levels of internal consistency,
inter-rater and test–retest reliability, but some HRSD items (e.g., “loss of insight”) are not
sufficiently reliable (Trajković et al. 2011).
The Quick Inventory of Depressive Symptomatology (QIDS-SR16) is a shortened 16-item
version of the 30-item Inventory of Depressive Symptomatology (IDS), a structured interview
that was constructed by selecting only items that assessed DSM-IV diagnostic criterion
items for MDD (Rush et al. 2000). The research group that developed the IDS obtained
feedback/critique from more than a dozen, largely US, clinical researchers who were experts
in depression. The nine domains of the QIDS-SR16 comprise sad mood, concentration,
self-criticism, suicidal ideation, interest, energy/fatigue, sleep disturbance (initial, middle,
and late insomnia or hypersomnia), decrease/increase in appetite/weight, and psychomotor
agitation/retardation. The total score ranges from 0 to 27. QIDS-SR16 has high internal
consistency, as well as high correlation with the IDS and the HAMD (Rush et al. 2003).
The Primary Care Evaluation of Mental Disorders (PRIME-MD) Patient Health Ques-
tionnaire (PHQ) was designed by the PHQ Primary Care Study Group to be a fully self-
administered survey; the original survey it was based upon was clinician-administered (Spitzer
et al. 1999). There is an optional fourth page that includes questions about menstruation,
pregnancy and child-birth, and recent psychosocial stressors. The original PHQ assessed
18 current mental disorders. By grouping several mood, anxiety, and somatoform cate-
gories together, the PHQ greatly simplifies the differential diagnosis by assessing only eight
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disorders: MDD, panic disorder, other anxiety disorder, bulimia nervosa, other depressive
disorder, probable alcohol abuse or dependence, and somatoform and binge eating disor-
ders. Patients indicate for each of the 9 depressive symptoms whether, during the previous
2 weeks, the symptom has bothered them “not at all,” “several days,” “more than half the
days,” or “nearly every day.”. Patients also indicate for each of the 13 physical symptoms
whether, during the previous month, they have been “not bothered,” “bothered a little,” or
“bothered a lot” by the symptom. The PHQ Primary Care Study Group found agreement
between PHQ diagnoses and those of independent mental health professionals; for the di-
agnosis of any 1 or more PHQ disorder, κ = 0.65; overall accuracy, 85%; sensitivity, 75%;
specificity, 90%, similar to the original PRIME-MD questionnaire. Furthermore, in addition
to making criteria-based diagnoses of depressive disorders, the PHQ-9 has also been show
to be a reliable and valid measure of depression severity (Kroenke et al. 2001). A slightly
shorter eight-question version of this survey, the PHQ-8, is also sometimes used.
The Center for Epidemiological Studies Depression (CESD) scale is a short self-report
scale comprised of 20 questions that ask how often over the past week a person experienced
symptoms associated with depression, such as restless sleep, poor appetite, or feeling lonely
(Radloff 1977). Each item is scored 0 to 3: 0 = Rarely or None of the Time, 1 = Some or
Little of the Time, 2 = Moderately or Much of the time, 3 = Most or Almost All the Time.
Total scores range from 0 to 60, with higher scores indicating greater depressive symptoms.
Cutoff scores identify individuals at risk for clinical depression with good sensitivity and
specificity, and high internal consistency (Lewinsohn et al. 1997).
The Beck Depression Inventory (BDI) consists of 21 multiple-choice questions that ask
how the subject has been feeling in the last week, and is a proxy for a structured clini-
cal interview (Beck et al. 1961). Questions inquire about symptoms of depression such as
hopelessness and irritability, cognitions such as guilt or feelings of being punished, physical
symptoms such as fatigue, weight loss, and lack of interest in sex. Each question has a
set of at least four possible responses, ranging in intensity. A value of 0 to 3 is assigned
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for each answer, and the values are summed to calculate a total sum up to 63. A higher
total score indicates more severe depressive symptoms. The BDI is one of the most widely
used psychometric tests for measuring the severity of depression; its successor is the BDI-II
which is now more common. The BDI was revised 1996 to the BDI-II in response to the
American Psychiatric Association’s publication of the Diagnostic and Statistical Manual of
Mental Disorders, Fourth Edition, which changed many of the diagnostic criteria for MDD
(Beck et al. 1996). The BDI-II is used to evaluate how the subject has been feeling over the
past two weeks instead of one week, in order to be consistent with the DSM-IV time period
for the assessment of MDD.
The Young Mania Rating Scale (YMRS) is an eleven-item clinician-administered scale
to rate manic symptoms. This score correlated with the number of days of subsequent stay
in hospital, and significantly differed in patients before versus after two weeks of treatment
(Young et al. 1978). A parent report version of the YMRS (P-YMRS) was assessed in a
cohort of 117 youths age 5-17 (Gracious et al. 2002). The P-YMRS demonstrated accept-
able internal consistency. Logistic regressions discriminated bipolar mood disorder versus
unipolar disorder, versus disruptive behavior disorder, and versus any other diagnosis. Clas-
sification rates exceeded 78%, and receiver operating characteristics analyses showed areas
under the curve greater than 0.82.
The Altman Self-Rating Mania scale (ASRM) is a self-administered survey that was
originally evaluated on a cohort of 22 schizophrenic, 13 schizoaffective, 36 depressed, and 34
manic patients (Altman et al. 1997). The Clinician Administered Rating Scale for Mania
(CARS-M) and Mania Rating Scale (MRS) were completed at the same time to measure
concurrent validity. Principal component analysis of ASRM items revealed three factors:
mania, psychotic symptoms, and irritability. Baseline mania subscale scores were signifi-
cantly higher for manic patients compared to all other diagnostic groups. Posttreatment
scores were significantly decreased in manic patients for all three subscales. ASRM mania
subscale scores significantly correlated with MRS total scores (r = 0.72) and CARS-M mania
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subscale scores (r = 0.77). Test-retest reliability for the ASRM was significant for all three
subscales. Mania subscale scores of greater than 5 on the ASRM resulted in sensitivity of
85.5% and a specificity of 87.3%.
The General Behavior Inventory (GBI) is a 73-question self-administered survey that
evaluates various aspects of mood and is designed to identify the presence and severity of
manic and depressive moods in adults (Depue et al. 1981). It consists of two scales to assess
depressive symptoms (46 items) and hypomanic / biphasic (mixed) symptoms (28 items)
(Youngstrom et al. 2008). GBI items use a Likert scale from 0-3: 0 (never or hardly ever
present), 1 (sometimes present), 2 (often present), and 3 (very often or almost constantly
present). The GBI has high internal consistency and retest reliability because of its large
number of items. Retest reliability also is good over a week or two week period, although
the required reading level and length make it challenging for some people to complete.
The Social Rhythm Metric (SRM) quantifies an individual’s social zeitgebers (time givers,
or circadian rhythm entrainment cues) (Monk et al. 1990). Social life may provide important
social cues that entrain circadian rhythms, including sleep habits, eating times, and occupa-
tional routines. Disturbance of these social cues could result in dis-entrainment of circadian
rhythms, which may increase the risk of developing mood disorders or other mental illnesses.
The SRM score is determined from the timing of 15 specific and 2 built-in activities that
constitute an individual’s social rhythm. If the timing of an activity that occurs at least
three times a week is within 45 minutes of the typical time, it is considered part of one’s
daily routine. The total number of these activities is divided by the total number of activities
occurring at least three times a week. The result is the SRM score. A higher SRM score was
found to relate to subjective better sleep, higher morning alertness and a deeper nocturnal
temperature trough, whereas lower SRM-scores correlated with higher reports of depressive
symptoms (Monk et al. 1994).
The Pittsburgh Sleep Quality Index (PSQI) is a self-administered survey which assesses
sleep quality and disturbances over a one month time interval (Buysse et al. 1989). Nineteen
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individual items generate seven component scores: subjective sleep quality, sleep latency,
sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and
daytime dysfunction. The sum of scores for these seven components yields one global score.
The Positive and Negative Syndrome Scale (PANSS) is a 30-question clinician-administered
survey that measures symptom severity of schizophrenia and has been widely used in the
study of antipsychotic therapy (Kay et al. 1987). Seven questions assess positive symptoms,
which refer to an excess or distortion of normal functions, e.g., hallucinations and delusions.
Seven questions assess negative symptoms, which represent a decrease or loss of normal func-
tion, e.g. blunted affect and social withdrawal. 16 questions assess general psychopathology,
e.g. feelings of guilt and poor attention. Each answer is rated 1 to 7 based on the interview
as well as reports of family members or healthcare providers. The overall PANSS score thus
ranges from 30 to 210. Kay’s original publication reported a mean score of 77 for patients
with schizophrenia.
The Calgary Depression Scale for Schizophrenia (CDSS) is a nine-item clinician-administered
survey, in which each item is on a four point Likert scale (Addington et al. 1990). It was
designed to assess depression specifically in psychotic populations, for whom previous depres-
sion instruments were not designed. Internal consistency is high, and significant and strong
correlations have been found between scores on the CDSS, BDI, and HRSD (Addington
et al. 1992; Addington et al. 1993). The CDSS depression score is obtained by adding each
of the item scores. A score above 6 has an 82% specificity and 85% sensitivity for detecting
a major depressive episode.
The Unified Parkinson’s Disease Rating Scale (UPDRS) is a clinician-administered in-
terview and exam that is used to describe the severity of Parkinson’s Disease (Fahn et al.
1987). It is made up of the 1) Mentation, Behavior, and Mood, 2) ADL, and 3) Motor
sections. Some sections require multiple grades assigned to each extremity. The score ranges
from 0 to 199; 0 represents no disability, and 199 represents total disability. Strengths of the
UPDRS include its wide utilization, its application across the clinical spectrum of PD, its
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nearly comprehensive coverage of motor symptoms, and its clinimetric properties, including
reliability and validity. Weaknesses include several ambiguities in the written text, inade-
quate instructions for raters, some metric flaws, and the absence of screening questions on
several important non-motor aspects of PD (Goetz 2003). The motor section of the UPDRS
(UPDRS-III) is often used in lieu of the entire UPDRS for patients with PD, and the exam is
ideally performed by a movement disorder specialist. In 2007 the Movement Disorder Society
(MDS) revised the UPDRS which originally placed nonmotor elements in PD throughout the
subscales, with mental features captured in Part I, pain in Part II, and sleep disorders and
dysautonomia in Part IV (Goetz et al. 2007). The scale was reorganized so that Part I of the
MDS-UPDRS is now titled “Nonmotor Experiences of Daily Living” and encompasses ques-
tions requiring medical expertise to answer (cognitive impairment, hallucinations, depressed
mood, anxious mood, apathy, and dopamine dysregulation) as well as simpler questions that
were considered better suited for a patient or caregiver questionnaire (sleep, staying awake,
pain and abnormal sensory sensations, urinary function, constipation, lightheadedness on
standing, and fatigue). Part II was retitled to “Motor Experiences of Daily Living”, Part
III remains “Motor Examination” to be completed by the rater, and Part IV was restricted
to “Motor Complications” which include dyskinesias and motor fluctuations. This revised
MDS-UPDRS is now commonly used in PD research.
The Hoehn and Yahr (HY) scale was originally designed to be a descriptive, clinician-
administered structured interview and staging scale that estimates clinical function in PD,
combining functional disability and objective signs of impairment (Hoehn et al. 1967).
Strengths of the HY scale include its wide utilization and acceptance. Higher stages correlate
with dopaminergic loss as confirmed via neuroimaging studies, and the HY scale has been
shown to highly correlate with some standardized scales of motor impairment, disability,
and quality of life (Goetz et al. 2004). Weaknesses include the scale’s mixing of impairment
and disability. Because the HY scale is weighted heavily toward postural instability in de-
termining disease severity, it does not capture impairments or disability from other motor
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features of PD, and gives no information on nonmotor problems which are also features of
the illness that contribute to decreased quality of life. The UPDRS has largely supplanted
the HY scale in clinical and research use.
The Short Form-36 (SF-36) is the most widely used health-related quality-of-life measure
in research to date, and can be either self-administered or administered by a trained inter-
viewer over the phone or in person (Ware Jr et al. 1992). The SF-36 yields eight scale scores
and two summary scores: a physical component summary (PCS), and mental component
summary (MCS). The physical and mental components were designed to be uncorrelated.
The eight scale scores represent physical functioning, bodily pain, role limitations due to
physical health problems, role limitations due to personal or emotional problems, general
mental health, social functioning, energy/fatigue or vitality, and general health perceptions.
A higher score represents better health. The PCS and MCS scores are calculated by z-
scoring each of the eight scores across the general U.S. population, then multiplying by the
corresponding factor scoring coefficient for each scale (Taft et al. 2001).
The Instrumental Activities of Daily Living (IADL) scale assesses independent living
skills, identifies how a person is functioning at the present time, and determines improve-
ment or deterioration over time (Lawton et al. 1969). In the original study, the survey was
administered by a social worker who gathered information from the subjects, family mem-
bers, employees, etc. Eight domains of function are measured: ability to use the telephone,
shopping, food preparation, housekeeping, laundry, mode of transportation, responsibility
for own medications, and ability to handle finances. The IADL Scale is intended to be used
among older adults, and may be used in community, clinic, or hospital settings, but is not
useful for institutionalized older adults. Although the IADL Scale is easy to administer and
focuses on practical functionality related to daily living, it relies on self-report or surrogate
report rather than a demonstration of the functional task.
The State Trait Anxiety Inventory (STAI) is a 40-item self-administered survey designed
to measure anxiety at two ends of the “affect curve”, e.g. feelings of anxiety due to a stressful
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state or situation, versus enduring personality traits (Spielberger et al. 1983). Each item
has a four-point Likert scale measure. Overall scores thus range from 20 to 80, with higher
scores suggesting more severe anxiety.
The Generalized Anxiety Disorder (GAD-7) is a 7-item self-administered survey used to
identify GAD (Spitzer et al. 2006). It was constructed from 965 adult primary care patients
who completed a questionnaire and telephone interview with a mental health professional
within a week, and achieved a sensitivity of 89% and specificity of 82% in assessing general-
ized anxiety disorder, with good agreement between self-report and interviewer-administered
versions of the scale.
The Apathy Evaluation Scale (AES) is used to evaluate apathy – the lack of will to act
and the inability to care about the consequences – in a patient based on interview of a person
familiar with the patient (Marin 1996). The scale consists of 18 questions that each use a
four point Likert scale measure ranging from 0 to 3. Overall scores thus range from 0 to 54;
the higher the score the greater the level of apathy.
The Brief Psychiatric Rating Scale (BPRS) is used for measuring general psychiatric
symptoms such as depression, anxiety, hallucinations and unusual behavior (Overall et al.
1962). During a structured clinical interview, 18-24 symptoms are scored, and each symptom
is rated 1-7 where 1 indicates absence of symptomatology or concern, and 7 indicates extreme




Table A1: Abbreviations used throughout review
Abbreviation Definition
AD Alzheimer’s disease
ADHD Attention deficit hyperactivity disorder
ADL Activities of daily living
ANS Autonomic nervous system
AUC Area under the receiver operating characteristic curve
BD Bipolar disorder
BLT Bright light therapy
CDC Centers for Disease Control and Prevention
DALY Daily adjusted life year
ECG Electrocardiogram
EMA Ecological momentary assessment
GPS Global positioning system
GSR Galvanic skin response
HF High frequency
HRV Heart rate variability
IS Interdaily stability
IV Intradaily variability
L5 Mean activity level during the least active five hours
LF Low frequency
M10 Mean activity level during the most active ten hours
MCI Mild cognitive impairment
MDD Major depressive disorder
Continued on next page
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Table A1 – continued from previous page
Acronym Definition
PPG Photoplethysmography
PTSD Post traumatic stress disorder
RA Relative amplitude
RMSSD Root mean square of the successive differences
rCBF Regional cerebral blood flow
SAD Seasonal affective disorder
SCID Structured clinical interview for the DSM-IV
SDNN Standard deviation of average normal-to-normal intervals
SMS Short message service
VLF Very low frequency power
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Table A2: Aberrations in physiology and behavior associated with neuropsychiatric illness
that are detectable by sensors in smartphones and wearables
Sensor type
Illness Accelerometry HR GPS Calls & SMS
Stress & depression Disruptions in circadian
rhythm and sleep
Emotion mediates vagal
tone which manifests as
altered HRV
Irregular travel routine Decreased social interac-
tions
Bipolar disorder Disruptions in circadian





Irregular travel routine Decreased or increased
social interactions
Schizophrenia Disruptions in circadian
rhythm and sleep, loco-





Irregular travel routine Decreased social interac-
tions
PTSD Inconclusive evidence ANS dysfunction via
HRV measures
Inconclusive evidence Decreased social interac-
tions
Dementia Disruptions in circadian
rhythm, diminished loco-
motor activity








Inconclusive evidence Voice features can indi-
cate vocal impairment
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Table A3: Questionnaires, surveys, and scales
Reference Survey (acronym) Indication
Cohen et al. 1983 Perceived Stress Scale (PSS) Stress
Hamilton 1960 Hamilton Rating Scale for Depression (HRSD or HAMD) Depression
Rush et al. 2000 16-item Quick Inventory of Depressive Symptomatology (QIDS-SR16) Depression
Spitzer et al. 1999 Patient Health Questionnaire (PHQ) Depressive disorders
Radloff 1977 Center for Epidemiological Studies Depression (CESD) Depression
Beck et al. 1961 Beck Depression Inventory (BDI) Depression
Young et al. 1978 Young Mania Rating Scale (YMRS) Mania
Altman et al. 1997 Altman Self-Rating Mania scale (ASRM) Mania
Depue et al. 1981 General Behavior Inventory (GBI) Mania and depression
Monk et al. 1990 Social Rhythm Metric (SRM) Circadian entrainment
Buysse et al. 1989 Pittsburgh Sleep Quality Index (PSQI) Sleep
Kay et al. 1987 Positive and Negative Syndrome Scale (PANSS) Schizophrenia
Addington et al. 1990 Calgary Depression Scale for Schizophrenia (CDSS) Depression in schizophrenia
Fahn & Elton 1987 Unified Parkinson’s Disease Rating Scale (UPDRS) Parkinson’s disease
Hoehn & Yahr 1967 Hoehn and Yahr (HY) scale Parkinson’s disease
Ware & Sherbourne 1992 Short Form-36 (SF-36) Quality of life
Lawton & Brody 1969 Lawton Instrumental Activities of Daily Living (IADL) –
Continued on next page
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Table A3 – continued from previous page
Reference Survey (acronym) Indication
Spielberger et al. 1983 State Trait Anxiety Inventory (STAI) Anxiety
Spitzer et al. 2006 7-item Generalized Anxiety Disorder (GAD-7) scale Anxiety
Marin et al. 1996 Apathy Evaluation Scale (AES) Apathy
Overall & Gorham 1962 Brief Psychiatric Rating Scale (BPRS) General psychiatric symptoms
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Table A4: Studies of smartphones and wearables for monitoring neuropsychiatric illness
Reference Key aim Population Sensors Design
Abdullah et al. 2016 Estimate social rhythms (assessed via SRM ques-
tionnaires) using smartphone data
Seven subjects with BD Smartphones recorded GPS data, accelerometry,
microphone audio, and social communication
Offline retrospective
Aguilera et al. 2015 Assess relationship between daily / weekly mood
scores and PHQ-9 scores
33 subjects Smartphone administered PHQ-9 surveys Offline retrospective
Albert et al. 2017 Distinguish subjects with PD from controls using
accelerometry of hand tremor
Eight subjects with PD and 18
controls
Smartphones recorded accelerometry of hand
tremor during motor tasks
Offline retrospective
AlHanai et al. 2017 Classify subject mood while reading happy or sad
stories using wearable data
Ten healthy subjects Audio was recorded using Apple iPhones. Sam-
sung Simband smartwatches recorded PPG, ECG,
accelerometry, skin impedance, galvanic skin re-
sponse, and skin temperature
Online real-time
Apiquian et al. 2017 Assess motor activity and sleep time before and af-
ter antipsychotic treatment
20 subjects with schizophrenia
and 20 controls
Wrist-worn devices recorded accelerometry Offline retrospective
Barnett et al. 2018 Predict clinical relapse from behavioral anomalies
in two-week window prior to event
17 subjects with schizophrenia Smartphones recorded mobility, social activity, and
questionnaires
Offline prospective
Beiwinkel et al. 2016 Depressive and manic symptoms (assessed via
HAMD and YMRS questionnaires administered ev-
ery three weeks) were classified using smartphone
data
13 subjects with BD Smartphones recorded GPS, accelerometery, and
cell tower data; mood states were assessed via a
self-reported two-item questionnaire
Offline retrospective
Ben-Zeev et al. 2015 Correlate smartphone features with daily stress rat-
ings, PHQ-9, PSS, and Revised UCLA Loneliness
Scale scores
47 healthy subjects Smartphones recorded GPS, accelerometry, sleep
duration, and time proximal to human speech
Offline retrospective
Berle et al. 2010 Assess motor activity and rest-activity characteris-
tics
46 subjects with schizophrenia
and 32 controls
Wrist-worn devices recorded actigraphy Offline retrospective
Bullock et al. 2014 Assess rest-activity metrics in BD patients with low
and high trait vulnerability (assessed via the GBI
questionnaire)
72 subjects with BD Wrist-worn devices recorded accelerometry Offline retrospective
Burns et al. 2011 Correlate EMA survey scores with smartphone fea-
tures
Eight subjects with MDD Smartphones recorded GPS, accelerometry, ambi-
ent light, and recent calls
Offline retrospective
Canzian et al. 2015 Correlate and predict PHQ score deviations with
smartphone features
28 healthy subjects Smartphones recorded GPS and accelerometry Offline prospective
Capecci et al. 2016 Identify freezing of gait events using accelerometry 20 subjects with PD Smartphones recorded accelerometry while subjects
walked and were video recorded
Offline retrospective
Cella et al. 2017 Assess autonomic dysfunction in schizophrenia us-
ing wearable device data
30 subjects with schizophrenia
and 25 controls
Empatica E4 devices recorded skin conductance,
HRV, and accelerometry
Offline retrospective
Ellis et al. 2015 Compare outcome measures of gait and gait vari-
ability in subjects with PD versus controls
12 subjects with PD and 12
controls
Steps were captured via a smartphone, heel-
mounted sensors, and a sensor mat
Offline retrospective
Continued on next page
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Table A4 – continued from previous page
Reference Key aim Population Sensors Design
Kamdar et al. 2016 Estimate variance of emotional state from wearable
data via random forest
13 healthy subjects Samsung Gear S smartwatches recorded accelerom-
etry, ambient light, heart rate; web app adminis-
tered mood surveys
Offline retrospective
Moore et al. 2012 Forecast mood time series using previous week’s
self-rated mood data via exponential smoothing
and Gaussian process regression
100 subjects with BD Mood surveys recorded via SMS Offline prospective
Faedda et al. 2016 Distinguish BD from ADHD using wearables data 48 subjects with BD, 65 sub-
jects with ADHD, and 42 con-
trols
Belt-worn devices recorded accelerometry for five
minutes
Offline retrospective
Faurholt-Jepsen et al. 2015 Correlate smartphone data with depressive and
manic symptoms via HDRS-17 and YMRS scores
assessed monthly
61 subjects with BD Smartphones recorded speech duration, social ac-
tivity, and accelerometry
Offline retrospective
Maria et al. 2016 Classify depressive and manic states (via HDRS-17
and YMRS scores) using smartphone data and voice
features
28 subjects with BD Smartphones recorded voice features (pitch, dura-
tion, etc.), speech duration, social activity, and ac-
celerometry
Offline retrospective
Fasmer et al. 2015 Fit resting and active periods to power law distri-
butions and assess differences in MDD
47 subjects with MDD and 29
controls
Wrist-worn devices recorded accelerometry Offline retrospective
Griffiths et al. 2012 Assess features of dyskinesia and akinesia from
wearable data, and identify improvements in UP-
DRS scores after medication
34 subjects with PD and 10
controls
Wrist-worn devices recorded accelerometry Offline retrospective
Grünerbl et al. 2015 Depressive and manic symptoms (assessed via
HAMD and YMRS questionnaires administered ev-
ery three weeks) were classified using smartphone
data
Ten subjects with BD Smartphones recorded GPS, accelerometry, number
and length of phone calls, and speech and voice fea-
tures
Offline retrospective
Hauge et al. 2011 Assess motor activity and rest-activity characteris-
tics
24 subjects with schizophre-
nia, 25 subjects with depres-
sion, and 32 controls
Wrist-worn devices recorded actigraphy Offline retrospective
Kassavetis et al. 2016 Correlate UPDRS scores with smartphone data 14 subjects with PD Smartphones recorded accelerometry while subjects
performed motor tasks
Offline retrospective
Kheirkhahan et al. 2016 Correlate impaired mobility from wearable data 1,135 subjects Hip-worn devices recorded accelometry Offline retrospective
Kim et al. 2015 Classify freezing episodes from normal walking us-
ing accelerometry
15 subjects with PD Smartphones recorded accelerometry while subjects
walked and were video recorded
Offline retrospective
Kostikis et al. 2014 Correlate accelerometry features with UPDRS hand
tremor scores
23 subjects with PD Smartphones recorded accelerometry of hand
tremor during motor tasks
Offline retrospective
Kostikis et al. 2015 Distinguish subjects with PD from controls using
accelerometry of hand tremor
25 subjects and 20 controls Smartphones recorded accelerometry of hand
tremor during motor tasks
Offline retrospective
Continued on next page
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Table A4 – continued from previous page
Reference Key aim Population Sensors Design
Krane-gartiser et al. 2014 Assess mean activity, variance, symbolic dynamics,
and power spectral features
18 subjects with mania and 12
subjects with BD
Wrist-worn devices recorded accelerometry Offline retrospective
Kuhlmei et al. 2013 Associate activity with apathy and depression (as-
sessed via AES and BDI questionnaires)
32 subjects with dementia, 21
subjects with MCI, and 23 con-
trols
Wrist-worn devices recorded accelerometry during
motor tasks
Offline retrospective
Lee et al. 2015 Compare RR peak detection, HRV measures, and
stress detection from wearable versus Holter moni-
tor
17 subjects Custom ECG patch was developed to record cardiac
activity
Offline retrospective
Lee et al. 2016 Correlate UPDRS scores with smartphone data 103 subjects with PD Smartphones recorded hand dexterity via timed
tapping test, rapid alternating movements, tremor
tracker via tracing between two parallel lines, and
a cognitive interference test
Offline retrospective
Martin et al. 2006 Assess time in bed, sleep consistency, daytime
sleeping, and circadian rhythm regularity
28 subjects with schizophrenia
and 28 controls
Wrist-worn devices recorded accelerometry and
light exposure
Offline retrospective
Nakamura et al. 2007 Fit resting and active periods to power law distri-
butions and assess differences in MDD
14 subjects with MDD and 11
controls
Wrist-worn devices recorded accelerometry Offline retrospective
Nero et al. 2015 Define accelerometer cut points for different walk-
ing speeds in adults with PD
30 subjects with PD Waist-worn devices recorded accelerometry Offline retrospective
Niwa et al. 2011 Assess if medication status, MMSE scores, activ-
ity, and HRV features differed by disease severity
(assessed via UPDRS scores) or disease duration
27 subjects with PD and 30
controls
Wrist-worn devices recorded accelerometry and
Holter monitors recorded ambulatory ECG
Offline retrospective
O’Brien et al. 2016 Assess relationship between quality of life, ADLs,
learning, and depression (assessed via SF-36 and
IADLS questionnaires) and smartphone data
29 subjects with MDD and 30
controls
Wrist-worn devices recorded accelerometry. Qual-
ity of life, ADLs, learning, and depression were as-
sessed via SF-36 and IADLS questionnaires
Offline retrospective
Osipov et al. 2015 Classify schizophrenic subjects from controls using
rest-activity characteristics and HRV features
16 subjects with schizophrenia
and 19 controls
Adhesive patches recorded locomotor activity and
ECG
Offline retrospective
Palmius et al. 20177 Estimate depressive symptoms (assessed via QIDS-
SR16 questionnaires administered weekly) and de-
tect depression using smartphone data
22 subjects with BD and 14
controls
Smartphones recorded GPS data Offline retrospective
Pan et al. 2015 Correlate accelerometry features with UPDRS
scores, and use features to detect hand resting
tremor and gait difficulty
40 subjects with PD Smartphones recorded accelerometry of hand
tremor and gait during motor and walking tasks
Offline retrospective
Patel et al. 2009 Estimate UPDRS scores using wearable data 12 subjects with PD Arm and leg-worn devices recorded accelerometry Offline retrospective
Place et al. 2017 Estimate depression and PTSD symptoms (assessed
via SCID questionnaires) using smartphone data
73 subjects with at least one
symptom of PTSD or depres-
sion
Smartphones recorded GPS, accelerometry, calls
and SMS activity, device use, and voice audio
Offline retrospective
Continued on next page
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Table A4 – continued from previous page
Reference Key aim Population Sensors Design
Reinertsen et al. 2017a Classify patients with PTSD using time-domain,
frequency-domain, and complexity features from
RR interval time series
23 subjects with PTSD and 25
controls
A Holter monitor recorded RR intervals for 24
hours
Offline retrospective
Reinertsen et al. 2017b Classify schizophrenic subjects from controls using
rest-activity characteristics and HRV features, and
evaluate relationship between number of days of
data and classifier accuracy
16 subjects with schizophrenia
and 19 controls
Adhesive patches recorded locomotor activity and
ECG
Offline retrospective
Roh et al. 2014 Compare RR peak detection, signal-to-noise, and
HRV measures from wearable versus Holter monitor
12-41 subjects (varied by test) Custom ECG patch was developed to record cardiac
activity
Offline retrospective
Roy et al. 2011 Classify tremor and dyskinesia from wearable data 11 subjects with PD Arm and leg-worn devices recorded accelerometry Offline retrospective
Saeb et al. 2015 Classify low from high PHQ-9 scores using smart-
phone features
28 healthy subjects Smartphones recorded GPS and phone usage Offline retrospective
Saeb et al. 2016 Correlate PHQ-9 scores with smartphone features
from weekend vs. weekday data
48 healthy subjects Smartphones recorded GPS and phone usage Offline retrospective
Sano et al. 2012 Fit resting and active periods to power law distri-
butions and assess differences in schizophrenia
19 subjects with schizophrenia
and 11 controls
Wrist-worn devices recorded accelerometry Offline retrospective
Sano et al. 2013 Distinguish stressed from non-stressed states using
wearable data
18 subjects Wrist-worn devices recorded accelerometry and skin
conductance. Smartphones recorded call and SMS
activity. Surveys assessed stress, mood, sleep,
tiredness, general health, alcohol or caffeine intake,
and electronics usage.
Offline retrospective
Sano et al. 2015 Estimate PSQI, PSS, and MCS questionnaire scores
from wearable data
66 subjects Wrist-worn devices recorded accelerometry and skin
conductance. Smartphones recorded call and SMS
activity. Sleep, stress, and mental health were as-
sessed via PSQI, PSS, and MCS questionnaires re-
spectively
Offline retrospective
Shin et al. 2016 Correlate symptom severity (assessed via the
PANSS questionnaire) with activity levels
61 subjects with schizophrenia Wrist-worn devices recorded accelerometry Offline retrospective
Stamatakis et al. 2013 Classify UPDRS score categories from wearable
data
36 subjects with PD and 10
controls
Finger-worn sensors recorded accelerometry during
a tapping test
Offline retrospective
Tung et al. 2014 Compare area, perimeter, and mean distance from
home in subjects with AD versus controls using
smartphone data
19 subjects with AD and 33
controls
Smartphones recorded GPS Offline retrospective
Walther et al. 2009b Assess if motor symptoms (assessed via PANSS
questionnaires) correlate with wearables data
55 subjects with schizophrenia Wrist-worn devices recorded actigraphy Offline retrospective
Walther et al. 2009a Assess if activity differs by schizophrenia subtype 60 subjects with schizophrenia Wrist-worn devices recorded actigraphy Offline retrospective
Continued on next page
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Table A4 – continued from previous page
Reference Key aim Population Sensors Design
Wang et al. 2014 Correlate smartphone data with PHQ-9, PSS, flour-
ishing scale, and UCLA loneliness scale scores
48 healthy subjects Smartphones recorded accelerometry, conversa-
tions, sleep, and location
Offline retrospective
Wang et al. 2016 Determine associations between EMA survey scores
and smartphone data via generalized estimating
equations
21 subjects with schizophrenia Smartphones recorded accelerometry, voice audio,
light sensor readings, GPS data, and application
usage
Offline retrospective
Weenk et al. 2017 Evaluate association between changes in HRV mea-
sures and stress in surgeons
20 subjects Adhesive patch measured single-lead ECG, respira-
tory rate, skin temperature, body posture, activity,
and steps
Offline retrospective
Wichniak et al. 2011 Measure association between activity levels and
mental status (measured via PANSS and CDSS
questionnaires)
73 subjects with schizophrenia
and 36 controls
Wrist-worn devices recorded accelerometry Offline retrospective
Winkler et al. 2005 Assess if light therapy can improve sleep efficiency
and stability in people with seasonal affective dis-
order (SAD)
17 subjects with SAD and 17
controls
Wrist actigraphy was recorded from which sleep-
wake amplitude, phase, and sleep efficiency was es-
timated
Offline retrospective
Woods et al. 2014 Distinguish PD from essential tremor using ac-
celerometry
14 subjects with PD and 18
subjects with essential tremor
Smartphones recorded accelerometry of hand
tremor during motor tasks
Offline retrospective
Vallance et al. 2011 Assess relationship between depression (assessed
via PHQ-9 questionnaires) and activity
2,862 subjects Wrist-worn devices recorded accelerometry Offline retrospective
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Table A5: Platforms, pilots, and ongoing studies.
Reference or study Sample size Methods
Faurholt-Jepsen, M. et al.
2017
400 subjects with BD Patients will be randomized to either 1) a smartphone-based monitoring system including a feedback loop between patients and clinicians,
and cognitive behavioral therapy, or 2) standard treaatment. The outcomes are number and duration of re-admissions, 2) severity of
depressive and manic symptoms, and 3) perceived stress, quality of life, symptomatology, etc.
AURORA 5,000 subjects with
trauma
Verily, University of North Carolina, and Harvard University are leading a 19-institution five-year endeavor to perform the most compre-
hensive observational study of trauma to date. Investigators will examine passive data collection methods using smartphone apps, as well
as in-person visits, genomic measurements, neurocognitive tests, patient surveys, and medical record reviews. This collaboration presents
a unique opportunity to discover new insights that could translate into fundamental advances in our understanding of post-traumatic
conditions. See https://www.nimh.nih.gov/news/science-news/2016/nimh-funded-study-to-track-the-effects-of-trauma.shtml.
Healthy Aging Study 100,000 subjects The overarching goal is to develop a midlife biomarker of Alzheimer’s disease, since it is now well established that the disease begins
about 2 decades prior to the onset of clinical symptoms. It is critical to develop new ways to detect the disease in the silent asymptomatic
phase in order to develop preventative treatments. To accomplish this goal, the Emory Healthy Aging Study first aims to recruit
100,000 individuals to participate in an online study to assess risk factors identified in health questionnaires and by apps to measure
cognition. The second aim is to deeply phenotype a subpopulation of about 3000 or more of these subjects every few years to assess
a variety of risk factors by profiling genetics, cardiovascular physiology, blood and spinal fluid biomarkers, brain and retinal imaging.
Multi-level longitudinal analyses of subjects profiles, including their amyloid status, will facilitate discovery of new biomarkers. See
https://healthyaging.emory.edu/about-the-study/.
Batista, E. et al. 2015 16 subjects Study of AD and MCI. The System for the Private and Autonomous Surveillance based on Information and Communication Technologies
(SIMPATIC) project is a smartphone app-based system for monitoring people with MCI. The smartphone app raises alarms under certain
conditions, such as an AD patient leaving a defined geographic zone (e.g. home), not moving after a certain amount of time, moving at
too high a speed (suggesting they are utilizing transportation), or the phone battery level reaching too low a level.
Faurholt-Jepsen, M. et al.
2013.
78 subjects Six month study of BD. The “MONARCA” smartphone app administered subjective questionnaires assessing mood, sleep, medicine intake,
etc., and monitored speech duration, social activity, and accelerometry.
RADAR-CNS: Remote As-
sessment of Disease and
Relapse - Central Nervous
System
Unknown A collaborative research program exploring the potential of wearable devices to help prevent and treat depression, multiple sclerosis
and epilepsy. Jointly led by King’s College London and Janssen Pharmaceutica NV, funded by the Innovative Medicines Initiative, and
includes 23 organizations from across Europe and the US.
UCLA Depression Grand
Challenge
Study aims to enroll
100,000 people
10-year study with aim of identifying will screen for depression, analyze participants’ genetics, measure early adversity and life stress and




the app; 9,520 people con-
sented to share data
This study will monitor individual’s health and symptoms of PD progression like dexterity, balance and gait using questionnaires and
sensors via the Parkinson mPower mobile phone application and wearable devices if available.
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A.3. Supplemental figures






























Figure A1: Mutual information ratio; numerator is mutual information between surrogate
HR and activity time series generated via random shuffling, and denominator is mutual
information between original HR and activity time series. Data is shown via notched box
plots; the horizontal red line denotes the median, the notches denote 95th percent confidence
intervals of the median, the lower and upper blue box denotes the 25th and 75th percentiles,
and the lower and upper whiskers denote the minimum and maximum values, respectively.
The horizontal red dashed line indicates unity, i.e. a ratio of 1. A ratio below unity indicates
significant mutual information, whereas a ratio equal to or greater than unity indicates the
same mutual information is generated from random data. A) Patients in the schizophrenia
study have high ratios for all time scales τ , demonstrating significant mutual information
compared to random chance, and suggesting coupling between HR and activity. B) Controls
in the schizophrenia study have ratios about an order of magnitude lower than controls,
although still > 1, suggesting much less coupling between HR and activity in healthy people.
C) Patients in the AFib study have low ratios < 1, suggesting observed mutual information
is due to random chance. D) Controls in the AFib study also have low ratios.
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Figure A2: Ratio metric of transfer entropy from HR to activity; numerator is transfer
entropy from surrogate HR to activity time series generated via random shuffling, and de-
nominator is transfer entropy from original HR to activity time series. Data is shown via
notched box plots; the horizontal red line denotes the median, the notches denote 95th per-
cent confidence intervals of the median, the lower and upper blue box denotes the 25th and
75th percentiles, and the lower and upper whiskers denote the minimum and maximum val-
ues, respectively. The horizontal red dashed line indicates unity, i.e. a ratio of 1. A ratio
below unity indicates significant directed transfer of information, whereas a ratio equal to
or greater than unity indicates the same level of directed information transfer is generated
from random data. A) Patients in the schizophrenia study have median transfer entropy
ratios below 1 for several time scales, demonstrating significant mutual information com-
pared to random chance, suggesting directed transfer of information from HR to activity.
B) Controls in the schizophrenia study have similar transfer entropy ratios. 95% confidence
intervals cross 1 for τ = 3 and τ = 4 suggesting less directed information transfer from HR
to activity in healthy people at certain time scales. C) Patients in the AFib study have
high median transfer entropy ratios, greater than 1 for all time scales, suggesting observed
directed information transfer is due to random chance. D) Controls in the AFib study also
have median transfer entropy ratios greater than unity.
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